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Abstract
This work investigates the effects of dietary polyphenols on intestinal glucose 
transport and gastrointestinal hormone secretion using an in vitro cell culture model, 
an in vivo rodent model and in vivo studies in healthy volunteers.
Glucose uptake was inhibited in Caco-2 cells under sodium-dependent 
conditions (favouring active transport) by the glycosides and the non-glycosylated 
dietary polyphenols whereas the aglycones and the phenolic acids had no significant 
effects. Under sodium-free conditions (favouring facilitated transport), the aglycones 
and the non-glycosylated dietary polyphenols showed the greatest effects, whereas 
the glycosides and the phenolic acids had no significant effects. This suggests that 
the aglycones inhibit facilitated glucose uptake whereas the glycosides inhibit the 
active transport of glucose. The non-glycosylated dietary polyphenols were effective 
under both sets of conditions and appear to exert their effects via steric hindrance.
Intragastric gavage studies in rodents using a standard oral dose of glucose 
(3.2 g/kg body weight) showed a reduction in blood glucose concentrations over the 
first 10 minutes of the time course when administered with quercetin-3-glucoside 
(P<0.05) and quercetin-4’ glucoside (P<0.10) (present at 1/50 molar concentration of 
glucose). These effects were transient since the inhibition was lost by 20 minutes. 
No effects were observed on plasma insulin, glucose-dependent insulinotropic- 
polypeptide (GIP) or glucagon-like peptide-1 (GLP-1) concentrations due to late 
blood sampling. These results suggest that quercetin glucosides interact with glucose 
transport proteins in the small intestine.
Studies in human volunteers showed that the absorption of 25 g of glucose, 
and the secretion of insulin, GIP and GLP-1 were significantly altered when 
administered with a polyphenol-rich food. Apple juice consumption significantly 
reduced plasma glucose, insulin, and GIP concentrations and increased plasma GLP- 
1 concentrations which is consistent with a delay in the upper intestinal uptake of 
glucose. Consumption of the glucose in an instant coffee drink showed a reduction 
in plasma GIP and an increase in plasma GLP-1 concentrations, observations again 
consistent with a delay in glucose absorption. Iso-genic onions with high and low 
flavonoid contents caused a significant reduction in plasma glucose, insulin and GIP 
concentrations when compared with the control which is attributable to the high
dietary fibre content. However, a larger reduction was observed after consumption 
of the high-flavonoid onions compared with the low-flavonoid onions suggesting a 
role for the quercetin glucosides. No effects on plasma GLP-1 concentrations were 
observed.
Taken together, these data indicate that dietary polyphenols exert the ability 
to inhibit intestinal glucose uptake in vitro and in vivo and suggests a possible role 
for these compounds as antihyperglycaemic agents.
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Chapter 1
Chapter 1 
INTRODUCTION
1.1 General Introduction
Polyphenols are a large and complex group o f chemicals that constitute one o f  
the most widely distributed groups o f  substances in the plant kingdom and thus form an 
integral part o f  both human and animal diets (Bravo 1998; Scalbert & Williamson 2000; 
Lindsay 2000). In recent years, there has been an increased interest in these compounds 
from both consumers and food manufacturers alike for many reasons, one o f  which 
includes an association between the consumption o f  polyphenol-rich food or beverages 
and disease-prevention. A  broad range o f  epidemiological studies increasingly suggest 
that increased fmit, vegetable, tea and wine consumption may help prevent the onset o f  
several types o f cancer, stroke and cardiovascular disease (Block et al, 1992; Keli et al, 
1996; Geleijnse et al, 2002). This is attributed in part to the fundamental chemical 
nature o f  these compounds to act as antioxidants, in addition to the fact that they are the 
most abundant antioxidants in the human diet (Scalbert & Williamson 2000). This 
would then suggest that polyphenols o f higher plants, in association with other known 
dietary antioxidants such as Vitamins C and E, and carotenoids, found in foods o f  plant 
origin may contribute to the protective effects against oxidative stress associated with 
diets rich in foods o f plant origin and thus the prevention o f the onset o f disease.
More recently however, there is a growing interest in the biological properties o f  
phenolic compounds above and beyond their antioxidant effects and accumulating 
evidence suggests that certain dietary phenols, through a variety o f  mechanisms, may 
result in an altered pattern o f intestinal glucose uptake. Reduced glucose transport as a 
consequence o f  exposure to phenolic compounds was first shown in 1922 by Nakazawa 
using phloridzin (phloretin 2 ’0-p-D-glucoside) (Nakazawa 1922). However, it was not 
until 1967 that Alvarado (Alvarado 1967) demonstrated that this was due to the 
competitive inhibition o f  the intestinal brush border membrane sodium-dependent
glucose transporter 1 (SGLTl) (Crane 1960). Furthermore, several workers have shown 
various tea polyphenols to inhibit intestinal a-amylase and/or sucrase activity thereby 
reducing the lumenal concentration of free glucose (Hara & Honda 1990; Honda & Hara 
1992; Matsumoto et a l,  1993) and more recently, Koboyashi et al. have shown that the 
green tea polyphenols (-)-epigallocatechin gallate and (-)-epicatechin gallate also inhibit 
glucose transport, possibly by via an SGLTl inhibition (Kobayashi et a l, 2000).
In addition to this, a phenolic-acid mediated decrease in intestinal brush border 
membrane (BBM) D-glucose uptake (Welsch et a l,  1989) and a flavonoid-mediated 
inhibition of the facilitated diffusion glucose transporter 2 (GLUT2), an intestinal 
transporter for glucose, have been shown (Song et a l, 2002). Moreover, Andrade-Cetto 
et al. have shown that extracts prepared from the leaves of Cecropia obtusifolia, a plant 
traditionally used for the treatment of diabetes, lowered plasma glucose levels in 
streptozotocin-induced diabetic rats to a level comparable with that of the reference 
compound glibenclamide (Andrade-Cetto & Wiedenfeld 2001)
It has already been suggested that phloridzin and other selective inhibitors of 
SGLTl may be pharmacologically useful as antidiabetic agents because o f their ability 
to prevent glucose uptake into the small intestinal cells as well as to stimulate blood 
glucose excretion into urine directly at the kidney (Tsujihara et a l,  1996). However, in 
addition to effects on lumenal glucose absorption per se, interactions between 
polyphenolic compounds and SGLTl may also affect the nutrient-dependent secretion of 
the insulinotropic gastrointestinal (GI) hormones glucose-dependent insulintropic- 
polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). These two incretin hormones 
enhance meal-induced insulin secretion and thus any modification of their secretion may 
have consequential effects on insulin secretion and glucose tolerance.
This research formed part of a European commission shared cost project called 
POLYBIND which aimed to investigate the health implications of polyphenols. More 
specifically, this particular part of the project was designed to investigate the effects of
polyphenols on intestinal glucose transport and the subsequent effects on gastrointestinal 
(GI) hormone secretion.
The following review o f the literature will summarise the structural-functional 
properties, absorption and metabolism o f dietary polyphenols. It vdll also discuss the 
biochemistry o f intestinal glucose transporters and glucose absorption, and 
gastrointestinal hormone secretion. Finally it will discuss possible effects o f dietary 
polyphenols on glucose absorption and more specifically, any therapeutic applications 
this may have.
1.2 Polyphenols
1.2.1 Basic structure
Natural polyphenols can range from simple molecules, like phenolic acids, to 
highly polymerised compounds such as tannins. Phenol itself is the simplest member o f  
this class although it is not found naturally in plants. Simple phenols consist o f  a single 
aromatic ring bearing one or more hydroxyl groups; however they usually contain other 
substituents (Figure 1.1).
Figure 1.1: Structure o f phenol
Conversely, polyphenols are a huge and diverse group o f aromatic compounds 
that contain a minimum o f two aromatic rings each bearing at least one aromatic 
hydroxyl and possibly other substituents (Haslam 1998). They occur primarily in the 
conjugated form with one or more sugar residues linked to hydroxyl groups, although 
direct linkages o f the sugar unit to an aromatic carbon atom also exist. The associated 
sugars can be present as monosaccharides, disaccharides or even as oligosaccharides 
with glucose as the most usual sugar residue however, others include galactose, 
rhamnose and xylose (Rice-Evans et al, 1996) (Figure 1.2). Conjugation with other 
compounds such as carboxylic acids, amines and lipids, and other phenols, are also 
common (Bravo 1998).
Glucose
HO OH
Figure 1.2: Phloridzin, a dihydrochalcone class o f  flavonoid
1.2.2 Subclasses of polyphenols
1.2.2.1 Simple phenols
The term simple phenol, is used to describe phenolics with a single Cô ring (e.g. 
arbutin) which may also bear either a -C i (e.g. gallic acid, vanillic acid), -C 2  (e.g. 
phenylacetic acid) or -C 3 (phenylpropanoid derivatives) sidechain (Clifford 1999). The 
most important phenylpropanoids are the hydroxycinnamic acids, the major 
representative o f  which is caffeic acid. This occurs in foods mainly as esters with quinic 
acid called chlorogenic acids. One o f these, 5-caffeoylquinic acid (5-CQA) is illustrated 
below (Figure 1.3) Phenolic acids, a subclass o f simple phenols, come second only to 
flavonoids in terms o f contribution to dietary polyphenol intake and constitute 
approximately one third o f  the total dietary phenolics consumed (Scalbert & Williamson 
2000). However, for moderate to heavy coffee drinkers, the daily intake o f  phenolic 
acids greatly exceeds that o f  flavonoids (Clifford 1999).
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Figure 1.3: 5-caffeoylquinic acid
1.2.2.2 Flavonoids
A term first used by Geissman in 1962 (Geissman 1962), flavonoids have a basic 
C6-C 3-C 6 skeleton, the primary structure o f  which consists o f  two characteristic 
aromatic carbon moieties; benzopyran (A and C-rings) and benzene (B-ring) (Figure 
1.4) which ultimately form a phenylbenzo(/)-pyrone-related structure (Di Carlo et al, 
1999). Flavonoids, an important subclass o f polyphenols, occur as monomers, usually 
but not always as glycosides, and some (the flavanols) are found as the monomeric 
constituents o f the condensed tannins. Flavonoids are collectively suggested to be the 
most abundant type o f  polyphenol in the human diet (Scalbert & Williamson 2000).
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Figure 1.4: Basic structure and numbering system of flavonoids
Their biosynthesis involves a common intermediate from which several groups 
of compounds are synthesised, the most studied of which are the 4-oxo-flavonoids 
(Manach et al, 1996). Flavonoids can be further subdivided into many structurally 
different subgroups based on variations in the interlinkage between the benzopyran and 
benzene groups (Figure 1.5). These include the flavanols (e.g. catechin, epicatechin), 
flavonols (e.g. quercetin, myricetin, kaempherol), flavanones (e.g. naringenin, 
hesperetin), flavones (e.g. apigenin, luteolin), isoflavones (e.g. genistein) and 
anthocyanidins (e.g. cyanidin, malvidin) (Diplock et al, 1998). Further variation is 
introduced by the patterns of aromatic hydroxyls and the pattern of conjugation (i.e. 
sugar(s) and acids, especially gallic acid) (Clifford 2001). The hydroxyl groups (either 
free or methoxylated) are generally located at positions 5 and 7 of the A ring, whereas 
on the B ring, the substitutions are most frequently found on the para position, or the 
para and meta positions, sometimes with a third substitution at the remaining meta 
position (Manach et al, 1996).
Flavonoids represent the most common and widely distributed group o f plant 
phenolics and over 8000 different naturally occurring flavonoids have been described 
(Harborne & Williams 2000). The flavones and flavonols are the most common
subclasses and although they do occasionally occur as aglycones, it is the water-soluble 
glycosides that predominate (Bravo 1998).
Flavones Flavonols
FlavanolsFlavanones
OH 0
,0H HO.
Anthocyanidins
HO.
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Figure 1.5: Subclasses o f flavonoids. Classification is based on variations in the
heterocyclic C-ring (taken from Hollman & Katan 1999)
1.2.2. s  Tannins
The term “tannin” has often been used synonymously, albeit incorrectly, with 
“polyphenol” in the literature. Although tannins do exhibit the usual functional 
properties o f  phenolic compounds, they also possess specific characteristics that cannot 
be used to describe polyphenols in general. The term tannin was first described in 1690 
and was originally used to define the fimctional characteristic o f specific polyphenols to 
convert animal hide into leather by forming cross-links with collagen molecules (Haslam 
1989). Tannins were then defined as water-soluble compounds with a molecular mass o f  
between 500 and 3000 daltons. They consist o f  12-16 phenolic groups and contain 5 -7  
aromatic rings per 1000 units o f  relative molecular mass. They are also efficient 
precipitators o f protein and some alkaloids, for example caffeine (Haslam 2001). 
Phenolic compounds that do not fit within this size range have not been traditionally 
classified as tannins since those with a mass o f  below 500 daltons are generally unable 
to cross link collagen and those with a mass o f greater than 3000 are unable to penetrate 
collagen fibres (Zhu et ah, 1997) and thus would not efficiently convert hides to leather. 
However, there is no doubt that chemically similar larger mass molecules also exist in 
foods and beverages (Haslam 2001).
Tannins are subdivided by origin and structure and fall naturally into three main 
groups. The first group is the proanthocyanidins, otherwise known as the condensed 
tannins which occur as oligomers and polymers o f flavanols and may also bear gallates 
(Clifford 2001). The second group, known as the hydrolysable tannins contains 
polyesters o f gallic acid or hexahydroxydiphenic acids, and are almost invariably found 
as multiple esters with D-glucose (Haslam 1996). The third group o f  tannins, the 
derived tannins, are compounds formed during the traditional processing o f  plant 
material and are virtually or completely absent fi'om intact, healthy plant tissues 
(Clifford 2001). The structures o f  these are often unknown, thus precluding a more 
precise nomenclature. They also do not possess the ability to convert hide into leather 
and are thus sometimes referred to as derived polyphenols (Haslam 1989).
10
Humans tend not to consume foodstuffs containing hydrolysable tannins. 
Condensed tannins and derived polyphenols are consumed in a multitude o f  foods and 
beverages; natural and processed alike. Derived polyphenols may be a major form o f  
the phenols in foods and beverages since they are characteristic o f  black tea, matured red 
wine, and cocoa and chocolate.
1.2.3 Functional properties
The described physical and chemical properties o f polyphenols bestow three 
distinct characteristics to this class o f compounds which, in essence derive from the 
properties o f  the simple phenolic nucleus itself. These include the ability to: i) bind and 
form complexes with metal ions such as Fe (III), Al(III), Zn(II) and Cu(II); ii) exert 
antioxidant and radical scavenging activities and, iii) complex with other molecules 
including macromolecules such as proteins and polysaccharides (Haslam 1996). 
Furthermore, it is these properties which underlie, at least in part, some o f the 
physiological and pharmacological actions typical o f  these compounds. For example, 
their ability to act as reducing agents and quench free radicals derives a from 
combination o f  the first two characteristics; chelation o f  oxidized and potentially 
damaging ions and from the stability o f the resonance structure afforded by the electron 
delocalisation once free radical scavenging has taken place (Croft 1998).
It is worthwhile noting at this point, that much o f the original interest in dietary 
polyphenols as a class o f  chemicals was as a result o f this third defining characteristic 
and the term ‘antinutrient’ has been used to describe this group o f  substances due to the 
deleterious effects caused by the binding and precipitation o f  macromolecules and 
digestive enzymes which thereby reduced food digestibility (Bravo 1998). It has since 
been recognized however that low molecular weight phenols, the type most commonly 
consumed by humans are in fact unable to precipitate protein, consequently the 
potentially beneficial effects are now receiving recognition.
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1.2.4 Phenols in foods
Thus far there are over 8,000 phenols that have been characterised in the plant 
kingdom and most plants contain several. Hundreds o f  these naturally occurring phenols 
exist in many kinds o f  foods and beverages that are commonly consumed by humans. 
This is in addition to the large number o f transformation products, i.e. derived 
polyphenols, which exist in food as a result o f processing.
In most foods, phenols constitute just a minor component o f  the consumable dry 
weight. This is however not always the case since tea leaves contain greater than 35% 
o f their dry weight as polyphenols (Balentine 1992). The levels o f polyphenols vary 
markedly even between cultivars o f  the same species since levels are greatly influenced 
by factors such as germination, ripening, storage and manufacturing procedures. For 
example, it has been demonstrated that higher catechin levels within cultivars o f  wine 
were found in those grown under damp, cool conditions compared with those grown 
under dry, sunny conditions (Arts et al, 2000). Furthermore the formation o f  flavone 
and flavonol glycosides greatly depends on light; therefore the highest concentrations o f  
these compounds are found generally in leaves and outer parts o f  plants with only trace 
amounts in the subterranean parts o f plants (Herrmann 1988). In addition to this, a 
significant loss o f  flavonoid content in the pre-processing o f  onions (peeling, trimming, 
and chopping) has been shown to occur although no further loss occurred during 
cooking irrespective o f the method (Ewald et al, 1999)
Polyphenols are partially responsible for the sensory qualities o f plant foods. For 
example, they provide much o f  the flavour and non-green colour o f vegetables i.e. 
flavanones contribute to the flavour o f citrus and anthocyanins produce the blue and red 
colouration o f  berry fiiiits (Peterson & Dwyer 1998). They also contribute to the texture 
o f many firesh and processed plant foods and account for most o f the dissolved solids in 
beverages such as tea, coffee, and wine (Hertog et al, 1992b).
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1.2.5 Dietary intake of phenols
There is a large body o f  literature on the polyphenolic composition and content 
o f plant foods and beverages. However, compositional data, in terms o f  human 
consumption is often obtained from unprocessed materials, while most foods are 
consumed after some sort o f processing either by the producer or the consumer (Dekker 
et al, 1999). This, in combination with both the structural complexity of, and the 
difficulty in characterising the derived polyphenols produced means that there is a lack 
o f reliable quantitative data and many polyphenols remain unidentified especially in the 
cooked material actually consumed.
It is generally accepted that flavonoids are the most abundant polyphenols in the 
human diet (Scalbert & Williamson 2000) and much effort has focused on the 
determining the bioavailability and biological activity o f these compounds. Several 
studies using various populations have shown daily consumptions ranging from 23 mg/d 
(Hollman & Katan 1999) up to 210 mg/d (Woods et al, 2003). However, a recent study 
by Gosnay et a l  using data on the content o f  phenols in foods gathered from the 
literature (with particular emphasis on the NEODIET review (Lindsay 2000)) showed 
that in a population o f young British woman (N=103), the average intake o f  phenols was 
0.75 g/day and that those with higher intakes consumed more coffee, black tea, brassica 
vegetables and yellow onions (Gosnay et al, 2002). Furthermore, Woods et a l,  having 
performed a similar dietary analysis, in a population o f  male shift workers (N=50), again 
showed that the majority o f  phenols consumed by these individuals were from coffee 
and black tea (mean intake = 1.05 g/d) (Woods et al, 2003). Interestingly, the total 
amount o f flavonoids consumed in both o f  these groups was significantly lower than that 
o f the derived polyphenols from black tea and the cinnamates from coffee. Data from 
both o f these studies indicate that the latter two classes o f dietary phenols, at least in a 
British population, appear to be the dominant groups consumed and are perhaps 
deserving o f  the same levels o f attention currently afforded to the flavonoids.
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1.2.6 Intestinal absorption and metabolism
To determine the exact mechanism, by which polyphenols exert in vivo 
biological effects, it is o f great importance to understand the bioavailability o f these 
compounds. This is in turn dependent on the absorption, metabolism and excretion o f  
these compounds within the body after ingestion, and the effects that these compounds 
or their metabolites may have at any one o f  these stages.
1.2.6.1 Biomarkers o f absorption
Indirect evidence for the absorption o f  polyphenols through the gut barrier is 
suggested by the increase in the antioxidant capacity o f  the plasma observed after the 
consumption o f  polyphenol-rich beverages, for example apple and blackcurrant juice 
(Young et al, 1999). However, it should be noted these effects may be related to 
several other components o f the juice (e.g. ascorbic acid) and cannot therefore be 
attributed solely to increased plasma concentrations o f  polyphenol metabolites. More 
direct evidence for the bioavailability o f some phenolic compounds has been obtained 
by measuring their concentrations in plasma and urine after consumption and it is now  
evident that a whole range o f  polyphenolic compounds are metabolised and absorbed 
within the upper gastrointestinal tract.
1.2.6.2 Factors affectins intestinal absorption
Aglycones, free simple phenolic compounds, and phenolic acids can be directly 
absorbed through the small intestinal mucosa (Jung & Fahey 1983; Wolffram et al, 
1995; King et al, 1996; Manach et al, 1997). Over the last decade, there has been 
much controversy as to whether or not flavonoids could be absorbed from the intestinal 
tract. It was hypothesised in a number o f early publications that flavonoids would not 
enter the circulation either as the glycosides or as the aglycone cleavage product because 
o f cleavage at the central heterocyclic ring by intestinal bacteria which would reduce the
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capacity for absorption and in addition, destroy the antioxidant properties o f the 
compound (Williams 1964; Griffiths 1982; Hackett 1986). Furthermore, it was also 
suggested that glucosides must be hydrolysed to their corresponding aglycones in order 
to be absorbed and because mammals were thought to lack the appropriate p-glycosidase 
enzymes, no intestinal absorption o f  these compounds would thus occur (Williams 1964; 
Griffiths 1982; Hackett 1986). It has since however been reported that the partial 
absorption o f several types o f  polyphenols in the small intestine does in fact take place.
1.2.6.3 Absorption and bioavailabilitv in humans
One o f  the major problems in studying the absorption o f  flavonoids, indeed many 
dietary components, in humans is the degradation by microorganisms in the colon. 
Measurement o f faecal excretion in normal human subjects would thus lead to an 
overestimate o f  the amount absorbed due to colonic microflora metabolism. To 
circumvent this problem, Hollman et al. indirectly calculated the absorption o f quercetin 
aglycone and quercetin glucosides using ileostomy patients as subjects (Hollman et al,
1995). Ileostomy patients have had their large intestine completely removed and the 
terminal ileum brought out onto the anterior abdominal wall as a fistula. Using this 
model, the measurement o f  flavonoids and their metabolites in urine and gastrointestinal 
fluid can be used as an indicator o f  small intestinal absorption. It was concluded fi’om 
this study that dietary quercetin is absorbed in appreciable amounts and that its 
absorption is enhanced by conjugation with glucose. In addition, subsequent studies 
observing the time course o f plasma quercetin concentrations in healthy volunteers, 
suggested that intestinal glucose transporters may be involved and that the positions o f  
the glycosidic bond, and the type o f sugar conjugate may be determining factors in the 
rate and extent o f  absorption (Hollman et al, 1996; Hollman et al, 1999; Graefe et al, 
2001). Further to this, a higher bioavailability o f  quercetin derived from quercetin- 
glucosides, irrespective o f the conjugation position, compared with the free aglycone or 
the quercetin-rhamnoglucoside rutin, has been observed and can be enhanced depending 
on the food source (Hollman et al, 1997; Olthof et al, 2000; Graefe et al, 2001).
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Not only has the absorption o f quercetin glucosides been confirmed in humans, 
the absorption o f  several other dietary polyphenols has also been studied in some detail. 
Olthof et a l have established that both caffeic acid and chlorogenic acid are absorbed in 
the small intestine o f humans when administered as a purified supplement (Olthof et al, 
2001). Meanwhile, DuPont et a l have shown that naturally occurring dietary 
polyphenols in cider are also absorbed, metabolised and excreted by humans after 
consumption o f  a cider beverage (Dupont et al, 2002). Furthermore, Rechner et al have 
also provided evidence for the absorption and metabolism o f  dietary polyphenols from a 
broad range o f  food sources (Rechner et al, 2002). The results o f  these studies provide 
irreflitable evidence that hydroxycinnamates and flavonoids are in fact absorbed, often 
in considerable amounts depending on the type and the source, however much work 
remains to be done to elucidate the specific mechanisms by which this occurs.
1.2.6.4 Putative mechanisms o f absorption
Results from human intervention studies investigating the bioavailability o f  
quercetin and its glucosides suggest some involvement o f  the intestinal glucose 
transporter SGLTl. This has been studied using both in vitro cell and tissue culture 
models, as well as in vivo feeding studies in rodents in order to elucidate the mechanism 
o f intestinal absorption.
1.2.6.4.1 Involvement of the intestinal transporter SGLTl
1.2.6.4.1.1 Cell models
The Caco-2 cell line is a human colon adenocarcinoma cell line which is 
susceptible to spontaneous enterocytic differentiation and is a well accepted model o f  
human intestinal absorption (Pinto et al, 1983; Zweibaum et al, 1991). Initial 
experiments using this cell line found no evidence for the active transport o f  quercetin 
glucosides but instead suggested that the facile absorption o f the quercetin aglycone was
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predominant (Walgren et al, 1998). It was later demonstrated by the same group that a 
specific efflux transporter, the multidrug resistance-associated protein-2 (MRP-2) plays 
an important role in the apparent lack o f  absorption o f these compounds (Walgren et al, 
2000a). MRP-2 has been shown to be responsible for the prompt transcellular efflux o f  
these components across the monolayer and thus provides an explanation as to the 
absence o f  these compounds intracellularly after uptake studies using this Caco-2 cell 
model. Further experiments using an MRP-2 inhibitor showed that quercetin-4’- 
glucoside (Q4G) was in fact transported into Caco-2 cells by SGLTl and these findings 
were subsequently confirmed using Chinese hamster ovary cells transfected with SGLTl 
as an expression vector for this protein (Walgren et al, 2000b). In addition, several 
examples o f glycoside transfer mediated by SGLTl expressed in Xenopus oocytes have 
also been described including the transport o f  cycasin (a p-D-glucoside o f  
methylazoxymethanol) (Hirayama et al, 1994) and several different phenyl glucosides 
(Lostaoe/ût/., 1994).
1.2.6.4.1.2 In vitro animal experiments
Experiments using a rat intestinal tissue culture model suggest that the quercetin 
glucosides are capable o f  interacting with SGLTl since results showed that quercetin 
glucosides stimulated the cumulative efflux o f radiolabelled galactose fi'om pre-loaded 
everted sacs, and that the rate followed saturable kinetics (Gee et al, 1998). Additional 
experiments by the same group corroborate results obtained firom bioavailability studies 
in humans suggesting the importance o f the glucose residue and the position o f  the 
glycosidic bond as determining factors in the rate and extent o f  absorption. Quercetin-3- 
glucoside, and to a lesser extent quercetin-4’-glucoside, but not quercetin 3,4’- 
diglucoside were transported into everted rat gut sacs significantly more quickly than the 
aglycone (Gee et al, 2000). Further work using similar in vitro protocols with the non- 
metabolisable glucose analogue methyl-alpha-D-glucopyranoside and quercetin-3- 
glucoside (Ader et al, 2001) also support these findings as do those using Ussing-type 
chambers (Wolffram et al, 2002). In addition to the flavonoid glucosides, the active
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transport of cinnamic acid and ferulic acid (3-methoxy-4-hydroxycinnamic acid) has 
been demonstrated across the brush border membrane of rat jejunum by a sodium- 
dependent, carrier mediated-process (Wolffram et al, 1995). Moreover, Mizuma & 
Awazu have shown that the transport of glycosylated p-nitrophenol conjugates to the 
serosal side of rat intestinal segments was reduced in the presence of phloridzin and in 
the absence of sodium; both of which indicate an active transport process (Mizuma & 
Awazu 1998).
L2.6A.2 Involvement of p-glucosidases
Glycosyl hydrolases (glycosidases) are a diverse group of evolutionarily 
conserved enzymes which cleave the glycosidic bond between two or more 
carbohydrates or between a carbohydrate and a non-carbohydrate (aglycone) moiety 
(Mian 1998). Various p-glucosidases are known to be present in the small intestine, 
including lactase phloridzin hydrolase (LPH) (EC 3.2.1.23/62) (Dahlqvist & Borgstrom 
1961) which is found on the lumenal side of the brush border membrane (BBM), and 
broad-specificity cytosolic p-glucosidase (CBG) (EC 3.2.1.21) which is present 
intracellularly (Daniels et al, 1981). LPH displays two enzyme activities which are 
located on two different sites and is known to hydrolyse phloridzin at one of the catalytic 
sites and lactose at the other (Leese & Semenza 1973). Early work using cell-free 
extracts obtained from human liver and small intestine indicated that p-glucosidase 
activity towards some flavonoid glucosides was present in these tissues (Day et al,
1998). Later work by the same group using LPH isolated from sheep small intestine 
showed that LPH could hydrolyse a range of flavonoid and isoflavone glucosides, albeit 
at the lactase domain (Day et al, 2000). Since then, work done using both cell-free 
human intestinal extracts (Nemeth et al, 2003) and rat everted jejunal sacs (Day et al, 
2003) has shown that deglycosylation is therefore a critical a first step in the absorption 
and metabolism of some dietary flavonoid glycosides within the intestinal lumen. 
Furthermore, the site of deglycosylation and subsequent transport into enterocytes is 
dependent on the nature of the aglycone moiety and the nature and position of the sugar
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attached (Day et al, 2003). O f particular relevance to the in vitro study o f the 
absorption o f glycosides is that Caco-2 cells when fully differentiated, show  
dramatically reduced expression o f LPH compared with that found in intact intestine 
(Chantret et al, 1994). Therefore, observations made using a Caco-2 cell model should 
be corroborated with either in vitro intestinal segments experiments or in vivo studies 
since using this cell culture model, SGLTl will almost certainly appear to play an 
exaggerated role in the transcellular movement o f  certain glycosidic compounds.
1.2.7 Biological effects of phenols
Polyphenols, with a particular focus on the flavonoid subclass, have been shown 
to act as powerful antioxidants in vitro (Rice-Evans et al, 1996) and much attention has 
been paid to their ability to affect oxygen free radicals and lipid peroxidation, both o f  
which have been implicated in several pathological conditions including cancer, 
atherosclerosis and chronic inflammation (Halliwell 1994). As a result o f  this, there has 
been much interest in the possibility that they could also enhance the body’s defences 
against free radical-mediated damage and other pathological conditions (Frankel et al,
1993). Much epidemiological evidence suggests that a diet rich in flavonoids has a 
protective effect against coronary heart disease and stroke (Keli et al, 1996; Knekt et 
al, 1996) possibly via inhibition o f  low density lipoprotein oxidation (Cook & Samman
1996) and/or platelet aggregation (Pace-Asciak et al, 1995). However, direct evidence 
for these mechanisms has proved elusive and there is a clear disparity between the 
reported potency o f flavonoids in vitro and their efficacy in vivo as measured using 
human intervention and epidemiological studies. For example, a recent prospective 
study in the USA looking at the dietary habits o f  38,445 women over seven years 
showed that flavonoid intake was not strongly associated with a reduced risk o f  
cardiovascular disease (CVD) and that the nonsignificant inverse associations for 
broccoli, apples and tea with CVD were not flavonoid-mediated (Sesso et al, 2003). In 
addition to this, many foods that contain high levels o f flavonoids also contribute 
substantially to the daily intake o f many other beneficial macro- and micronutrients (e.g.
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dietary fibre, vitamin E, vitamin C) and thus the results o f  these studies cannot be 
extrapolated to the potential benefit o f  any one dietary component
To elaborate somewhat on the possible limitations o f this antioxidant theory, one 
must first define an antioxidant, and then determine whether or not dietary polyphenols 
can behave as such in vivo. To be classified as antioxidant a compound must first satisfy 
two basic conditions. Firstly, when present in low concentrations relative to the 
substrate to be oxidised, it must delay, retard, or prevent the autoxidation or free-radical 
mediated oxidation o f  said substrate. Secondly, the resulting radical formed after 
scavenging must be stable— through intramolecular hydrogen bonding on further 
oxidation (Halliwell 1994). One possible explanation to account for the lack o f  
observed antioxidant effects in vivo is based on the relative electrode potentials o f the 
polyphenol metabolites in question.
While quercetin aglycone has a relative electrode potential o f 330 millivolts 
(mV), conjugation in the C-ring or B-ring (as occurs in humans) raises this value to 
approximately 600 mV. This is lower than the relative electrode potential for both the 
hydroxyl radical and superoxide radical anion (2310 mV and 1800 mV respectively) 
(Buettner 1993) but higher for those o f the well characterised vitamin antioxidants like 
a-tocopherol (500 mV) and ascorbic acid (282 mV) (Buettner 1993). Therefore, while 
said metabolites may still scavenge hydroxyl radicals and superoxide radical anions, the 
resulting flavonoid radicals must also be removed. Removal could involve reactions 
with glutathione, a-tocopherol, or ascorbic acid —  the same scavengers that would 
operate in the absence o f the flavonoid metabolites. Furthermore, the plasma 
concentrations o f  these phenolic metabolites have in many studies been shown to reach 
only high nanomolar, low micromolar concentrations (Olthof et al, 2000; Dupont et al, 
2002; Schramm et al, 2003) which relative to replete plasma concentrations o f  a- 
tocopherol (8.6-10.8 pg/ml) (McLaren et al, 1991) and ascorbic acid (2mg/ml) (Halsted 
1991) are largely insignificant and therefore likely to be incapable o f exerting a 
noticeable antioxidant effect.
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Despite, the lack of evidence for the antioxidant effects of polyphenols in vivo, 
other beneficial effects of dietary polyphenols in vivo have been well documented. For 
example Cassidy et al (1994) have shown that isoflavones, which are phytoestrogenic in 
nature possess a potent conferred biological activity (after gut flora transformation) that 
may reduce the risk of hormone-dependent diseases such as breast cancer (Cassidy et al,
1994). These effects are presumed to be due to non-steroidal oestrogens of the 
isoflavone class, which behave as partial oestrogen agonists/antagonists and may explain 
why populations that have a particularly high intake of soy (Japan and China) also have 
a low incidence of breast cancer. Furthermore, the evidence that suggests that many of 
the various subclasses of dietary polyphenols are capable of interacting with intestinal 
transporters (SGLTl for example) strongly implies that this is potentially a very 
important site at which dietary polyphenols can exert some biological effects since the 
concentrations found in the intestinal lumen are much higher than those achieved in the 
circulation.
2 1
1.3 Transepithelial transport of nutrients
The small intestine is subjected to a wide range o f  humoral and lumenal stimuli 
and can therefore modify its physiology accordingly. Perhaps the most important 
influences are provided by the rapid fluctuations in lumenal nutrient levels during and 
post-feeding with particular attention to macronutrients such as glucose, that need to be 
assimilated rapidly in the jejunum in order to avoid osmotic effects in the lower regions 
o f the intestine (Williams & Sharp 2001). For animals, including man, where dietary 
intake can vary tremendously in quantity and quality on a day-to-day basis, extreme 
fluctuations in the nutrient content o f  the diet must be accommodated in order to 
maintain adequate absorption (Philpott et al, 1992). Indeed, one o f  the major functions 
o f the small intestine is the efficient absorption o f  dietary nutrients and nature has 
developed a cohort o f  co-ordinated cellular mechanisms responsible for controlling the 
rate o f  transfer o f nutrients firom the lumen to the circulation (Williams & Sharp 2001). 
It is therefore o f paramount importance to understand the mechanisms underlying these 
adaptive changes when contemplating the alterations in intestinal function and nutrient 
absorptive capacity that can occur in response to a number o f  physiological and 
pathological conditions. These include alterations in type and quantity o f  diet, surgical 
resection o f  the intestine, disease states such as diabetes and starvation, and pregnancy 
and lactation (Philpott et al, 1992). Although it has been shown that there are specific 
carrier-mediated transport systems in the intestine which facilitate the absorption o f  
amino acids, oligopeptides, monosaccharides, mono- and dicarboxylic acids, phosphate, 
iron, bile acids, and several water soluble vitamins (Tsuji & Tamai 1996) o f  these, it is 
the absorption o f glucose that has been studied the most extensively.
The ubiquitous use o f  glucose as the common currency o f metabolism is 
undoubtedly linked to the extreme abundance in nature o f  glucose units in the form o f  
starch. Glucose functions as a precursor for the synthesis o f  glycoproteins, triglycerides 
and glycogen and provides an important energy source by generating ATP through 
glycolysis (Olson & Pessin 1996). To fully understand the alterations in uptake that may
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occur, the multiple pathways for nutrient absorption at the brush-border membrane must 
be considered.
1.3.1 Glucose transport
1.3.1.1 Glucose transporters
Specific kinds of carrier molecules exist throughout the hydrophobic plasma 
membrane to mediate the uptake of glucose from the intestinal lumen. Uptake occurs 
either by traversing the enterocyte (transcellular route) or by entering between cells 
(paracellular route) (Olson & Pessin 1996). The latter involves the tight junctions that 
exist between enterocytes which are dynamic structures that allow passive diffusion of 
glucose from the lumen to the serosa (Philpott et al, 1992) although under physiological 
conditions, the percentage of total glucose uptake by this route is relatively minor (4-7 % 
of total uptake) (Lane et al, 1999). The former involves glucose transport proteins 
which either actively transport glucose from the BBM or simply facilitate passive 
diffusion into the enterocytes. The plasma membrane, whose basic structure is a 
phospholipid bilayer is essentially impermeable to hydrophilic molecules such as 
glucose and thus these integral membrane proteins play a pivotal role in the transfer of 
glucose across the epithelial cell layer (Takata 1996).
1.3.1.1.1 Sodmm-Dependent Glucose Transporters (SGLT Family)
In the late 1950s, sodium-dependent glucose uptake was first detected in 
intestinal epithelial cells (Riklis & Quatsel 1958; Csaky & Thale 1960) but it was Crane 
in 1960 who formulated the hypothesis that the uptake may be energised by the Na"^  
gradient across the cell membrane (Crane 1960). It was eventually demonstrated, after 
methods were developed to measure transport in membrane vesicles with controlled 
solutes on both sides of the membrane that sodium gradients energise the uptake of D -
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glucose and that D-glucose gradients may in turn drive sodium uptake (Hopfer et ah, 
1973; Murer & Hopfer 1974; Kinne et ah, 1975).
The transporter suggested to be responsible, named SGLTl, is a member o f  the 
SGLT family which so far is known to have in excess o f 250 members found variously 
in bacteria, yeast, invertebrates and vertebrates (Wright et al, 2002). Using a 
combination o f experimental and computational methods it has been postulated that all 
family members share a common core o f  13 transmembrane (TM) helices, and that 
some, including SGLTl, have one or more additional TM helices at the N- or C-termini 
(Figure 1.6).
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Figure 1.6 The secondary-structure model o f human SGLTl which has 14 transmembrane 
helices. The N- and C-termini face the extracellular compartment, and the site o f  V-linked 
glycosylation is indicated by the carbohydrate tree. Also shown are the sugar 
binding/translocation domain (helices 10-13), and the A-terminal Na^ binding and 
translocation domain. The five mutations identified in the C5 domain o f SGLTl in 
Glucose-Galactose-Malabsorption patients (reproduced from Wright et al, 1998).
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Thus far, it has been commonly accepted that there is a single fimctional high- 
affinity cotransporter in the small intestine, SGLTl, and three isoforms o f the 
cotransporter in the proximal renal tubule, SGLT 1-3. SGLTl is a high-affinity, low- 
capacity transporter and conversely, SGLT2 is a low-affinity, high-capacity transporter. 
SGLT3 however has functional characteristics intermediate between the two with 
similar stoichiometry to SGLTl but with sugar affinity and specificity similar to SGLT2 
(Diez-Sampedro et al, 2001). Although SGLT3 is similar to SGLTl in its tissue 
distribution, its functional significance within the intestinal epithelium is unclear (Diez- 
Sampedro et al, 2001). For example, patients who suffer from glucose-galactose 
malabsorption (GGM), a rare autosomal recessive disease that presents in newborns and 
causes severe diarrhoea, is caused by missense mutations in the SGLTl isoform only, 
and thus the functional role o f SGLT3 remains unclear (Wright et al, 2002).
The SGLTl transporter translocates D-glucose against a concentration gradient 
into the enterocytes together with two sodium ions and is not influenced by anions 
(Koepsell & Spangenberg 1994). Functional studies on SGLTl expressed in different 
systems have shown that Na^-D-glucose cotransport exhibits Michaelis-Menten-type 
transport kinetics, that it accepts sugar molecules in the conformation o f  D-glucose 
and that the OH groups at C2 , C3 , C4 and Ce appear to be important for transport (Hopfer 
et al, 1973; Murer & Hopfer 1974; Kinne et al, 1975; Ikeda et al, 1989). The transport 
o f the sugar molecule is dependent on the chemical gradient o f N a \  which is maintained 
by the action o f  a Na'^ /K'^  ATPase with the hydrolysis o f ATP.
1.3.1.1.2 Facilitated Diffusion Glucose Transporters (GLUTFamily)
The facilitative glucose transporters are probably the most thoroughly studied o f  
the facilitated transport systems and in contrast to the highly restricted tissue specificity 
o f the SGLT transporters, all mammalian cells contain one or more members o f the 
facilitative glucose transporter gene family (Olson & Pessin 1996). These types o f  
transporters are often called passive carriers. A  passive transport carrier is an energy- 
independent system that can only transport its substrate down a concentration gradient.
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and is most effective when the cell is exposed to a fairly constant level o f the carrier 
substrate. The facilitative glucose transporters essentially form selective pathways 
between three major pools o f glucose; the blood, the extracellular fluids and the cellular 
cytoplasm (Mueckler 1994).
The mammalian GLUT genes belong to a large superfamily o f genes whose 
protein products are involved in the transport o f  a variety o f  hexoses and other carbon 
compounds. There are three general characteristics common to all o f  the GLUT 
proteins: i) the expression o f the genes is developmentally regulated, ii) the isoforms 
exhibit a tissue-specific distribution, and iii) they transport glucose using heterologous 
transport systems (Mueckler 1994). Hydropathic analysis o f their primary structure 
indicates that the GLUTs are transmembrane proteins that span the lipid bilayer 12 times 
with both amino- and carboxy-termini facing the cell cytoplasm (figure 1.7). There are 
several conserved amino acid motifs that have functional significance, however 
sequence similarity between pairs o f family members can be very weak (Bell et ah, 
1993).
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Figure 1.7: Predicted topology o f GLUTl. The 12 predicted transmembrane helices are 
numbered 1-12. The single V-linked oligosaccharide is designated by CHO (reproduced 
from Mueckler 1994)
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So far, the mammalian GLUT family comprises nine well-characterised 
members, G LU Tl-5 and, GLUT8-11 (Doege et al, 2000). GLUT6 is a pseudogene that 
is not expressed at the protein level (Kayano et al, 1990) and GLUT? has been 
identified as a component o f the glucose-6-phosphatase complex in liver but is not a 
functional transporter (Waddell et al, 1992). A  possible tenth member, GLUT 12, has 
recently been identified but, its functional role in glucose uptake is still under 
investigation (Rogers et al, 2002). The cDNA molecules encoding the five most 
recently identified GLUT transporters have much weaker homology to GLUT 1-5 and 
for the purposes o f  glucose transport in this thesis will be discussed no further.
GLUTl is ubiquitously expressed and fulfills basal glucose transport needs in 
many cell types. GLUT2 is present in pancreatic B cells, hepatocytes and at the BLM o f  
enterocytes where is plays an important role in transporting glucose into the 
bloodstream. GLUTS is expressed in cells with a high glucose demand such as neurons. 
GLUT4 is expressed in skeletal and cardiac muscle, and adipose cells; tissues in which 
glucose uptake is stimulated by insulin. GLUT5 is a high affinity fructose transporter 
that is expressed in relatively high levels in the BBM and is thought to be the major 
route o f dietary fructose uptake. It exhibits the weakest inter-isoform homology o f  any 
o f  the first five members o f  the GLUT family, which is consistent with its identity as a 
fructose transporter rather than a glucose transporter (Mueckler 1994).
1.3.1.2 Recent debates in intestinal slucose uptake transport mechanisms
Until very recently, the accepted model o f  intestinal glucose transport stated that 
glucose entry across the BBM is mediated by SGLTl which is subsequently followed by 
GLUT2 mediated exit across the BLM into the bloodstream. However, a recent series o f  
publications have challenged this theory by suggesting that GLUT2 is in fact present at 
the BBM and is responsible for a large proportion o f glucose uptake from the lumen o f  
the small intestine (figure 1.8) (Kellett & Helliwell 2000; Helliwell et al, 2000a; 
Helliwell et al, 2000b). These authors have shown, using rat intestinal segments, that 
GLUT2 is rapidly recruited to the BBM under the control o f protein kinase C (PKC) pil
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and that as a result, sugar transport in vivo is some 3 to 4 times greater than that 
observed in vitro. Furthermore, they also suggest that since PKC is activated by 
endogenous hormones which are in turn activated by the transport o f  glucose via 
SGLTl, it thus follows that inactivation o f PKC mediated cascade will occur after the 
excision o f the tissue necessary to perform in vitro experiments. This would ultimately 
result in the loss o f  GLUT2 from the BBM which would then subsequently result in a 
large underestimation o f  sugar uptake in vitro. In contrast to this however, a recent 
study using both healthy and diabetic human subjects showed no evidence for the 
presence o f  GLUT2 at the BBM when analysis o f biopsied tissue was performed despite 
immediate fixation o f the tissue upon excision (Dyer et al, 2002). A  likely explanation 
for these latter observations is that the patients would have been fasted before biopsy 
and thus the proposed SGLTl-dependent PKC mediated recruitment o f  GLUT2 
suggested in rats, is o f  no physiological relevance under these fasted conditions.
A pivotal point in this debate over the mechanistics o f glucose uptake is based on 
the common agreement that SGLT-mediated glucose transport begins to saturate at BO­
SS mM in vivo, yet glucose uptake in the small intestine increases linearly up to 
concentrations as high as 250 mM (for a review see (Kellett 2001). Further to this, all 
studies providing clear evidence for the involvement o f  a passive component have been 
obtained from in vivo studies which implies that there is a significant difference between 
in vivo versus in vitro preparations and transport kinetics under the two circumstances 
must be carefully considered when extrapolating results from one system to another.
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Figure 1.8: Current model o f intestinal glucose transport including the suggested
possibility o f the presence o f GLUT 2 at the BBM
1.4 Postprandial glucose tolerance
Glucose is the only sugar to circulate in the blood in more than trivial amounts 
and it is, for all practical purposes, the only source o f energy for the brain which extracts 
glucose from the blood continuously at a fairly constant rate (Marks et al, 1991). After 
a meal, the level o f glucose in the blood rises to a maximum in about 30 minutes and 
then returns slowly to the fasting level (4-6 mM) after 90-180 minutes (Englyst & 
Kingman 1991). Glucose homeostasis is known to be achieved by a coordinated 
physiological response to the ingestion o f food, the two main effectors o f  which are i) 
limitations on the delivery o f glucose into the pool, i.e. the maximum rate o f glucose 
absorption, and ii) the rate o f disposal o f glucose into the tissues, which is itself mainly a 
consequence o f increased insulin action (Marks et al, 1991). In addition to the actions 
o f insulin, many other hormonal agents that are released by endocrine cells within the 
intestinal mucosa also have an important effect on glucose metabolism either by 
stimulating insulin secretion or by direct action on peripheral tissue.
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1.5 Insulin and ‘incretin’ gastrointestinal hormones
Although glucose is the major regulator o f insulin secretion, ‘incretin gut factors’ 
have been estimated to be responsible for as much as 50% o f the insulin secretion 
observed after an oral glucose load. The term “enteroinsular axis” was introduced by 
Unger and Eisentraut to encompass the gut factors responsible for enhanced insulin 
stimulation (Unger & Eisentraut 1969). Although many gut hormones have the ability 
to stimulate insulin release, in order to qualify for a physiological role as endocrine 
mediators they must not only stimulate release at concentrations that occur in vivo but 
they must also be released in response to the ingestion o f  nutrients, especially glucose 
(Morgan fl/., 1988)
1.5.1 Insulin
Insulin is a two-chain polypeptide hormone with a molecular weight o f  5808 
daltons which plays a central and essential role in the metabolism o f  carbohydrate and 
lipids. Its mechanism o f action as well as the conditions resulting from its pathology are 
well characterised. These include both insulin-dependent and non-insulin-dependent 
diabetes mellitus (IDDM and NIDDM respectively) and cardiovascular disease; the 
latter two o f  which are part o f the spectrum o f  so called “Western Diseases”. Insulin is 
synthesised by the endoplasmic reticulum o f  the B-cells in the pancreas and the 
predominant stimulus for its secretion is the direct action o f plasma glucose on 
pancreatic-B cells (Ashcroft 1980) although elevated plasma concentrations o f  amino 
acids, notably arginine and leucine, and fatty acids v^ll also stimulate its secretion. 
Other dietary sugars such as galactose and sucrose can also stimulate insulin secretion 
follo’wing hydrolysis to yield glucose with subsequent activation o f  the enteroinsular 
axis in addition to any hyperglycaemia they may themselves produce. The insulin- 
releasing effects o f glucose are due to the pancreas’ ability to transport and metabolise it 
(Ashcroft 1980). The B-cells o f the pancreas function optimally with a narrow range o f  
plasma glucose concentrations (~ 4 -7  mM) since the insulin response to concentrations
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below this is severely blunted and at concentrations above this, it is initially enhanced 
but then rapidly suppressed (Rasmussen et al, 1990). Insulin exerts many different 
effects on a broad range o f tissues, however, probably one o f  its most important roles is 
to maintain blood glucose concentrations within the correct physiological range. This is 
achieved by increasing the rate o f glucose assimilation into peripheral tissue (i.e. muscle 
and fat cells) by increasing the number o f  insulin-sensitive GLUT4 glucose transporters 
within the cell membrane.
1.5.2 Gastrointestinal hormones
The largest hormone-producing organ in the body, both in terms o f  number o f  
endocrine cells and number o f  hormones is the gut region (Rehfeld 1998). The very 
word ‘hormone’ was first used by Bayliss and Starling in 1902 to describe the action o f  
the gastrointestinal (GI) hormone secretin. However, the firm establishment o f  the gut’s 
endocrine status was not achieved until 1970 when the primary structure o f the three 
classical endocrine gut hormones, secretin, gastrin and cholecystokinin (CCK) was 
finally determined. According to classic biology, a gut hormone is a substance produced 
by one type o f  endocrine cell dispersed in a relatively well defined area o f  the proximal 
GI tract. From here it is then released to the blood by specific stimuli to reach its target 
organ that subsequently elicits an acute response (e.g. secretion or muscle contraction).
In the 1960s it was shown that GI hormones could be peptides o f  some 20-30  
amino acids residues and since 1970, a increasing number o f larger, regulatory gut 
peptides, i.e. hormones, peptide transmitters and gro^vth factors have been identified. 
The complexity o f  this field has been further increased by the fact that individual genes 
for gut regulatory peptides encode different peptides, which in a tissue- and cell-specific 
manner release a number o f  different bioactive peptides (Rehfeld 1998).
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1.5.2.1 Glucose-devendent însulinotrovic volwevtide (GIF)
1.5.2.1.1 Discovery and characterisation of GIF
The existence o f a hormone called ‘enterogastrone’ was postulated many years 
ago to account for the inhibition o f  gastric acid secretion and the delay in gastric 
emptying that occurs following a meal (Kosaka & Lim 1930). GIF is a highly conserved 
42-amino acid polypeptide hormone that was isolated from crude porcine 
cholecystokinin (CCK) preparations in 1970 by Brown and colleagues on the basis o f  its 
ability to inhibit gastric acid secretion (Brown et al, 1970). The major biological 
actions o f GIF were initially thought to be the inhibition o f  gastrin, pepsin and gastric 
acid secretion, however, it was subsequently discovered that GIF had the ability to 
potentiate insulin secretion and it was thus given the alternate name o f glucose- 
dependent insulinotropic polypeptide which retained the acronym ‘GIF’ (Dupre et al, 
1973)
1.5.2.1.2 Secretion o f GIF
GIF is produced in the neuroendocrine K-cells o f  the duodenum and proximal 
jejunum (Buchan et al, 1978) and although the highest concentration o f  GIF as 
measured by radioimmunoassay (RIA) is found in the upper jejunum (Morgan et al, 
1978), there are significant amounts in the duodenum and ileum also (Bloom 1974). 
The main form o f GIF found in the plasma is bioactive GIF (1-42) and unless othervvdse 
stated, the term GIF refers to this bioactive peptide (Fehmann et al, 1995). GIF release 
from the intestinal mucosa occurs almost immediately after eating a meal that contains 
absorbable carbohydrate. Carbohydrate stimulated secretion occurs only when hexoses 
are actively transported from the BBM into the enterocytes via the active transporter, 
SGLTl (Nauck et al, 1993). However, on a molar basis, long-chain fatty acids are even 
more potent stimulants o f GIF secretion but the degree to which fat stimulates GIF 
secretion is species-dependent (Fenman et al, 1981; Kwasowski et al, 1985). For 
example, in humans, who consume a diet relatively high in lipid content fat is a more
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potent stimulator o f  GIF release than carbohydrates; the opposite is true for rats and pigs 
whose diets usually contain less than 10% fat (Morgan et al, 1995). GIF is also very 
sensitive to acute and chronic changes in the diet, especially changes in dietary lipid 
content (Yip & Wolfe 2000).
1.5.2.1.2 Circulating GIF
The concentration o f GIF in the plasma remains elevated for as long as there is 
still food in the intestinal lumen (Marks et al, 1991) and in most healthy human beings, 
GIF levels do not fall to basal levels until many hours after eating (Morgan et al, 1988). 
Moreover, the postprandial levels o f circulating GIF is dependent on meal size and the 
contribution o f the enteroinsular axis is proportionately greater after a large meal 
(Hampton et al, 1986; Murphy et al, 1995). GIF stimulates insulin secretion by the 
pancreatic B-cells only when blood glucose is raised above fasting levels, therefore, GIF 
released from the gut when fat alone is ingested does not stimulate insulin secretion 
serving as a guard against hypoglycaemia and inappropriate insulin secretion (Morgan et 
al, 1988).
1.5.2.1.4 Actions o f GIF
The potential for GIF to act as an incretin hormone; an intestinal hormone that 
enhances meal-induced insulin secretion, was identified shortly after it was isolated. 
Human subjects were given an intravenous (I.V.) infusion o f  porcine GIF together with a 
simultaneous I.V. infusion o f glucose. A  greater insulin response and improved glucose 
tolerance was observed when GIF was infused compared vUth when glucose was infused 
alone (Dupre et al, 1973). These results were later confirmed in a similar set o f  
experiments using synthetic human GIF (Fuessl et al, 1988). It has also been shown in 
rats that vascular infusion o f saline containing GIF increased the maximal transport rate 
for carrier-mediated glucose uptake in jejunal basolateral membrane vesicles, suggesting 
a role for this peptide hormone in regulating GLUT2 activity with subsequent effects on 
intestinal glucose transport (Cheeseman & Tsang 1996). Furthermore, GIF also appears
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to have an effect fat deposition by increasing fatty acid incorporation into adipocytes in 
rats (Oben et al, 1991).
1.5.2.2 Glucason-like vevtide-1 (GLP-1)
1.5.2.2.1 Discovery and characterisation o f GLP-1
The presence o f glucagon or glucagon-like peptides in the gut was predicted on 
the ability o f  gut mucosal extracts to stimulate the production o f cyclic AMP in tissues 
in exactly the same way as pancreatic glucagon (cited in Marks et al, 1991). After the 
cloning o f the mammalian cDNAs and genes that encode both pancreatic and intestinal 
proglucagon, two glucagon-like peptides, designated GLP-1 and GLP-2, were found to 
be tandemly encoded C-terminal to glucagon in the proglucagon precursor (Drucker
1999). GLP-1 and GLP-2 are designated “glucagon-like” because with respect to amino 
acid sequence they are 50% homologous to glucagon and to each other (Bell et al, 
1983b). Glucagon is a 29-amino acid peptide which after posttranslational processing 
by limited proteolysis is produced and secreted by pancreatic islet A-cells. However, 
when the prohormone is processed in the gut, the glucagon sequence remains within a 
large peptide designated glicentin and the two glucagon like peptides are cleaved out and 
secreted separately (0rskov 1986). Together, all these molecular forms have been 
designated ‘intestinal proglucagon-derived peptides’ (Holst 1999) (Figure 1.9)
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Figure 1.9: Diagrammatic representation o f the structure o f preproglucagon,
proglucagon, and its posttranslational processing (reproduced from Holst 1994). GRPP 
represents glicentin-related pancreatic peptide. IP-1 indicates the intervening peptide 
between glucagon. MPGF represents the major proglucagon fragment
1.5.2.2.2 Secretion of GLP-1
Glucagon-like peptide 1 (GLP-1) (7-36) amide is a 30 amino acid peptide 
hormone that is expressed in both the A-cells o f the pancreas and in the endocrine L- 
cells o f the intestinal mucosa (Bell et al, 1983a; Mojsov 1986). Large amounts o f GLP- 
1 are secreted from L-cells in the lower gut in response to meal ingestion with lipids and 
carbohydrates being the most potent stimulators (0rskov et al, 1991; Elliott et al, 
1993). It has been suggested that the lumenal concentration o f lipids and carbohydrates 
might regulate L-cell secretion directly since L-cells are open-type endocrine cells with 
apical microvilli reaching the gut lumen. The paradox that GLP-1 secretion starts 
rapidly (within 5-10 minutes) after nutrient ingestion, long before the digesta has
37
reached the distal small intestine, has not been resolved conclusively and the details of 
the stimulatory mechanisms are still unknown (Holst 1999).
L5.2.2.2 Actions of GLP-1
The fact that GLP-1 stimulates insulin secretion means that like GIP, it is 
considered to be an ‘incretin’ hormone. Its insulinotropic effect is crucially dependent 
upon the extracellular glucose concentration, i.e. it potentiates glucose-induced secretion 
(Nauck et al, 1993; Wang et al, 1995). Fully processed GLP-1 was isolated from 
intestinal extracts partly on the basis of its insulinotropic activity and experiments 
conducted to compare the insulinotropic effects of GLP-1 and GIP, suggest that on a 
molar basis GLP-1 is a far more potent regulatory stimulator of insulin secretion (Siegel 
et al, 1992) than GIP although circulating levels in the plasma are much lower (Elahi et 
al, 1994) due to rapid inactivation by the enzyme dipeptidyl peptidase-IV (DPPIV) 
(Deacon et al, 1994). In addition to stimulating insulin secretion, GLP-1 also stimulates 
insulin biosynthesis (Fehmann et al, 1995) and some data indicate that it might be 
trophic to the B-cell (Egan et al, 1998). GLP-1 is also a powerful inhibitor of glucagon 
secretion, therefore, increased concentrations of GLP-1 have a dual action on the islets, 
stimulation of insulin secretion as well as inhibition of glucagon secretion (0 rskov et al,
1988). The incretin actions of GLP-1 are additive to those of GIP and together, the two 
hormones can fully explain the incretin effect in humans (Nauck et al, 1993).
Other major functions of GLP-1 include its ability to reduce appetite and food 
intake (Schick et al, 1992) and inhibit postprandial gastrointestinal motility and 
secretion (Layer et al, 1995). Although the incretin effect of GLP-1 is well established, 
it might be that under physiological circumstances other effects of GLP-1 are more 
prominent. GLP-1 appears to act as one of the hormones of the ‘ileal brake’ -  an 
endocrine mechanism elicited by the presence of yet unabsorbed nutrients in the lower 
small intestine, whereby upper gastrointestinal motility and secretion are inhibited 
(Schirra et al, 2000). For example, when GLP-1 is infused during ingestion o f a meal, it 
is the suppression of gastric emptying that predominates and insulin responses are
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decreased in a dose-related manner because o f the gradual deferred emptying and 
absorption o f nutrients which consequently corresponds to the decrease in nutrient- 
induced insulin secretion (Nauck 1997). Thus, because the GLP-1 responses are related 
to both the size and the emptying rate o f  meals, it seems that a main function o f  GLP-1 
might be to adjust upper intestinal processing and delivery o f  ingested foodstuffs 
according to the digestive and absorptive capacity o f the gut (Holst 1999).
1.6 Potential effects of polyphenols on glucose transport and gut 
hormone secretion
As stated, phloridzin (phloretin 2 ’-0-P-D-glucoside) is a powerful inhibitor o f  the 
Na^-dependent active transport o f D-glucose and its derivatives in the mammalian small 
intestine and has long been used in physiology experiments studying transport kinetics 
in the gut. The inhibition o f sugar transport in the presence o f  phloridzin is purely 
competitive and during in situ perfusion experiments using rat small intestine, the action 
o f phloridzin can be abolished and normal glucose transport kinetics re-established 
simply by perfusing the segment o f  gut with Krebs buffer to wash away the inhibitor and 
then re-perfusing with glucose solution.
A number o f  polyphenolic compounds have been shown to be absorbed from the 
lumen o f the small intestine into the bloodstream, but the effects o f  many o f  these on the 
absorption o f glucose has not been established. For example it is known that several 
dietary phenolic compounds cause an inhibition o f  Na^- dependent D-glucose uptake in 
rat intestinal BBM vesicles possibly via dissipation o f the Na^-gradient (Welsch et al,
1989) however, it still remains to be established exactly via which mechanisms the 
absorbed flavonoid glycosides affect glucose uptake.
It has already been suggested that phloridzin and other selective inhibitors o f  
SGLT-1 may be pharmacologically useful as antidiabetics in terms o f  their ability to 
prevent glucose uptake into the small intestinal cells as well as to stimulate blood
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glucose excretion into urine directly at the kidney (Tsujihara et al, 1996). Not only 
does this have major implications as to how nutrient absorption may be affected, but 
there also exists the possibility that interactions between polyphenolic compounds and 
SGLTl may affect the nutrient-dependent secretion o f insulinotropic gastrointestinal 
hormones GIP and GLP-1. These two incretin hormones enhance meal-induced insulin 
secretion and thus modification o f  their secretion may have consequences on insulin 
secretion and glucose tolerance. In addition, GIP is secreted only in response to the 
active absorption o f  glucose via SGLTl (Sykes et al, 1980) and thus its measurement 
will provide insight into the mechanisms by which these polyphenols exert their possible 
hypoglycaemic effects.
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1.7 Aims and objectives of the current research
The aims o f this project were to first establish the effects o f  polyphenol 
interactions with SGLTl and their subsequent affects on glucose uptake and 
gastrointestinal hormone secretion using in vitro methods. An in vitro model o f  
intestinal glucose transport, namely the well-characterised Caco-2 human intestinal cell 
line, provides a quick and convenient method for establishing alterations in patterns in 
glucose uptake in the presence o f dietary polyphenols and allows for a high-throughput 
screening to determine the bioactivity o f these compounds. Once the most active 
compounds had been identified their affects on acute glucose tolerance and insulin and 
GI hormone secretion were to be determined in vivo in animals. Finally, the acute 
effects o f these same polyphenols would be determined on glucose tolerance and GI 
hormone secretion, in humans using feeding studies. These latter types o f  studies would 
provide further information on the mechanism o f action o f bioactive polyphenols and 
their overall impact in the human diet on glucose homeostasis.
The objectives o f the following series o f experiments were therefore as follows:
1. To establish the effects o f polyphenol interactions with SGLTl and their subsequent 
effects on glucose uptake using in vitro methods.
2. To establish the effects o f  dietary polyphenols on acute glucose tolerance and insulin 
and GI hormone secretion in vivo in rodents.
3. To establish the acute effects o f specific polyphenol-rich foods on glucose tolerance 
and insulin and GI hormone secretion in human volunteers
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Chapter 2
MATERIALS AND METHODS
The following chapter will describe the materials and methods used to carry out 
the experimental work. Individual protocols for each set o f  experiments or study will be 
described in detail at the beginning o f each chapter.
2.1 Materials
2.1.1 Equipment
Becton, Dickson and Company, Oxford, UK
Plastic syringes; 1 ml, 5 ml, 10 ml, 20 ml, 50 ml 
Chromos Express, Macclesfield, UK 
Target® PVDF 0.2 pm filter 
Cliffmar Associates Ltd, Guildford 
Plastic columns (3 ml)
HiChrom Ltd, Berks.
Chromatography columns 
Life Technologies, UK 
Sterile tissue culture plastic-ware 
LIP Ltd, Shipley
Fluoride Oxalate Tubes (1 ml). Lithium Heparin tubes (5 ml, 10 ml), LP3 tubes, LP4 
tubes. Potassium EDTA tubes (1 ml)
Molecular Light Technology Research Ltd, Cardiff, UK
Immuno-chemiluminometric insulin assay
Perkin-Elmer, Germany
Lambda 5 UV-VIS spectrophotometer
Roche Products Ltd, Welwyn Garden City
Cobas Mira automated analyser. Cuvettes
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Roche Diagnostics, Lewes, E. Sussex
Glucotrend Monitor®, Accu Chek® Glucose test strips
Sigma Chemical Company Ltd, UK
Dialysis tubing
Simcare, Maidenhead
Cannulae (Y-Can 19 g)
Spectra Physics, Thermoseparation products Inc., USA
P4000 gradient pump, AS3000 autosampler, UV2000 lamp. Spectra Focus software 
Sterilin, Stone
Autoanalyser cups, falcon tubes
Terumo Europe N.V., Leuven, Belgium
Needles, 0.5 x 16 mm, 0.8 x 40 mm, 1.1 x 50 mm
Virtis, Gardener N.Y., USA
Freeze mobile 6  freeze drier
Wallac Wizard, Wallac International, Finland
Wallac 1470 wizard automatic gamma counter, Wallac 1410 liquid scintillation counter 
Whatman International, Maidstone, Kent 
Whatman No. 1 filter paper
2.1.2 Chemicals and reagents
All solvents and chemicals were o f AnalaR grade unless otherwise stated.
Aldrich Chemical Company Ltd, UK
Ellagic acid, j7 -Coumaric acid, Naringin 
Amersham Pharmacia Biotech, UK 
D-[6 -^H] Glucose (37 MBq/ml)
Antigen Pharmaceuticals Ltd., Roscrea, Ireland 
Lignocaine Hydrochloride Injection B.P. 2 % w/v 5 ml 
Bio-Rad Laboratories, Germany 
Protein assay dye reagent concentrate
44
BDH Laboratory Supplies, UK
Charcoal activated Norit PN.5, Citric acid, Cysteine hydrochloride. Hydrochloric acid. 
Magnesium chloride hexahydrate (MgCl2 '6 H2 0 ), Polyethylene glycol (PEG), Potassium 
dihyrogen orthophophate (KH2PO4), Sodium acetate trihydrate (C2H3O2 -Na.3 H2 0 )
Digen Ltd, Oxford, UK
Boehringer Mannheim Sucrose / D-Glucose / D-Pructose enzymatic bioanlaysis kit 
Extrasynthèse, Genay, France 
Quercetin-3 -glucoside 
Fisher Scientific, UK
Acetonitrile (ACN), Calcium chloride dihydrate (CaCl2 ’2 H2 0 ), Disodium hydrogen 
orthophophate (Na2HP0 4 ), Formic acid. Glacial acetic acid. Methanol, Potassium 
chloride (KCl), Potassium ferrocyanide trihydrate, Optiphase safe scintillant cocktail. 
Sodium chloride (NaCl), Sodium dihydrogen orthphosphate (NaH2P0 4 ), Sodium 
hydroxide. Zinc acetate dihydrate 
Dayman Ltd, UK 
Absolute ethanol 
ICN Biomedical, Oxon.
^^^I-sodium iodide (3.7 GBq/ml)
Life Technologies, UK
Dulbecco’s modified eagle’s minimal essential medium (DMEM), Penicillin 
streptomycin (1 %), Non-essential amino acids, L-glutamine, Trypsin EDTA,
NHS Supplies, UK 
0.9 % w /y  saline 
Oxoid Ltd, UK
Phosphate buffered saline (PBS)
Polyphenols AS, Norway 
Quercetin-4’-glucoside, Quercetin-3,4’-diglucoside
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Randox Laboratories, Co. Antrim, UK
Glucose GOD/PAP test kit
Sigma Chemical Company Ltd, UK
a-Amylase, Apigenin, Agarose type III-A, Aprotinin, Arbutin, Bovine serum albumin 
(BSA) Fraction V, CafFeic acid, (+)-Catechin, Chlorogenic acid, Chloramine T, (-)-  
Epicatechin, Ferulic acid, Gallic acid, D-(+)-Glucose anhydrous, GIP (synthetic human), 
GLP-1 fragment 7-36 amide (synthetic human). Heat inactivated Fetal Bovine Serum, 
Human serum albumin (HSA) Fraction V, D-Mannitol, Lactose, Myricetin, Phloretin, 
Phloridzin, Pronase, Quercetin, Rutin, Sephadex G-15 (for gel filtration). Sodium azide. 
Sodium carbonate (Na2 C0 3 ), Sodium hydrogen carbonate (NaHC0 3 ), Sodium 
metabisulphate, Trifluoroacetic acid (TFA)
Unilever, UK
(-)-Epicatechingallate (EGG), (-)-Epigallocatechingallate (EGCG)
Professor M.N. Clifford 
Neohesperidin dihydrochalcone
2.1.3 Sera and antisera
IDS Ltd, Bolton, Tyne & Wear
Donkey anti-rabbit Sac-cel
Dr. S. M. Hampton, University of Surrey, Guildford
Donkey anti-guinea pig (DAGP) antisera. Donkey anti-rabbit (DAR) antisera, Guinea
pig anti-insulin antisera. Normal guinea pig serum
Dr. L. M. Morgan, University of Surrey, Guildford
Rabbit anti-GIP antisera, RIG 34 iii J, Rabbit anti-GLP-1 antisera, G2-30/6/89
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2.1.4 Solvents and buffers
Affinity purification column bicarbonate buffer (pH 9.8)
1 0 . 6  g ofNaiCOs
8.5 g o f NaHCOs
These were dissolved in 1 litre o f water, adjusted to pH and stored at 4°C.
GIP and GLP-1 radioimmunoassay buffer (pH 6.5)
54.4 g o f KH2 PO4  A 
56.8 g o f  Na2HP0 4  B
These were dissolved in 1 litre o f  water each. Solution A  was added dropwise to 
solution B until the pH reached 6.5. This was stored at 4°C.
Hanks balanced salt solution (HBSS) buffer (pH 7.4)^
8.2 g o f NaCl 
373 mg o f KCl
138 mg o f NaH2P0 4  
147 mg o f CaCl2 '2 H2 0  
1 0 2  mg o f  MgCl2 '6 H2 0
These were dissolved into 1 litre o f water and stored at 4°C.
Insulin radioimmunoassay buffer (pH 7.4)
4.6 g o f Na2HP0 4
1 . 2  g ofN aH 2P0 4
These were dissolved in 1 litre o f  water and stored at 4®C.
Krebs bicarbonate buffer (KBB) (pH 7.4)
Solution 1 69.2 g/L o f NaCl
3.54 g/L o f KCl
 ^When a sodium free buffer was required, NaCl and NaH2P0 4  were replaced with equimolar amounts of 
KCl and KH2PO4 respectively.
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21.0 g/L o f NaHCOs 
Solution 2 2.54 g/L o f MgS0 4  7 H2 0
Solution 3 1.62 g/L o f KH2 PO4
Solution 4 5.57 g/L o f CaCl2 ‘6 H2 0
1 part each o f  solutions 1 to 4 was added to 6  parts water. This was gassed with 
9 5 %0 2 :5 % CO2 until the pH reached 1 2 -1 A and stored at 4°C.
Protein elution buffer (pH 5.0) for GIP and GLP-1 iodination
13.6 g o f  CH3CO2 -Na.3 H2 0
This was dissolved into 1 litre o f  water, titrated to pH 5.0 with 1 M glacial acetic acid 
and stored at 4°C.
Saline buffer
0.9gN aC L
This was dissolved into 1 litre o f  water and stored at 4°C.
Solvent A for HPLC analysis of phenolic compounds in apple juice
0.1% v/v TFA in milli-Q water
Solvent B for HPLC analysis of phenolic compounds in apple juice
35% solvent A  
65% ACN
Solvent A for HPLC analysis of chlorogenic acids in coffee
0.5% v/v TFA in milli-Q water
Solvent B for HPLC analysis of chlorogenic acids in coffee
55% solvent A  
45% ACN
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Solvent A for LC/MS analysis of flavonol glycosides in onions
0.1% v/v TFA in milli-Q water
Solvent B for LC/MS analysis of flavonol glycosides in onions
0.1% v/v TFA in methanol,
2.2 Methods
2.2.1 Cell culture
2.2.1.1 Growth conditions
Stock cultures o f  Caco-2 cells, (sub-clone TC7, obtained from Dr. Paul Sharp, 
University o f Surrey) were maintained in 25 cm^ plastic flasks at 37 °C in a 95 % air, 5 
% CO2  atmosphere in Dulbecco’s modified eagle’s minimal essential medium (DMEM) 
supplemented with 20 % heat inactivated Fetal Bovine Serum, 1 % penicillin 
streptomycin, 1 % non-essential amino acids and 1 % L-glutamine. Medium was 
changed after 72 hours and every 48 hours thereafter. For all experiments, stock cells 
were washed twice with warmed phosphate buffered saline (PBS), trypsinised for five 
minutes with trypsin EDTA, resuspended in DMEM and seeded at a density o f  1 x 
lOVcm^ onto collagen coated six-well plates. All cells were used for experiments after a 
minimum growth period o f 19 days.
2.2.1.2 Préparation o f test solutions
Glucose uptake assays using were performed using Hank’s balanced salt solution 
(HBSS) containing ImM glucose and 100 pM o f either the test compound or the 
equimolar control (mannitol).
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Both the test compounds and the mannitol were dissolved in absolute ethanol to give a 
resulting concentration o f 10 mM. This was then diluted 100-fold in HBSS containing 1 
mM glucose, and sonicated where necessary to ensure complete dissolution to give a 
final concentration o f  100 pM treatment and 1% ethanol. d-[6 -^H] glucose was used as 
the tracer and the final amount o f radioactivity in the control or test solutions was 125 
kBq per ml.
2.2.1.3 Radiolabelled slucose uptake studies
To determine the nature o f  glucose transport in the presence o f  phenolic 
inhibitors, Caco-2 cells were placed in serum free media at least 24 hours prior to uptake 
studies. Cells were then incubated for 15 minutes at room temperature in HBSS. 
Uptake was initiated by the addition o f  the control or test solutions and each plate 
consisted o f 2 control and 4 treatment wells. After two minutes the test solution was 
rapidly aspirated from the wells and the reaction was terminated by the addition o f  ice- 
cold PBS. Cells were washed twice more in ice-cold PBS and 1 ml o f  200 mM NaOH 
was added to each well. Cells were left to solubilise overnight at 4°C and scintillation 
counting was used to determine glucose uptake (0.5 ml o f the solubilised cell suspension 
to 4.5 ml o f scintillation cocktail). The intra-assay coefficient o f variation was 18%.
2.2.1.4 Protein assay
In order to express glucose transport as nmoles uptake per milligram o f  protein, 
the total amount o f protein in each well o f  the final solubilised cell suspension was 
determined. The Bio-Rad Protein Assay is a Coomassie blue dye-binding assay based 
on the differential colour change o f a dye in response to various concentrations o f  
protein.
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2.2.1.4.1 Preparation of standard curve
Human serum albumin (HSA) was used as the standard protein for comparison 
and was dissolved in milli-Q water to give a final concentration o f 1 mg m l'\ This was 
then diluted with 200 mM NaOH to give a range o f  values from 10 pg ml'  ^ to 1000 pg 
m l'\ BIO RAD Protein assay dye reagent was diluted 5-fold with milli-Q water and 4 
ml o f this was added to 100 pi o f each o f the standard solutions. This mixture was left 
to complex for five minutes at room temperature and the resulting absorbance read o f  
the samples was read in duplicate at 600 nm. Figure 2.1 shows an example o f  an HSA 
standard curve
0.»w
I■sOiff
2
1.8
1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
y = 0.0185x
R = 0.9976
100 12060 8020 400
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Figure 2.1: Standard calibration curve for HSA
2.2.1.4.2. Preparation of samples
10 pi o f  the solubilised cell suspension was added to 90 pi o f  200 mM NaOH. This was 
then added to 4 ml o f the diluted dye reagent and left to complex for five minutes at 
room temperature. The resulting absorbance was read at 600 nm and concentration o f
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protein was determined by comparison with the standard curve. Interassay coefficients 
o f  variation were 2.70% (bottom standard) and 5.69% (top standard)
2.2.2 Oral gavage studies
2.2.2.1 Animals and their housins conditions
Male Wistar albino rats (220-270 g) were obtained from the Rodent Breeding 
Unit, University o f  Surrey. 4 -6  animals were housed per cage with sawdust bedding 
and exposure to a standard 12 hour photoperiod (0700-1900 hours) at 22 ± 2°C and 50% 
humidity. Food in the form o f standard rodent chow (48 % carbohydrate, 21.5 % 
protein, 3.5 % fat and 2.7 % fibre) and water were provided ad libitum (BK Universal 
Ltd, Hull). Where necessary food was withdrawn 12 hours prior to experimental 
procedures.
2.2.2.2 Preparation and administration o f test solutions
Standard oral glucose tolerance tests (OGTT) were assessed by straight tipped 
gavage administration o f test substances intragastrically. 3.2 g o f  glucose per kg body 
weight was administered using 3 ml o f 0.9 % w/v saline as a vehicle. Each test solution 
contained either a test compound or the control (mannitol) at 1/50 the molar 
concentration o f glucose in the sample. Solutions were sonicated where necessary to 
ensure complete dissolution o f  the test compound or the control. Animals were removed 
from the cage immediately prior to dosing and held securely throughout the procedure 
which was performed rapidly to minimise distress to the animal. All procedures were in 
full compliance with the Home Office Animals (Scientific Procedures) Act, 1986. 
(Project license number PPL 50/7660)
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2.2.2.3 Collection o f blood samples
Blood samples for whole blood glucose analysis were taken regularly from the 
cut tail tip and measured immediately using a Glucotrend® monitor with Accu Chek® 
glucose test strips. At the termination o f experimental procedures, the animals were 
deeply anaesthetised by intraperitoneal administration o f pentobarbital (80 mg/kg) and a 
blood sample taken via cardiac puncture. Animals were then killed by cervical 
dislocation. The blood sample was decanted into a 5 ml lithium heparin tube containing 
200 KlU/ml aprotinin as preservative and placed on ice to reduce degradation before 
centrifugation at 4°C at 1750 g for ten minutes. Immediately after centrifiigation, the 
plasma was separated from the red cells using a plastic pasteur pipette, stored in LP3 
tubes and frozen at -20°C until subsequent analysis.
2.2.3 Analytical HPLC for quantification of food-borne phenolic compounds
2.2.3.1 Preparation ofreasents
Carrez Reagent A  was prepared by dissolving 21.9 g zinc acetate dihydrate and
3.0 g o f glacial acetic acid in 100 ml water. Carrez Reagent B was prepared by 
dissolving 10.6 g potassium ferrocyanide trihydrate in 100 ml water. These were stored 
at4°C.
2.2.3.2. Preparation o f standards
(+)-catechin, (-)-epicatechin, phloretin, phloridzin and 5-caffeoylquinic acid 
standards were prepared by dissolving 10 mg into 10 ml o f 70 % v/v aqueous methanol. 
Serial dilutions in 35 % v/v aqueous methanol were then made to give a range o f  
standards between Ipg/ml and 1 0 0  pg/ml.
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2.2.3.2 Prevaration ofsamvles
2.2.3.3.1 Apple juice
Commercial brands o f both clear and cloudy apple juice were randomly sampled 
and analysed for concentrations o f  various phenolic compounds. Containers were 
inverted several times to ensure adequate mixing o f  the juice and then 15 ml o f  each 
liquid was decanted into a plastic universal tube. 0.5 ml each o f Carrez A  and Carrez B 
reagent was added and mixed by inverting several times. The precipitate was allowed to 
settle and the samples were centrifuged at 1750 g at room temperature for twenty 
minutes. The supernatant was decanted into another universal tube and centrifuged at 
1750 g for a further twenty minutes. 1.5 ml aliquots o f the supernatant were then stored 
in eppendorf tubes and frozen at -20°C until analysis. All samples were analysed in 
duplicate.
2 2 3.3.2 Instant coffee
Commercial brands o f  both caffeinated and decaffeinated coffee were randomly 
sampled and analysed for chlorogenic acid content. 1 0 0  mg o f coffee granules were 
dissolved into 10 ml o f  milli-Q water and mixed vigorously by vortexing until the 
granules had dissolved. Aliquots were then prepared and stored in an identical marmer 
to the apple juice. Before analysis the coffee samples were diluted 4-fold with milli-Q  
water. All samples were analysed in duplicate.
2.2.3.4 Instrumentation
The gradient HPLC system used was a Spectra Physics P4000 gradient pump 
coupled to an AS3000 autosampler with detection by Spectra Physics UV2000. The 
column used was a Spherisorb® 5p ODS-2 reverse phase column (250 mm x 4.6 mm).
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Chromatographic and spectral data collection as well as integration were performed 
using Spectra Focus software.
2.2.3.5 Solvent systems
Different linear solvent systems were used for the analysis o f the apple juice and 
coffee samples respectively. All solvents were degassed with helium for 10-15 minutes 
before use.
2.2.3.5.1 Apple juice
Table 2.1: Solvent composition versus time
Time (min) A% B%
0 90 10
20 50 50
25 35 65
30 90 10
35 90 10
Flow Rate 1 ml/min 
Injection volume 100 p,l 
Detection 280, 320 and 360 nm.
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2.23.5.2 Instant coffee
Table 2.2: Solvent composition versus time
Time
(min)
A% B%
0 100 0
10 78 22
20 56 44
30 34 66
40 12 88
45 0 100
50 100 0
55 100 0
Flow rate 1 ml/min 
Injection Volume 100 pi 
Detection 280 and 315 nm.
2.2.4 Nutrient analysis and quantification of flavonol glycosides in onions
The quantification o f flavonol glycosides was kindly carried out using HPLC/MS by Dr. 
Sonia de Pascual -Teresa, Institute o f Food Research, Norwich.
2.2.4.1 Quantification o f flavonol slvcosides in onions
2.2.4.1.1 Preparation o f samples
The onions samples were frozen at -20°C for 16 hours and were subsequently 
freeze-dried at -60°C and 10'  ^ mbar. The freeze-dried tissue samples were resuspended
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in 1 ml milli-Q water, vortexed for 3 min and were subsequently filtered (0.2|im, 
Target® PVDF). The internal standard used was 25 |iM rutin. All samples were 
analysed in triplicate (3 x 10 mg onion for Q-3 4 ’-diglucoside and quercetin-4’- 
monoglucoside analyses).
2.2.4.1.2 Instrumentation
For the HPLC-MS analysis a Hewlet Packard 1050 system connected to a 
Micromass Quattro II mass spectrometer was used. lon-Pair ESI LC/MS using Selected 
Ion Monitoring (SIM) was calibrated by using 25 \iu  Rutin with 0-100 pM Quercetin- 
4 ’-monoglucoside and 25 pM Rutin with O-lOOpM Quercetin-3, 4 ’-diglucoside. The 
column was a Phenomenex Lima™ 5p C l8 (2) 25 x 4.60 cm with Security-guard™ pre­
column.
2.2.4.1.3 Solvent system
Table 2.3: Solvent composition versus time
Time (min) A% B%
0 83 17
2 75 25
7 65 35
15 50 50
20 0 100
25 0 100
30 83 17
45 83 17
Flow Rate 1 ml/min 
Injection volume 30 pi 
Detection 270 and 370 nm.
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2.2.4.L4. LC/MS
The solvent flow rate was split between the diode array and the MS at an 
approximate ratio o f 8:1. MS was done using a ESI source in the positive mode. The 
nebulising gas flow was 1 0 - 2 0  L/h and the drying gas flow 400 -  500 L/h. Desolvation 
temperature was 300°C and the source temperature was set at 120°C. The capillary 
voltage was 3.4 kV and the cone voltage 29 V. MS analyses were recorded in the SIM 
mode at 303 m/z for the quercetin aglycone, 465 for the monoglucoside, 627 for the 
diglucoside and 611 for rutin. Quantification o f  the free quercetin and its glucosides was 
carried out by integrating the SIM peaks with the integration software incorporated in 
the MassLynx suite o f programs.
2.2.4.2 Complete nutrient analysis o f onions
Complete nutrient analysis o f  the onions was kindly carried out by Ms. Pilar 
Martin-Lopez and Dr. Celestino Santos Buelga, Universidad de Salamanca, Spain
Moisture, ashes, calcium, crude protein and sugars were analysed according to the 
methods o f  analysis recommended by the Association o f Official Analytical Chemists ( 
1993). In brief, moisture was calculated from the loss o f  weight obtained after heating 
in air oven at 100 ±2°C to constant weight. Crude protein was analysed by the Kjeldahl 
method, using a factor for transformation o f  nitrogen to protein o f  6.25. For analysis o f  
sugars an extraction was first made with boiling water followed by clarification with 
neutral lead acetate solution. Reducing sugars were determined as glucose before and 
after inversion with HCl at 65°C by iodometric titration following ferricyanide reduction 
in alkaline medium using Fehling solutions. Ashes were obtained in a furnace at 525°C. 
Calcium was analysed by atomic absorption spectrophotometry after dry ashing o f  the 
sample and further solution in 3N HCl
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For lipids and crude fiber the Spanish official methods of analysis were used ( 1985). In 
brief, total lipids were determined gravimetrically after Soxhlet extraction following acid 
hydrolysis of the sample with 3N HCl. Crude fiber was calculated on ignition of the 
dried residue remaining after digestion with 1.25% H2 SO4  and 1.25% KOH (method of 
Weende).
2.2.5 Simulated digestion of freeze-dried onion samples
This method was adapted from Gee & Johnson (1985) and is described in brief
below.
2.2.5.1 Preparation of samples
The onions samples were frozen at -80°C for 2 hours and were subsequently 
freeze-dried at -60°C and 10’  ^ mbar overnight. The dried samples were ground to a fine 
powder using a pestle and mortar and 10 g of each onion type was homogenised in 
individual flasks containing Krebs bicarbonate buffer (KBB) (pH 7.4).
2.2.5.2 Simulated disestion procedure
The pH of the homogenate was adjusted to approximately 2.5 using 1 M HCl 
prior to incubation for 1 hour at 3TC  with frequent stirring to mimic the ‘gastric phase’. 
The pH was then readjusted to 7.2 using 2 M NaOH and both a non-specific protease 
(pronase) (610 units) and a-amylase (8126 units) were added to each flask of 
homogenate in order to ensure complete starch hydrolysis. Samples were kept at 37°C 
in a water bath and shaken at 60 cycles per minute. Duplicate samples for ethanol 
extraction and a single sample for determination of wet:dry weight ratio were taken at 
various intervals over 120 minutes.
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2.2.5.3 Dry weîsht determination
Samples taken for dry weight determination were weighed and then freeze dried 
overnight at -60°C and 10'  ^mbar.
2.2.5.4 Ethanol extraction
Hydrolysis o f  starch in weighed samples taken for ethanol extraction was 
arrested by the immediate addition o f  0.75 ml o f absolute ethanol. These were 
centrifuged at 11752 g for ten minutes, the supernatant removed, and the samples 
centrifuged again to ensure no particulate matter remained. Samples were diluted 1 in 
40 with KBB and determination o f free glucose was carried out using an enzymatic 
bioanalysis kit (section 2.2.6)
2.2.6 Mono/disaccharide analysis of apple juice and freeze-dried onion samples
D-glucose, D-fructose and sucrose concentrations o f commercial apple juice 
samples, and D-glucose concentration o f ethanol extracted onion homogenate (section 
2.2.5.4) was determined by a UV method using an enzymatic bioanalysis kit (Digen Ltd, 
Oxford, UK). The D-glucose concentration was measured before and after the 
enzymatic hydrolysis o f sucrose; D-fructose was measured subsequent to the 
determination o f D-glucose. The intra-assay coefficients o f variation were 1.53% 
(fructose) and 2.52% (glucose)
Determination ofD-slucose before inversion:
At pH 7.6, the enzyme hexokinase (HK) catalyses the phosphorylation o f  D- 
glucose by ATP with the simultaneous formation o f  D-glucose-6-phosphate (G-6-P) and 
ADP. In the presence o f glucose-6-phosphate dehydrogenase (G6P-DH) the G-6-P is 
oxidised by NADP to D-gluconate-6-phosphate with the formation o f  NADPH. The
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amount o f  NADPH is stoichiometric to the amount o f  D-glucose and is measured by 
means o f  its light absorbance at 340 nm.
HK
D-glucose + ATP ---------------------------------^  G-6-P + ADP
G6P-DH
G-6-P + NADP^___________   ^  D-gluconate-6-phosphate + NADPH + H^
Determination o f D-fructose:
Hexokinase also catalyses the phosphorylation o f D-fructose to D-fructose-6- 
phosphate (F-6-P) with the aid o f  ATP. On completion o f the reaction the F-6-P is 
converted by phosphoglucose isomerase (PGI) to G-6-P. G-6-P reacts again with NADP  
resulting in the formation o f D-gluconate-6-phosphate and NADPH. The amount o f  
NADPH formed is now directly proportional to the amount o f  D-fructose
HK
D-fructose + ATP ^  F-6-P + ADP
PGI
F-6-P ► G-6-P
G6P-DH
G-6-P + NADP^ ---------------------------------► D-gluconate-6-phosphate + NADPH + H^
Enzymatic inversion:
At pH 4.6, sucrose is hydrolysed by the enzyme B-fructosidase (invertase) to D- 
glucose and D-fructose.
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p-fructosidase
Sucrose+ H2O ► D-glucose + D-fructose
The determination o f D-glucose after inversion (total D-glucose) is carried out according 
to the principle outlined above. The sucrose content is calculated from the difference 
between the D-glucose concentrations before and after enzymatic inversion.
2.2.7 Measurement of circulating metabolites and hormones
2.2.7.1 Collection o f blood samples
Blood samples were taken at regular intervals from subjects via an intravenous 
cannula inserted into an antecubital vein for the duration o f the study (see study 
protocols for further details on blood sampling times). Samples were withdrawn using 
20 ml plastic syringes and were decanted into 1 ml fluoride oxalate tubes for the analysis 
o f glucose, 5 ml lithium heparin tubes for the analysis o f insulin and GIP and 10 ml 
lithium heparin tubes with 200 KlU/ml aprotinin as preservative for the analysis o f  GLP-
1. These tubes were then placed on ice to reduce degradation before centrifugation at 
4°C at 1750 g for ten minutes. Immediately after centrifugation, the plasma was 
separated from the red cells using a plastic pasteur pipette, stored in LP3 tubes and 
frozen at -20°C for subsequent analysis.
2.2.7.2 Production of charcoal stripved serum
Charcoal stripped serum (CSS) is plasma that has been stripped o f  
immunoreactive peptides and proteins. It is required when running the standard curve 
for plasma hormone radioimmunoassays to minimise plasma matrix effects.
Blood samples were taken from six fasted volunteers (to give a total volume o f  
approximately 500 ml) and left to clot without preservatives in falcon tubes for 4 hours
62
at room temperature. The blood was then stored overnight at 4°C. The following day, 
the serum was poured from the individual clots, pooled and the total volume measured. 
25 g o f  Norit A activated charcoal per 200 ml o f  serum was added and the resulting 
mixture was left gently stirring overnight at 4°C. The slurry was then centrifuged at 
6500 g for 60 minutes and the supernatant removed and filtered. An aliquot o f this was 
then centrifuged at 13000 g to check for remaining charcoal particles. This procedure 
was repeated until no charcoal remained. 5 ml and 10 ml aliquots o f the stripped serum 
were stored at -20°C until ready for use.
2.2.7.3 Production o f plasma quality controls
In order to obtain quality controls (QCs) for use in the GIP, GLP-1 and insulin 
radioimmunoassays, plasma was pooled from several volunteers who had donated blood 
after either an overnight fast or 1 hour after consuming a high fat, high carbohydrate 
meal (3 assorted doughnuts). This was in order to produce the low and high QCs 
respectively. QCs for the measurement o f plasma glucose were obtained from Randox 
Laboratories Ltd, and was supplied with minimum, maximum and mean levels for 
acceptance.
2.2.7.4 Plasma slucose analysis
Plasma glucose was analysed by an automated enzymatic colourimetric method 
on the Cobas Mira Biochemical Analyser (Roche Products Ltd, Welwyn Garden City, 
Hertfordshire). The Glucose GOD/PAP test kit was used (Randox Laboratories, Co. 
Antrim, UK) which determines glucose concentration after enzymatic oxidation in the 
presence o f  glucose oxidase. The hydrogen peroxide formed reacts, under catalysis o f  
peroxidase, with phenol and 4-aminophenazone to form a red-violet quinoneimine dye 
as indicator. The concentration o f  quinoneimine formed is directly proportional to the 
amount o f  glucose in the sample which is determined by measuring the absorbance o f  
quinoneimine at 500 nm.
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glucose oxidase
D-glucose + O2  + H2 O -------------------------------------► gluconic acid +H2 O2
peroxidase
2 H2O2  + 4-aminophenazone + phenol ---------------------------- ^  quinoneimine + 4 H2 O
Quality control samples were included both at the beginning and the end o f  each assay. 
Using QC values, the intra- and inter- assay coefficients o f variation were 2.07% and 
2.42% respectively.
2.2.7.5 Whole blood slucose analysis
Whole blood samples were taken from the tail tip o f  rats during animal 
experiments in order to measure blood glucose concentrations. This was measured using 
a Glucotrend® monitor Accu Chek® glucose test strips (Roche Diagnostics, Lewes, 
E.Sussex) which gave an immediate estimate o f whole blood glucose concentrations. 
The test principles are the same as for plasma glucose analysis (2.2.7.4). The coefficient 
o f variation for fasted and fed plasma was 4.87 % and 1.77 % respectively.
2.2.7.6 Immunoassays for analysis o f insulin, GIP and GLP-1
2.2.7.6.1 Plasma Insulin Analysis
Plasma insulin concentrations were determined using a method developed by Dr. 
Shelagh Hampton and colleagues at the University o f  Surrey ((Hampton & Withey 
1993). This assay uses antiserum raised by immunising guinea pigs with porcine insulin 
conjugated to ovalbumin. The percentage crossreactivity o f  this antiserum at 50 % 
displacement o f  the tracer is as follows: 100 % with human biosynthetic insulin, 42 % 
with human biosynthetic proinsulin, 76 % with Des 64-65 biosynthetic proinsulin and
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61 % with Des 31-32 biosynthetic proinsulin. Radiolabelled insulin was prepared 
at the University o f Surrey using the method described in section 2.2.7.6.4. This was 
used as the tracer in this assay. Natural insulin extracted from human pancreas was used 
as the standard in this assay and was supplied by the National Institute o f Biological 
Standards and Controls. Separation o f the bound and free insulin was carried out by a 
double antibody plus polyethylene glycol (PEG) method.
Assav procedure (see table 2.4)
Analysis was performed on a cold tray or on ice and all samples were assayed in 
duplicate and for non-specific binding. Plasma samples were defrosted at room 
temperature at the time o f the assay and centrifuged at 1300 g for 10 minutes at 4°C to 
remove any fibrin clots that may have prevented accurate pipetting. The assay diluent 
used throughout the duration o f  the assay consisted o f  0.04 M phosphate buffer (pH 7.4) 
with 0.5 % w/v BSA and was added to all tubes. Standards were produced by double 
diluting the top standard with assay buffer to produce a range from 1500 pM to 23 pM. 
50 pi o f these standards were then added to the standard curve tubes using a positive 
displacement pipette. Sample plasma (50 pi) was added to the sample tubes and one set 
o f non-specific binding (NSB) tubes and 50 pi o f charcoal stripped serum (section 
2.2.12) was added to the standard curve tubes. Positive displacement pipetting was 
used for all samples. Anti-insulin antiserum (100 pi ) at a dilution o f  1:12000 in assay 
diluent was added to each set o f tubes except for the NSB tubes. Tubes were then vortex 
mixed and stored overnight at 4°C.
The ^^ i^odine label was prepared at the University o f  Surrey by Dr. Shelagh Hampton 
using the chloramine-T method. The label was then diluted in assay diluent to 10,000 
counts per minute (cpm) and 100 pi o f this was added to all o f  the assay tubes. A  set o f  
tubes containing just 100 pi o f label was also set up at this stage. Tubes were vortexed 
and incubated at 4°C overnight.
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On day three o f  the assay normal guinea pig serum (NGPS) was diluted 1:200 in assay 
diluent and 100 pi o f this was added to all tubes except totals. This was followed by the 
addition o f 100 pi o f  donkey anti-guinea pig serum (DAGP) at a 1:16 dilution in assay 
diluent. Finally, 700 pi o f  4 % (PEG) was added to each tube to aid in the separation o f  
the bound and free antigen. Tubes were vortex mixed and incubated at 4°C for two 
hours before centrifugation at 1300 g for thirty minutes. The supernatant was aspirated 
under vacuum and the pellet containing the antibody bound insulin was counted on a 
gamma counter for 2 minutes per sample (Wizard 1470, Wallac International, Finland). 
Each sample was counted against the standard curve in order to ascertain the 
concentration o f insulin in each sample.
Low and high QC plasma samples were included at the beginning and the end o f  each 
assay. The intra-assay coefficient o f  variation for low and high quality control samples 
at 62 and 410 pmol/L were calculated to be 9.00 % (low QC) and 2.89 % (high QC). The 
interassay coefficient o f  variation was 6.44 % (low QC) and 10.59 % (high QC).
66
Table 2.4: Insulin radioimmunoassay protocol
Reagents Tubes
Day 1
Totals NSB
Standard
Zero
Standard
Standard NSB
QC
QC NSB
Unknown
Unknown
Assay diluent -- 350 pi 250 pi 2001 350 pi 250 pi 350 pi 250 pi
Insulin Standard -- -- -- 50 pi -- -- — --
CSS 50 pi 50 pi 50 pi -- -- --
QC Plasma -- -- -- -- 50 pi 50 pi -- --
Sample -- -- -- -- 50 pi 50 pi
Antiserum -- 100 pi 100 pi -- 100 pi -- 100 pi
Vortex mix all tubes and incubate for 24h at 4‘*C
Day 2
Insulin tracer 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix all tubes and incubate for 24h at 4“C
Day 3
NGPS -- 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
DAGP -- 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
4% PEG 700 pi 700 pi 700 pi 700 pi 700 pi 700 pi 700 pi
Vortex mix all tubes and incubate for 2h at 4“C. Centrifuge at 1300 g for 30 min, aspirate and
count the pellet
2.2.7.6.2 Plasma GIP analysis
Plasma GIP concentrations were measured using a double antibody 
radioimmunoassay developed by Dr. Linda Morgan and colleagues at the University o f  
Surrey (Morgan et al, 1978). The antiserum was raised by immunising rabbits against 
porcine GIP conjugated to ovalbumin and crossreacts 100 % with human, rat and mouse 
GIP, exhibiting negligible cross reactivity with secretin, glucagon, GLP-1, VIP, 
pancreatic polypeptide, insulin. Radiolabelled GIP (^ ^^ I) was prepared at the University 
o f Surrey and was used as the tracer in this assay. Biosynthetic human GIP (Sigma- 
Aldrich, Poole, Dorset) was used as the standard and the CSS was produced at the 
University o f  Surrey using Norit A  charcoal and serum collected from fasted volunteers
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(section 22.12). Anti-rabbit Sac-Cell (IDS, Tyne and Wear, UK), a solid second 
antibody suspended in cellulose was used in the separation o f the antibody-bound and 
free GIP.
Assav procedure (see table 2.5)
Analysis was performed on a cold tray or on ice and all samples were assayed in 
duplicate and for non-specific binding. Plasma samples were defrosted at room 
temperature at the time o f  the assay and centrifuged at 1300 g for 10 minutes at 4°C to 
remove any fibrin clots that may have prevented accurate pipetting. The assay diluent 
used throughout the duration o f  the assay consisted o f  0.04 M phosphate buffer (pH 6.5) 
with 0.5 % w/v HSA and 50,000 KTU/lOO ml o f  aprotinin. Standards were produced at 
the time o f  the assay by adding 1.254 ml o f assay diluent to 100 ng o f lyophilised 
synthetic human GIP (section 2.2.1.6.6). After the addition o f diluent, the vial was left 
to stand for at least fifteen minutes to ensure complete solubilisation o f the peptide. 100 
pi o f this was added to 1.9 ml o f assay diluent to form the top standard o f  800 pM which 
was then double diluted down to give the range o f standards required. 100 pi o f  these 
were then added to the standard curve tubes using a positive displacement pipette. 
Sample plasma (100 pi) was added to the sample tubes and one set o f non-specific 
binding (NSB) tubes and 100 pi o f charcoal stripped serum (section 2.2.1.2) was added 
to the standard curve tubes. Positive displacement pipetting was used for all samples. 
Anti-GIP antiserum (100 pi) prepared at a dilution o f  1:9000 in assay diluent was added 
to each set o f  tubes except for the NSB tubes. Tubes were then vortex mixed and stored 
overnight at 4°C.
The ^^ i^odine label was prepared at the University o f  Surrey by using the chloramine-T 
method (section 2.2.T.6.4) and was affinity purified at the time o f  the assay (section
2.2.1.6.5). The label was then diluted in assay diluent to give approximately 5000 cpm 
and 100 pi o f was added to all o f the assay tubes. A  set o f  tubes containing just 100 pi 
o f label (totals) was also set up at this stage. Tubes were vortexed and incubated at 4°C 
for 48 hours.
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On day four o f  the assay 100 pi o f anti-rabbit sac cell was added to all tubes except total, 
vortexed and left at room temperature for thirty minutes. 1 ml o f R.O. water was added 
to the tubes which were then subsequently centrifuged at 4°C at 1300 g for thirty 
minutes. The supernatant was aspirated under vacuum and the pellet containing the 
bound GIP was counted on a gamma counter for 2 minutes per sample (Wizard 1470, 
Wallac International, Finland). Each sample was counted against the standard curve in 
order to ascertain the concentration o f  GIP in each sample.
Low and high QC plasma samples were included at the beginning and the end o f each 
assay. The intra-assay coefficient o f variation for low and high quality control samples 
at and 60 pmol/L and 383 pmol/L were calculated to be 12.08% (low QC) and 4.32% 
(high QC). The interassay coefficients o f  variation were 20.16% (low QC) and 7.89% 
(highQC).
69
Table 2.5: GIP radioimmunoassay protocol
Reagents Tubes
Day 1
Totals NSB
Standard
Zero
Standard
Standard NSB QC QC NSB
Unknown
Unknown
Assay diluent -- 300 pi 200 pi 100 pi 300 pi 200 pi 300 pi 200 pi
GIP Standard -- — — 100 pi -- -- --
CSS -- 100 pi 100 pi 100 pi -- --
QC Plasma -- — — -- 100 pi 100 pi -- --
Sample -- — — -- — — 100 pi 100 pi
Antiserum -- — 100 pi 100 pi — 100 pi -- 100 pi
Vortex mix all tubes and incubate for 24h at 4®C
Day 2
GIP tracer 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix all tubes and incubate for 48h at 4°C
Day 4
Sac cell -- 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix and incubate at room temporalTire for thirty minutes
R.O. water — 1 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml
Centrifuge at 4®C at 1300 g for thirty minutes, aspirate and count
2.2.7.6.3 Plasma GLP-1 analysis
Plasma GLP-1 concentrations were measured using radioimmunoassay methods 
already established at the University o f  Surrey (Elliott et al, 1993). Antiserum specific 
for the C-terminal amidated forms o f  the peptide was raised in rabbits against synthetic 
human GLP-1 (7-36) amide conjugated to bovine serum albumin. The percentage cross 
reactivity o f this antiserum is as follows: 100 % cross reactivity with GLP-1 from all 
species tested and is specific for the C-terminal end o f  GLP-1, requiring a C-terminal 
amide for cross-reactivity. Negligible cross reactivity with GLP-1 (7-37), GIP, secretin, 
glucagon, GLP-2, VIP, pancreatic polypeptide, motilin, somatostatin. Radiolabelled 
GLP-1 (7-36) amide (^ ^^ I) was prepared at the University o f Surrey and was used as the
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tracer in this assay. Biosynthetic human GLP-1 (Peninsula, St. Helens, USA) was used 
as the standard and the CSS was produced at the University o f  Surrey using Norit A  
charcoal and serum collected from fasted volunteers. Separation o f antibody-bound and 
free antigen was achieved by the use o f  anti-rabbit Sac-Cell, a solid phase second 
antibody suspended in cellulose (IDS, Tyne and Wear, UK)
Assav procedure fsee table 2.6)
Analysis was performed on a cold tray or on ice and all samples were assayed in 
duplicate and for non-specific binding. Plasma samples were defrosted at room 
temperature at the time o f the assay and centrifuged at 1300 g for 10 minutes at 4°C to 
remove any fibrin clots that may have prevented accurate pipetting. The assay diluent 
used throughout the duration o f the assay consisted o f 0.04 M phosphate buffer (pH 6.5) 
with 0.5 % w/v HSA and 50,000 KIU/100 ml o f aprotinin. Standards were produced at 
the time o f  the assay by adding 0.948 ml o f  assay diluent to 100 ng o f  lyophilised 
synthetic human GLP-1 (section 22.1.6.6). After the addition o f diluent, the vial was 
left to stand for at least fifteen minutes to ensure complete solubilisation o f  the peptide. 
100 pi o f  this was added to 0.9 ml o f CSS to form a 3200 pM standard which was then 
subsequently diluted 1:20 to form the top standard o f 160 pM. This was then double 
diluted down with CSS to give the range o f  standards required. 200 pi o f  this was then 
added to the standard curve tubes using a positive displacement pipette. Sample plasma 
(200 pi) was added to the sample tubes and one set o f  non-specific binding (NSB) tubes 
and 200 pi o f charcoal stripped serum (section 2.2.7.6.4) was added to the standard 
curve tubes. Positive displacement pipetting was used for all samples. Anti-GLP-1 
antiserum (100 pi) prepared at a dilution o f  1:6000 in assay diluent was added to each 
set o f  tubes except for the NSB tubes. Tubes were then vortex mixed and incubated 
overnight at 4°C.
The ^^ i^odine label was prepared at the University o f  Surrey by using the chloramine-T 
method (section 2.2.7.6.4) and was affinity purified at the time o f  the assay (section
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2.2.7.6.S). The label was then diluted in assay diluent to give approximately 5000 cpm 
and 100 pi o f was added to all o f the assay tubes. A  set o f  tubes containing just 100 pi 
o f  label (totals) was also set up at this stage. Tubes were vortexed and incubated at 4 °C 
for 48 hours.
On day four o f  the assay 100 pi o f anti-rabbit sac cell was added to all tubes except total, 
vortexed and left at room temperature for thirty minutes. 1 ml o f R.O. water was added 
to the tubes which were then subsequently spun at 4°C at 1300 g for thirty minutes. The 
supernatant was aspirated under vacuum and the pellet containing the bound GLP-1 was 
counted on a gamma counter for 2 minutes per sample (Wizard 1470, Wallac 
International, Finland). Each sample was counted against the standard curve in order to 
ascertain the concentration o f  GLP-1 in each sample.
Low and high QC plasma samples were included at the beginning and the end o f each 
assay. The intra-assay coefficients o f variation for low and high quality control samples 
at 13 pmol/L and 39 pmol/L were calculated to be were 12.08% (low QC) and 4.32% 
(high QC). The interassay coefficients o f  variation were 20.16% (low QC) and 7.89% 
(highQC).
72
Table 2.6: GLP-1 radioimmunoassay protocol
Reagents Tubes
Day 1
Totals NSB
Standard
Zero
Standard
Standard NSB
QC
QC NSB
Unknown
Unknown
Assay diluent --- 200 pi 100 pi 100 pi 200 pi 100 pi 200 pi 100 pi
GLP-1 Standard -- — — 200 pi -- --
CSS -- 200 pi 200 pi -- -- -- --
QC Plasma -- — — -- 200 pi 200 pi -- --
Sample -- — — -- -- 200 pi 200 pi
Antiserum -- — 100 pi 100 pi -- 100 pi — 100 pi
Vortex mix all tubes and incubate for 24h at 4°C
Day 2
GLP-1 tracer 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix all tubes and incubate for 48h at 4“C
Day 4
Sac cell -- 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix and incubate at room temperature for thirty minutes
R.O. water — 1 1 ml 1 ml 1 1 ml 1 ml 1 ml 1 ml 1 ml
Centrifuge at 4“C at 1300 g for thirty minutes, aspirate and count
2.2.7.6.4 lodînation of GIP and GLP-1
^^ I^-GIP and ^^ I^-GLP-1 were produced at the University o f  Surrey using the 
same method. 3 g o f G-15 Sephadex was left to swell overnight at room temperature in 
15 ml o f  0.1 M sodium acetate buffer pH 5.0. On the day o f  the iodination, the swollen 
sephadex was poured into a plastic chromatography colunrn (35 pm filter), attached to 
which was a small disposable pipette tip and 30 cm o f 1 mm diamter PVC tubing. 15 ml 
o f protein elution buffer (0.5 % HSA and 5000 KlU/ml aprotinin in 0.1 M  sodium 
acetate buffer pH 5.0) was allowed to drip through the column.
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10 pi o f  (corresponding to 37 MBq) was added to the autoanalyser cup containing 
either 5 pg o f GIP or 3 pg o f GLP-1 (7-36) amide dissolved in 10 pi o f 0.04 M 
phosphate buffer (pH 6.5). This was immediately followed by the addition o f  10 pi o f  
chloramine T solution (7.5 mg in 5 ml o f 0.04 M phosphate buffer pH 7.4) and resulting 
solution was mixed using a positive displacement pipette for fifteen seconds. The 
reaction was terminated by the addition o f  10 pi o f sodium metabisulphite solution (10 
mg in 5 ml o f 0.04 M phosphate buffer pH 7.4) and 200 pi o f  protein elution buffer was 
added to the mixture. The entire contents o f  the autoanalyser cup were transferred to the 
Sephadex column using a plastic pasteur pipette and separation o f  the products was 
achieved using simple gel permeation chromatography. The solution was allowed to 
drip through and 18-20 fractions o f approximately 400 pi (10 drops) were collected into 
LP4 tubes. A  reservoir o f  protein buffer was continuously maintained at the top o f  the 
column during collection. 10 pi o f  each fraction was transferred by pipette to an LP3 
tube and was counted for 60 seconds in an LKB 1260 Multigamma II to produce an 
elution profile with two peaks (Figure 2.2). Two peaks o f  radioactivity were obtained, 
the first containing the iodinated peptide and the second containing the free iodine. The 
highest fraction o f the first peak was aliquoted (20 pi) into LP3 tubes containing 100 pi 
o f  10 % w/v HSA and stored at -2 0  °C until ready for use. Both the leading and the 
trailing fraction o f the highest one were also stored. The stability o f the tracer was 
usually in the order o f  6 to 8 weeks.
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Figure 2.2: Elution profile o f a GLP-1 iodination (counts per minute in 10 pi o f 
fraction)
2.2.7.6.5 Affinity purification of GIP and GLP-1
The purified GIP or GLP-1 label was added on day two o f the radioimmunoassay 
and affinity purification was carried out immediately prior to addition o f the tracer. The 
chromatography columns were kept stored under bicarbonate buffer at 4°C and consisted 
o f low-avidity anti-rabbit GIP or GLP-1 covalently linked to activated silica beads (gift 
from Cliffmar Associates Ltd, Guildford). Using this method, immunologically active 
^^ -^I-GIP could be separated from that which had been damaged during the iodination 
procedure.
The purification was carried out at room temperature. The column was securely 
clamped and the beads allowed to settle and the bicarbonate buffer allowed to drain from 
the column. The column was then washed with 0.3 % v/v HCl which was passed 
through under pressure using a 5 ml plastic syringe. Following this the colunrn was
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equilibrated with 20 ml of assay buffer which was slowly allowed to drain through. Up 
to a maximum of three aliquots of the stored radiolabel were reconstituted with a total of 
3 ml of assay buffer and this was carefully layered onto the stoppered column. The 
column was capped, carefully secured with plastic film and mixed at room temperature 
for 30 minutes using a rotormixer. After this time the column was reclamped, allowed 
to settle and drained of the buffer containing the unbound, damaged label. The silica 
beads were washed with 20 ml of R.O. water and then 5 ml of 0.3 % v/v HCL was 
carefully added to the column to elute the bound label from the beads. The purified 
hormone was collected in a 5 ml glass vial coated with assay buffer which, when full 
was immediately transferred to a cold tray at 4°C. An aliquot of this tracer was then 
counted to determine the level of radioactivity present and the tracer was diluted with 
assay diluent to provide 5500 cpm per 100 pi before addition to assay tubes. The 
column was further washed with 10 ml of R.O. water and 10 ml of bicarbonate buffer 
and then stored at 4°C under bicarbonate buffer.
22.7.6.6 Production of GIP and GLP-1 standards
Pure synthetic human GIP or synthetic human GLP-1 (7-36) amide 
(approximately 10 pg) was weighed on a microbalance and were dissolved in 0.1 M 
formic acid containing 0.14 M lactose, 0.04 M HSA, 11 mM citric acid, 6 mM cysteine 
hydrochloride and 1600 KlU/ml aprotinin. 100 pi aliquots o f this (containing 100 ng of 
peptide) were freeze dried in glass vials to a constant vacuum. The vials were then 
stoppered under vacuum and stored at -20°C until use. Aliquots were defrosted only 
once before use and remaining unused standard was discarded.
2.2.7.6.7 Enzyme-linked immunosorbent assay for measurement of insulin
The method used to measure plasma insulin concentrations in chapters 4 and 7 
was an immuno-chemiluminetric assay provided by MLT Research Ltd., Cardiff. It is a
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a two-site immunoassay employing an insulin specific solid phase antibody immobilised 
on microtitre wells, and a soluble antibody labelled with a chemiluminescent acridinium 
ester. Cross-reactivity o f this assay was investigated by measuring the signal caused by 
various structurally related proteins at 100 pM and is as follows: 100 % with human 
biosynthetic insulin, 1.2 % with human biosynthetic intact proinsulin, 44 % with Des 
64-65 biosynthetic proinsulin and 0.8 % with Des 31-32 biosynthetic proinsulin.
The plasma sample is incubated simultaneously with the labelled antibody solution in 
the microtitre well, followed by a wash step to remove unbound labelled antibody before 
measurement. The bound luminescence is quantified by a microtitre plate luminometer 
capable o f in situ reagent addition. The luminescent reaction is a rapid flash type (>95 
% complete in 1 second) which permits the entire plate to be read in approximately five 
minutes. Lyophilised recombinant insulin in a serum matrix calibrated against WHO 
International Reference Preparation 1974 (66/304) was used as the standard in this 
assay. Low and high QC plasma samples were included in all microtitre wells . The 
intra-assay coefficients o f variation for low and high quality control samples at 62 
pmol/L and 265 pmol/L were calculated to be were 7.7 % (low QC) and 4.2% (high 
QC).
2.2.8 Data Handling and Statistical Analyses
The linear regression coefficient and calibration curve for each set o f  protein assay and 
analytical HPLC standard solutions were generated using Microsoft® Excel 2000 SR-1 
(Microsoft Corporation, 2000, USA).
Statistical analysis o f the results was performed using either GraphPad™ InStat Version 
3.0 for Windows (San Diego, CA, USA) or STATISTICA for Windows (StatSoft, Inc. 
(1997) Tulsa, OK, USA) and details o f analyses are described in each chapter.
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Chapter 3
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Chapter 3
A COMPARISON OF THE EFFECTS OF SELECT DIETARY 
POLYPHENOLS ON INTESTINAL GLUCOSE TRANSPORT 
USING A CACO-2 CELL LINE MODEL
3.1 Introduction
The primary biological function o f the gastrointestinal tract (GI) is to absorb 
nutrients from food in addition to serving as a barrier against toxins and bacteria. The 
bioavailability o f  a nutrient can be defined as that proportion which can be utilised for 
normal physiological functions within the body, the main component o f  which is the 
initial digestion and absorption o f  nutrients within the gut; often the rate-limiting factor 
(Ekmekcioglu 2002). Depending on the nature o f  the nutrient in question, the evaluation 
o f intestinal absorption in humans directly is not always an easy task and there are often 
difficulties associated with these kinds o f studies. In order to circumvent such problems, 
which include large inter-individual variation, high cost and relatively limited amounts 
o f data produced for the amount o f effort required, several in vitro experimental models 
have been used to indirectly study various aspects o f gastrointestinal physiology.
Caco-2 cells, which are derived from human colon adenocarcinoma cells 
spontaneously differentiate into enterocyte-like cells and acquire, when confluent, the 
morphological and functional characteristics o f  human enterocytes (Pinto et ah, 1983; 
Zweibaum et al, 1991). The polarisation o f  these cells that occurs when grown in vitro 
has proven particularly useful since the protein and lipid composition o f  the brush border 
membrane (BBM) and the basolateral membrane (BLM) are very distinct and thus easily 
identifiable (Harris et al, 1992). Further to this, the distribution o f Na^-dependent 
(SGLT) transport systems to the BBM but not to the BLM means that Caco-2 cells can 
be used to study the regulation o f enterocyte functioning and the vectorial transfer o f  
sugars in great detail (Bissonnette et al, 1996a)
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Caco-2 cells have been widely used in many different kinds o f  studies to 
determine the transport kinetics and metabolism o f  various different nutrients including 
those o f glucose and its analogues (Harris et al, 1992; Bissonnette et al, 1996a; 
Bissonnette et al, 1996b) and several different types o f dietary polyphenols (Walgren et 
al, 1998; Kuo 1998; Walle et al, 1999; Walgren et al, 2000a; Vaidyanathan & Walle 
2001; Oitate et al, 2001; Murota et al, 2002). However, in spite o f  the knowledge that 
certain dietary polyphenols have the potential to exert antagonistic effects on glucose 
uptake, for example those like phloridzin which contain a glucose moiety, little work has 
been done using this cell line to assess the possible inhibitory effects o f  dietary 
polyphenols on glucose uptake.
3.2 Objectives
The Caco-2 cell model closely mimics the nutrient-intestinal tract interaction in 
vivo and thus affords a quick and convenient method for establishing alterations in 
patterns o f glucose uptake in the presence o f  dietary polyphenols. Given the large 
number o f  dietary polyphenols known to man and the lack o f  information available as to 
their effects on intestinal glucose uptake it was decided to test various polyphenols from 
different subclasses. Moreover, in light o f  recent information from rodents in vivo 
suggesting that GLUT2 is in fact present at the BBM and is responsible for a large 
proportion o f glucose uptake from the lumen o f the small intestine (Kellett & Helliwell 
2000; Helliwell et al, 2000a; Helliwell et al, 2000b), Caco-2 cells are an ideal model to 
use, since facilitated glucose transport proteins are present on the BBM o f  the 
differentiated polarised cells (GLUTl-3) (Mahraoui et al, 1994). Thus, the aim o f this 
study was to complete a high-throughput screening o f a variety o f polyphenolic 
compounds to establish possible interactions with SGLTl and other facilitated transport 
proteins by measuring alterations in glucose uptake in Caco-2 cells under conditions that 
favour either active transport (sodium-dependent) or facilitated transport (sodium-free).
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3.3 Materials and methods
3.3.1 Cell culture
Caco-2 cells were maintained as described in section 2.2.1.1
3.3.2 Test compounds
Preparation o f  test solutions is described in section 2.2.1.2 
The following compounds were tested:
The dietary glycosides: arbutin, naringin, neohesperidin dihydrochalcone, phloridzin 
(positive control) and rutin.
The dietary phenolic acids: caffeic acid, chlorogenic acid, ellagic acid, gallic acid, p- 
coumaric acid and ferulic acid.
The model aglycones: apigenin, myricetin, phloretin and quercetin.
The non-glycosylated dietary polyphenols: (+)-catechin, (-)-epicatechin, EGC, ECG, 
and EGCG.
3.3.3 Radiolabelled glucose uptake studies
Radiolabelled glucose uptake studies were performed as described in section 2.2.1.3
3.3.4 Protein assay
Protein assay was performed as described in section 2.2.1.4.
3.3.5 Statistical analysis
Normal distribution o f the data was confirmed using Kolmogorov-Smimov’s one 
sample goodness o f  fit test. Since the incubation time o f  the cells in serum free media
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varied per set o f experiments performed, (by up to six hours), a one-sample Mest was 
performed for data obtained from each individual six-well plate. This was done to 
ensure a fair comparison between uptake in the control versus the test wells since an 
increased incubation period under what are essentially starved conditions, is likely to 
result in an overall increase in the absolute amount o f  glucose uptake. Therefore, an 
average o f all the control values compared with averaged values obtained from test wells 
would result in a large standard deviation between plates and would not adequately 
represent the magnitude o f effect o f these test substances. Hence, the values obtained 
from the control wells on a single plate (two wells per plate) were averaged and this was 
set to 100 percent. Subsequently, the uptake values from the corresponding test wells 
(four wells per plate) were expressed as a percentage o f this and these normalised values 
then subjected to a one-sample Mest using 100 as the hypothetical mean.
A type I error, which is the rejection o f  a true null hypothesis, is more likely to occur 
under circumstances where multiple testing is performed. Thus, in order to minimise the 
likelihood o f obtaining false positive results it was decided not to apply the standard 
Bonferroni correction for multiple comparisons since this is too conservative and would 
render each individual test almost powerless. Instead, it was decided simply to reduce 
the level o f significance (a-value) to P<0.01 which should be sufficient enough an 
adjustment to rule out the obtainment o f a false positive result (personal communication. 
Dr. R.J. Howland, Statistical advisor. University o f Surrey).
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3.4 Results
3.4.1 Effects of dietary glycosides on glucose uptake
Figure 3.1 shows the effects o f  the dietary glycosides on glucose uptake into 
Caco-2 cells under sodium-dependent conditions. Each o f the five test compounds used 
caused a marked reduction in glucose uptake when compared with the control solution. 
Naringin, rutin, and arbutin showed a 14 %, 15 % and 23 % reduction in glucose uptake 
respectively, however this was not statistically significant. Neohesperidin 
dihydrochalcone and phloridzin however, caused a significance reduction in glucose 
uptake with a 51 % and 56 % reduction in glucose uptake respectively.
?  100
■  Control
□  Naringin
□  Rutin
□  Arbutin
□  N eohesperidin
□  Phloridzin
Figure 3.1: Glucose uptake in Caco-2 cells in the presence o f dietary glycosides under 
sodium-dependent conditions. Results are expressed as mean ± SEM (N=4). There were 
significant reductions in cellular glucose uptake in wells treated with neohesperidin 
dihydrochalcone (*P<0.01 ) and phloridzin (**P<0.001)
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Figure 3.2 again shows the effects o f  the dietary glycosides on glucose uptake 
into Caco-2 cells, this time however, under sodium-free conditions. In contrast to the 
results obtained using a sodium-containing buffer, none o f  the five test compounds had 
any effect on glucose uptake when compared with the control solution.
?  100
B  Control
□  Naringin
□  Rutin
□  Arbutin
O N eohesperidin
□  Phloridzin
Figure 3.2: Glucose uptake in Caco-2 cells in the presence o f dietary glycosides under 
sodium-free conditions. Results are expressed as mean ± SEM (N=4). There was no 
effect o f the glycosides on glucose uptake under these conditions
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3.4.2 Effects of dietary phenolic acids on glucose uptake
Figure 3.3 shows the effects o f the phenolic acids on glucose uptake into Caco-2 
cells under sodium-dependent conditions. Caffeic acid and chlorogenic acid (5-CQA) 
had a negligible effect on glucose uptake. Gallic acid, ^-coumaric acid and ferulic acid 
caused a slight reduction in glucose uptake compared with the control solution (16%, 
18% and 22 % respectively), however, none o f these reached statistical significance. 
Despite a reduction o f 34 % by the addition o f ellagic acid, this was not statistically 
significant (P>0.10).
B  Control
□  Caffeic
□  Chlorogenic
□  Gallic acid
□  Ellagic acid
□  p-Coumaric
□  Ferulic
Figure 3.3: Glucose uptake in Caco-2 cells in the presence o f phenolic acids under 
sodium-dependent conditions. Results are expressed as mean ± SEM (N=4). There was 
no effect o f the phenolic acids on glucose uptake under these conditions
85
Figure 3.4 again shows the effects o f the phenolic acids on glucose uptake into 
Caco-2 cells, this time under sodium-free conditions. As with the sodium-dependent 
conditions, /?-coumaric acid and ferulic acid showed a slight reduction in glucose uptake 
(11 % and 13 % respectively) however, none o f the compounds tested had a statistically 
significant effect.
_  100
b£ 70
□  Control 
O Caffeic
□  Chlorogenic
□  Gallic acid
□  Ellagic acid
□  p-Coumaric
□  Ferulic
Figure 3.4: Glucose uptake in Caco-2 cells in the presence o f phenolic acids under 
sodium-free conditions. Results are expressed as mean ± SEM (N=4). There was no 
effect o f the phenolic acids on glucose uptake under Na^ free conditions
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3.4.3 Effects of model aglycones on glucose uptake
Figure 3.5 shows the effects o f the model aglycones on glucose uptake into 
Caco-2 cells under sodium-dependent conditions. Phloretin and quercetin showed no 
effect whatsoever. Apigenin and myricetin caused a noticeable reduction in glucose 
uptake (10 % and 30 % respectively) again however, neither o f these reached statistical 
significance
□  Control
□  Phloretin
□  Quercetin
□  A pigenin
□  Myricetin
Figure 3.5: Glucose uptake in Caco-2 cells in the presence o f model aglycones under 
sodium-dependent conditions. Results are expressed as mean ± SEM (N=4). There were 
no significant reductions in cellular glucose uptake under these conditions
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Figure 3.6 shows the effects o f the model aglycones on glucose uptake into Caco-2 
cells under sodium-free conditions. Each o f the four test compounds used caused a 
marked reduction in glucose uptake when compared with the control solution which 
were all statistically significant. The most effective at reducing uptake was myricetin 
(82 % reduction) which was followed by quercetin (75 % reduction), then phloretin (47 
% reduction) and lastly, the least effective, apigenin (39 % reduction).
***
****
* * * *
■  Control
□  Phloretin 
O Quercetin
□  A pigenin
□  Myricetin
Figure 3.6: Glucose uptake in Caco-2 cells in the presence o f model aglycones under 
sodium-free conditions. Results are expressed as mean ± SEM (N=4). There were 
significant reductions in cellular glucose uptake in wells treated with phloretin 
(*P<0.01), apigenin (***P<0.0005), and quercetin and myricetin (****P<0.0001)
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3.4.4 Effects of non-glvcosvlated dietary polyphenols on glucose uptake
Figure 3.7 shows the effects o f the non-glycosylated dietary polyphenols on 
glucose uptake into Caco-2 cells under sodium-dependent conditions. Again, all test 
compounds caused a reduction in glucose uptake when compared with the control.. (+)- 
Catechin, (-)-epicatechin, and EGCG caused a reduction in uptake by 46 %, 51 % and 
46 % respectively. EGC and ECG however showed an 80 % or greater inhibition o f  
glucose uptake under sodium-dependent conditions.
-= 100
* * *
* * *
* * * *
B  Control 
O (+)-Catechin
□  (-)-Epicatechin
□  EGCG
□  EGC
□  ECG
Figure 3.7: Glucose uptake in Caco-2 cells in the presence o f non-glycosylated dietary 
polyphenols glycosides under sodium-dependent conditions. Results are expressed as 
mean ± SEM (N=4). There were significant reductions in cellular glucose uptake in 
wells treated with (+)-Catechin, (—)-Epicatechin, EGCG, EGC (***P<0.0005) and ECG 
(****P<0.0001)
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Figure 3.8 shows the effects o f the non-glycosylated dietary polyphenols on 
glucose uptake into Caco-2 cells under sodium-free conditions. Both (+)-catechin and 
(-)-epicatechin appeared to stimulate glucose uptake (111 % and 107 % respectively) 
when compared with the control although neither o f these differences were statistically 
significant. As with the sodium-dependent set o f experiments, EGCG, EGC and ECG 
all caused a reduction in glucose uptake (37 %, 60 % and 65 % respectively) when 
compared with control values
D Control
□  (+)-Catechin
□  (-)-Epicatechin
□  EGCG
□  EGC
□  ECG
Figure 3.8: Glucose uptake in Caco-2 cells in the presence o f non-glycosylated dietary 
polyphenols under sodium-free conditions. Results are expressed as mean ± SEM 
(N=4). There were significant reductions in cellular glucose uptake in wells treated with 
EGCG (***P<0.0005), and EGC and ECG (****p<0.0001).
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3.5 Discussion
Evidence is accumulating that epithelial BBM transport proteins play a role in 
the absorption o f  dietary polyphenols. Several studies have previously established that 
this is via an interaction with one or more o f  the glucose transport proteins found within 
the small intestine (Gee et al, 1998; Gee et al, 2000; Ader et al, 2001). The aim o f  this 
study was not to assess the absorption and bioavailability o f  dietary polyphenols, but 
rather to use alterations in glucose transport to clarify the mechanisms by which these 
compounds interact with the gut mucosa. Any changes observed in glucose uptake in 
response to different treatments under the various conditions can effectively be used as a 
biomarker o f exposure and effect and may provide insight as to the possible mechanisms 
o f interaction. For example, a reduction in glucose uptake under sodium-dependent 
conditions suggests an interaction with SGLTl, whereas a reduction in glucose uptake 
under sodium-ffee conditions, suggests an interaction facilitated transport proteins.
Phloridzin, was used as the positive control under sodium-dependent conditions 
in these experiments since it inhibits glucose uptake via competitive inhibition o f  
SGLTl. However, it has no effect under sodium-free conditions due to the abolition o f  
SGLTl-mediated active glucose transport which is rendered non-functional due to the 
inactivity o f  the basolaterally located Na* /^K  ^ATPase. Therefore, without the presence 
o f sodium in the transport buffer, any glucose uptake would occur via facilitated 
transport through one o f the GLUT transport proteins that is known to be present at the 
BBM o f differentiated Caco-2 cells (Mahraoui et al, 1994). Under sodium-free 
conditions, the aglycone o f  phloridzin, phloretin, was used as the positive control since it 
is a known inhibitor o f  sodium-independent glucose transport (Lefevre & Marshall 
1959). A  positive control plate under both sodium-dependent and sodium-free 
conditions was therefore included with each set o f  experiments to ensure the integrity o f  
the cells and o f the assay. Glucose uptake (measured as nmoles glucose/mg 
protein/minute) throughout these experiments ranged from 0.2 -  2.0 depending on how
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long the cells were left in serum free media, with a greater rate o f  uptake observed in 
those cells left in the serum free media for longer.
For the purposes o f  this study, the polyphenols were grouped into four distinct 
classes based on their chemical structures.
3.5.1 Dietary glycosides
The first group o f  compounds tested, the dietary glycosides, are probably the 
most studied to date as far as interactions with the intestinal mucosa is concerned. It is a 
well known fact that glycosides are substrates for Na^/glucose cotransporters (Lostao et 
al, 1994) and the effects on glucose uptake for all but one o f the compounds tested here 
corroborate what has been previously published in the literature using a series o f  
expression vectors mo\uAm% Xenopus oocytes and Chinese hamster ovary cells (CHO).
Naringin, a flavanone present in citrus fruits, caused a 14 % reduction in glucose 
uptake under sodium-dependent conditions that was not statistically significant. 
Furthermore, when measured under sodium-free conditions, naringin had a negligible 
effect on glucose uptake which implies little, i f  any interaction with facilitated transport 
proteins. The bioavailability o f  naringin has been previously investigated using an 
animal model. Studies involving the intragastric administration o f a naringin containing 
solution (60 mg/ml) to rabbits at a dose o f  225 mg/kg showed that when administered 
with glucose, there was a slight reduction in naringin uptake by 12 % although this 
effect was not statistically significant (Hou et al, 2001). Moreover, the measurement o f  
plasma metabolites showed that the Cmax o f naringenin (the aglycone) and its conjugates 
were much lower after oral administration o f naringin compared with oral administration 
o f naringenin even though naringin was given at a much higher dose (Hsiu et al, 2002). 
Although neither o f  these studies directly address the issue o f  possible antagonistic 
effects o f  naringin on glucose transport, the inability o f  glucose to affect naringin uptake 
and the fact that naringin appears to have poor bioavailability, in addition to the results
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found here, suggest that this compound does not interact with BBM transporters to any 
significant degree.
Rutin (querctin-3 -rhamnoglucoside), a fiavonoid found at high quantities in 
black tea caused a slight reduction (15 %) in glucose uptake under sodium-dependent 
conditions although this effect was not statistically significant. As with naringin, rutin 
also appeared not to interact with facilitated GLUT transporters since it failed to exhibit 
any inhibitory effects under sodium-fi*ee conditions. The inability o f  rutin to interact 
with SGLTl has been previously shown due to its lack o f  effect on the uptake o f  the 
non-metabolisable glucose analogue (methyl-a-D-glucopyranoside) (Ader et al, 2001) 
and also since its intestinal absorption kinetics closely resemble that o f  quercetin, which 
is has been shown in Xenopus oocytes not to interact with SGLTl (Manach et al, 1997; 
Song et al, 2002). The results obtained here further support these observations.
Arbutin, a hydroquinone o f  glucose which can be found in pears, has previously 
been shown to be transported by SGLTl in hamster tissue (Alvarado & Crane 1962) and 
in Xenopus oocytes (Lostao et al, 1994). In addition to this, the effects o f  arbutin on 
glucose uptake when studied in vivo in mice showed an 18 % inhibition o f  glucose 
uptake which did not quite reach statistical significance (Takii et al, 1997). These 
observations are in close agreement with the results obtained in these experiments which 
showed a 23 % reduction in glucose uptake under sodium-dependent conditions that also 
did not reach statistical significance. As with both naringin and rutin, arbutin appears 
not to interact with GLUT transporters since no effect was observed under sodium-ffee 
conditions.
The significant effects o f neohesperidin dihydrochalcone were surprising. The 
inhibitory effect o f this compound on glucose uptake was 51 % and almost matched that 
o f phloridzin (56 %). Due to inclusion o f a rhamnoglucoside moiety, one would expect 
that neohesperidin dihydrochalcone would behave in a similar manner to that o f  rutin, 
i.e. no significant effects under either sodium-dependent or sodium-ffee conditions. 
Based on its sugar attachment, neohesperidin dihydrochalcone is not a substrate for the
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lumenally exposed lactase-phloridzin hydrolase (LPH). Moreover, the expression o f  
LPH is significantly reduced in Caco-2 cells (0-0.12 mU/mg) (Petri et al, 2003) even in 
the “high LPH” clone (0.1-0.3 mU/mg) (Chantret et al, 1994) when compared with 
human enterocytes (20-80 mU/mg) which rules out any lumenal processing occurring 
prior to apical transport protein interaction. However, the fact that neohesperidin 
dihydrochalcone exerts no effect under sodium-free conditions would suggest that the 
inhibitory action o f this compound is not via an interaction with GLUT transport 
proteins and that it is not just the result o f steric hindrance. There remains the possibility 
that this compound aids with the dissipation o f the Na^ electrochemical gradient, the 
driving force for active glucose assimilation, which is evidenced by the lack o f  effect 
seen under sodium-free conditions. Furthermore, there exists the possibility that 
hydrophobic interactions between neohesperidin dihydrochalcone and the surrounding 
bilayer under sodium-dependent conditions could contribute to the loss o f  active glucose 
transport that is seen. This could possibly be explained by specific interactions caused 
by the presence o f  both an open C-ring structure and a glucose moiety, two components 
also present in the positive control phloridzin. However, there is currently no evidence 
for this hypothesis and it must therefore remain speculative. To fully elucidate the 
mechanisms by which neohesperidin dihydrochalcone inhibits glucose transport, a dose- 
response assay would provide more insight as to the range o f efficacy. In addition to 
this, the use o f  an expression vector such as CHO cells or Xenopus oocytes, to 
individually express SGLTl under both sodium-dependent and sodium-free conditions, 
would allow for a more detailed analysis and provide greater insight as to the nature o f  
the interaction with this protein, if  any.
3.5.2 Dietary phenolic acids
The dietary phenolic acids form the second group o f chemicals tested. This 
group consists o f  hydroxycinnamic acids, associated conjugates and the common dietary 
benzoic acids. Previous in vitro experiments using rat tissue have suggested that some 
o f  these compounds may inhibit sodium-dependent glucose uptake (Welsch et al, 1989).
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Ellagic acid and gallic acid, both o f which are found at relatively high 
concentrations in gall nuts showed no inhibitory effects under either sodium-dependent 
or sodium-ffee conditions. This is in part supported by previous observations by Welsch 
and colleagues who despite using gallic acid at a 20-fold greater concentration than 
glucose, still failed to observe any significant effects on sodium-dependent glucose 
transport
This study however showed that none o f the other compounds tested had a 
significant effect under either sodium-dependent or sodium-free conditions. This is in 
contrast to the above work by Welsch et al who although having used rat brush border 
membrane vesicles (BBMV) as opposed to human cells, showed that caffeic, ferulic and 
chlorogenic acid (5-CQA) all caused an inhibition in sodium-dependent glucose uptake. 
N o statistical tests appear to have been done (i.e. inhibition was just expressed as a 
percentage o f  control with no corresponding P-values) and so the significance o f  these 
observations is unknown. However, the percentage inhibition observed in these 
experiments is far greater than those obtained in this study (for example chlorogenic acid 
inhibited uptake by 81 %). A  likely explanation for the discrepancies in these 
observations could be attributed to the differences in the ratio o f  test substance to 
substrate. In these experiments, the phenolic acids were present at 1/10 the 
concentration o f the substrate which amounted to 100 pM versus ImM respectively. 
However, Welsch and coworkers, used ImM o f  inhibitor to 50 pM radiolabelled substrate 
which results in a 20-fold greater concentration o f inhibitor to substrate. Under no 
circumstances other than those involving pharmacological dosing, would one ever 
observe a 20-fold greater concentration o f dietary polyphenols to dietary sugars in the in 
vivo situation and thus, when considered in the context o f  the human diet these 
experiments have a much greater biological relevance.
Interestingly, other studies done in vivo using rodent models have suggested a 
role for various hydroxycinnamic acids as the responsible agent in a reduction o f  
hyperglycaemia that has been observed. Hsu et al observed a dose-dependent decrease 
in plasma glucose concentrations in streptozotocin-induced diabetic rats after
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intravenous administration o f a caffeic acid extract (Hsu et al, 2000). Furthermore, 
Andrade-Cetto et al. showed that 5-CQA containing plant extracts lowered plasma 
glucose levels in streptozotocin-induced diabetic rats to a level comparable with that o f  
the reference compound glibenclamide (Andrade-Cetto & Wiedenfeld 2001). It is 
possible that these effects were due in part to other components present in the unpurified 
extracts and thus the isolation and contribution o f each specific component present 
would be necessary to determine their individual effects. Nonetheless, both o f  these 
observations suggest a role for the involvement o f  these compounds in regulation o f  
plasma glucose concentrations, although the effects appear to be the result o f direct 
action on peripheral tissue more so than via a blockade mechanism at the BBM.
3.5.3 Model aglycones
The model aglycones form the third group o f  compounds, a group not generally 
found at any appreciable level in the diet. The rationale behind testing this group o f  
compounds is due to their structural similarity to phloretin (i.e. the lack o f a sugar 
moiety), which as previously stated is a known inhibitor o f sodium-independent glucose 
transport and is therefore used experimentally for those reasons (Lefevre & Marshall 
1959). As anticipated, none o f  the compounds within this group had a statistically 
significant effect on glucose uptake under sodium-dependent conditions which in part, 
has been previously shown in vitro using quercetin (Song et ah, 2002). However, under 
sodium-fi*ee conditions all o f the compounds significantly reduced glucose transport to 
an appreciable level, especially myricetin and quercetin which showed a greater than 75 
% reduction in glucose uptake. It is likely that this is via inhibition o f  GLUT 
transporters which, as far as quercetin is concerned, has been shown in previous 
observations (Song et al, 2002).
Interestingly, Ong and workers showed the opposite effect o f  myricetin on 
glucose transport to the results obtained in this study. Using adipocytes, the authors 
showed that incubation in the presence o f  myricetin increased the rate o f  glucose uptake 
as compared with adipocytes incubated in the absence o f myricetin (Ong & Khoo 1996).
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Immimoblot analysis o f  GLUT4 distribution, the facilitated transporter responsible for 
glucose uptake in adipocytes, showed that there was no increase in the relative number 
o f GLUT4 transporters in the plasma membranes and thus this change could not be 
attributed to increased trafficking o f  these transporters fi*om within the cell to the 
membrane. Later studies by the same group using streptozotocin-induced diabetic rats 
provided evidence that as far as in vivo situation was concerned, the observed effect o f  
myricetin was in part due to decreased hepatic glycogenolysis which reduced serum 
glucose levels by 50 % after two days o f treatment (Ong & Khoo 2000). As with the 
previously mentioned work using caffeic acid and 5-CQA extracts in a streptozotocin- 
induced diabetic rat model, myricetin appears to reduce hyperglycaemia although via 
some other peripheral mechanism and not by directly blocking glucose uptake at the 
BBM. Given the time course o f  the uptake experiments in this chapter, and the 
structural similarities o f  myricetin to both quercetin and phloretin, compounds 
previously shown to inhibit GLUT-mediated transport, it is likely that myricetin is 
exerting an inhibitory effect via a transient blockade o f  facilitated transport proteins.
3.5.4 Non-glvcosvlated dietary polyphenols
The final group o f compounds tested are referred to as the non-glycosylated 
dietary polyphenols. All o f  these compounds significantly reduced glucose uptake under 
sodium-dependent conditions which has previously been shown by other groups in vivo 
in animals (Matsumoto et al, 1993), in vitro using animal tissues (Kobayashi et al, 
2000) and using a Xenopus oocyte expression vector (Hossain et al, 2002). 
Furthermore, a crude extract o f  tea was also shown to inhibit the intestinal absorption o f  
glucose and sodium in rats although the magnitude o f  effect o f  the individual 
components involved was not determined (Kreydiyyeh et al, 1994) and more recently, 
an instant tea preparation administered with a bolus o f glucose was postulated to have 
similar effects in healthy human subjects (Bryans et al, 2003) Interestingly, under 
sodium-free conditions, only those compounds containing a both a galloyl residue and a 
catechin residue had a significant effect on inhibition o f  glucose uptake whereas under 
sodium-dependent conditions the presence o f  a catechin residue appeared to be
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determining factor since under these conditions both (+)-catechin and (-)-epicatechin 
significantly reduced glucose uptake. The fact that neither gallic acid nor ellagic acid 
had any effect under either condition suggests that the presence a bulky galloyl residue 
does not simply result in steric hindrance. The effects o f EGCG, ECG and EGC are 
likely to be the result o f  steric hindrance caused by incorporation into the membrane 
with subsequent disruption o f the surrounding lipid-bilayer. This has been previously 
been shown by Hossain et al, (2002) using transfected Xenopus oocytes as an 
expression vector
The findings o f these studies indicate the potential for a variety o f  classes o f  
dietary polyphenols to affect intestinal glucose transport in vivo. The Caco-2 model is a 
usefiil tool since when fully differentiated, these cells express both sodium-dependent 
and sodium-independent transport mechanisms at the BBM. Recent evidence has 
suggested that GLUT2 may in fact be the major intestinal transporter under 
physiological conditions (Kellett & Helliwell 2000; Helliwell et al, 2000a; Helliwell et 
al, 2000b) and thus the use o f this cell model under both sodium-dependent and 
sodium-free conditions has a much greater relevance as far as establishing the efficacy 
o f dietary polyphenols is concerned. However, the use o f  a monolayer cell culture to 
model intestinal transport has its disadvantages. For example, two limitations o f  using 
the Caco-2 cell model are the lack o f the complex mucosal barrier that occurs in gut 
tissue (Ekmekcioglu 2002) and, more importantly as far as the uptake o f glycosides is 
concerned, the lack o f the lumenally expressed lactase phloridzin hydrolase (LPH) 
(Chantret et al, 1994). Both o f these components significantly contribute to the 
regulatory processes that occur at the brush border membrane (BBM) in vivo and may 
play an important role in the intestinal processing and ultimately, the resulting 
bioactivity o f these compounds.
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3.6 Conclusions
In conclusion, the results obtained from these experiments provide preliminary 
evidence suggesting that a broad range o f dietary polyphenols exert inhibitory effects on 
intestinal glucose uptake with varying degrees o f  efficacy through a variety o f  different 
mechanisms. However, the degree o f activity o f these compounds needs to be 
confirmed by similar observations obtained in vivo using a relevant animal model, or 
perhaps in humans.
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Chapter 4
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Chapter 4
A COMPARISON OF THE EFFECTS OF DIFFERENT 
QUERCETIN GLUCOSIDES ON GLUCOSE TOLERANCE AND 
HORMONE SECRETION USING AN IN VIVO RODENT MODEL
4.1 Introduction
Polyphenols exist in foods and beverages in various chemical forms that 
determine their gut absorption. Flavonoids are suggested to be the most abundant 
polyphenols in the human diet and much effort has been made to determine their 
mechanism o f interaction within the intestine in order to better understand their 
absorption process. As far as the bioavailability o f dietary polyphenols is concerned, 
much o f  the literature to date has paid special attention to the uptake and metabolism o f  
the flavonol subclass o f flavonoids, particularly to that o f quercetin. Quercetin is 
generally the most abundant fiavonoid in our diet and occurs naturally not in the 
aglycone form, but mainly as a P-glycoside. The sugar moiety to which quercetin is 
attached is one o f  the determining factors as to the bioavailability o f  the compound since 
the position o f  attachment and type o f sugar may enhance its ability to interact with the 
Na^-dependent glucose transporter (SGLTl) (Hollman et al, 1996; Hollman et al, 
1999; Graefe et al, 2001). It was first shown by Hollman et al, (1995) that dietary 
quercetin is absorbed in appreciable amounts and that this is in fact enhanced by 
conjugation with glucose. Interestingly, despite the fact that SGLTl is considered to be a 
major route o f glucose uptake from the small intestine there are just a few studies to date 
that have directly investigated the effects o f quercetin glucosides on sugar translocation 
within the small intestine. In vitro methods (Gee et al, 1998; Gee et al, 2000; Ader et 
al, 2001; Day et al, 2003) and in situ intestinal perfusion studies (Crespy et al, 2001), 
ail o f  which used a rodent model o f  absorption have been utilized in order to elucidate 
the process by which this absorption occurs. Results from these studies all corroborated 
Hollman’s original theory and indicated a role for the apical transporter SGLTl in the
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absorption o f flavonol glycosides which to date, remains one o f  the most accepted 
theories so far.
In light o f  these findings we decided to undertake a study to investigate the 
effects o f  quercetin-3-glucoside (Q3G), querecetin-4’-glucoside (Q4’G) and quercetin- 
3,4’-diglucoside (Q3,4’diG), three o f  the most dietarily abundant flavonoids (Herrmann 
1988) on intestinal glucose transport in animals in vivo.
4.2 Objectives
SGLTl actively transports D-glucose against a concentration gradient into the 
enterocytes and is suggested to be a major route o f  apical glucose uptake. It then 
follows that any compound capable o f  interacting with this transporter could potentially 
cause a reduction in the translocation o f glucose across the intestine which, in the in vivo 
situation, would be reflected in modified blood glucose profiles. Furthermore, this could 
then have subsequent effects on nutrient-dependent hormone secretion. Therefore, the 
direct measurement o f blood glucose levels together with that o f  insulin and the incretin 
hormones, in vivo in animals, would provide further information about the mechanism o f  
interaction o f  quercetin glucosides and their overall impact on glucose homeostasis. 
Thus the aim o f this study was to establish the effects o f  purified quercetin glucosides on 
acute glucose tolerance and gastrointestinal (GI) hormone and insulin secretion in vivo 
in rodents.
4.3 Materials and methods
4.3.1 Oral savage studies
Animals and their housing conditions are described in section 2.2.2.1.
The preparation and administration o f test solutions are described in section 2.2.2.2.
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The following compounds were tested: phloridzin (positive control), quercetin-3- 
glucoside (Q3G), quercetin-4’-glucoside (Q4’G) and quercetin-3,4’-diglucoside 
(Q3,4’diG).
4.3.2 Collection of blood samples
Collection o f  blood samples for whole blood glucose analysis, and plasma insulin and 
gut hormone analysis are described in section 2.2.2.3
4.3.3 Measurement of circulating metabolites and hormones
Analysis o f  whole blood for glucose concentrations is described in section 22.1.5. 
Radioimmunoassays (RIAs) for GIF and GLP-1 are described in sections 2.2.T.6.2 and
2.2.7.6.3 respectively and the enzyme-linked immunosorbent assay (ELISA) for insulin 
is described in section 2.2.1.6.1.
4.3.4 Statistical analysis
Glucose data was analysed using two factor repeated-measures analysis o f variance 
(ANOVA) and GIF and GLF-1 data were analysed using one way ANOVA. Normal 
distribution o f  the data was confirmed using Kolmogorov-Smimov’s one sample 
goodness o f  fit test. This test revealed that the values obtained for plasma insulin 
concentrations were not normally distributed and thus the Kruksal-Wallis test, a non- 
parametric one-way ANOVA, was performed instead. Significant differences were 
identified using Tukey’s post hoc analysis and values o f p<0.05 were considered 
significant.
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4.4 Results
4.4.1 Effects of purified quercetin glucosides on whole blood glucose concentration
Figure 4.1 shows the absolute differences in whole blood glucose concentrations 
following intragastric administration o f the control or treatment solutions. Due to the 
large differences at baseline between the five groups (statistically significant differences 
between the groups when sub-group analysis at time-point zero was performed 
(P<0.05)) it was necessary to correct for baseline before attempting to interpret the 
effects o f the phloridzin and quercetin glycosides treatments.
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Figure 4.1: Whole blood glucose concentrations in rats following intragastric 
administration o f glucose solution (3.2 g/kg by weight) as control or with the addition o f  
either phloridzin, Q3G, Q4’G or Q3,4’diG (1/50 the molar concentration o f glucose). 
Results are expressed as mean ± SEM (N=6).
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Figure 4.2 shows the differences in whole blood glucose concentrations between 
the control and the quercetin glucoside treatments when corrected for baseline by 
expressing the results as the difference from individual basal values. Two-factor 
repeated measures ANOVA over the entire time course o f  the experiment showed that 
there was both a highly significant treatment effect (P<0.00001) and a highly significant 
treatment by time interaction (P<0.00001). Post hoc analysis revealed that ten minutes 
post-gavage there was a significant difference between the control and phloridzin 
(P<0.005) and the control and Q3G (P<0.05) resulting from lower whole blood glucose 
concentrations after administration o f both o f these treatments. There was also a trend 
towards lower glucose concentrations (P<0.10) after treatment with the Q4’G. There 
was however no effect o f  Q3,4’diG and there were also no significant differences 
between the three quercetin glucoside treatments at this time. At twenty minutes post- 
gavage there were again significant differences in blood glucose concentrations and post 
hoc analysis revealed that this was the result o f lower concentrations after treatment with 
the phloridzin compared with the control and the three glucoside treatments (P<0.01). 
There were no differences between the control and any o f the quercetin glucoside 
treatments and yet again, there were no significant differences between quercetin 
glucoside treatments at this time. Finally, at thirty minutes there was a significant 
treatment effect (P<0.001) and post hoc analysis revealed that the differences lay 
between the control and phloridzin (P<0.001), with lower plasma glucose after 
consumption o f the latter. There were also differences between the control and Q3G 
(P<0.001), control and Q4’G (P<0.05) and control and Q3,4’diG (P<0.05) with higher 
blood glucose concentrations in animals administered the quercetin glucoside 
treatments. Again, there were no significant differences between the quercetin glucoside 
treatments at this time.
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Figure 4.2: Incremental blood glucose concentrations in rats following intragastric 
administration o f  glucose solution (3.2 g/kg by weight) as control or with the addition o f  
either phloridzin, Q3G, Q4’G or Q3,4’diG (1/50 the molar concentration o f glucose). 
Results are expressed as mean ± SEM (N=6). Two-factor repeated measures ANOVA  
showed there to be a significant treatment effect (P<0.00001) and a significant treatment 
by time interaction (P<0.00001).
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4.4.2 Effects of purified quercetin glucosides on plasma insulin concentrations
Figure 4.3 shows the differences in plasma insulin concentrations thirty minutes 
following intragastric administration o f the control or treatment solutions. One-way 
non-parametric ANOVA (Kruksal-Wallis test) revealed that there were no significant 
differences between the control and either the positive control or the treatments.
Control Phloridzin Q3G
Treatment
Q4'G Q3,4'diG
Figure 4.3: Plasma insulin concentrations thirty minutes following intragastric 
administration o f glucose solution (3.2 g/kg by weight) as control or with the addition o f  
either phloridzin, Q3G, Q4’G or Q3,4’diG (1/50 the molar concentration o f  glucose). 
Results are expressed as mean ± SEM (N=5). There were no significant differences 
between control and treatments.
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4.4.3 Effects of purified quercetin glucosides on plasma GIP concentrations
Figure 4.4 shows the differences in plasma GIP concentrations thirty minutes 
following intragastric administration o f the control or treatment solutions. One-way 
ANOVA revealed that there were no significant differences between the control and 
either the positive control or the treatments although mean levels after the positive 
control were lower.
Ô 140
« 100
Control Phloridzin Q4'G Q3,4'diGQ3G 
Treatment
Figure 4.4: Plasma GIP concentrations thirty minutes following intragastric 
administration o f glucose solution (3.2 g/kg by weight) as control or with the addition o f  
either phloridzin, Q3G, Q4’G or Q3,4’diG (1/50 the molar concentration o f glucose). 
Results are expressed as mean ± SEM (N=6). There were no significant differences 
between control and the treatments
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4.4.4 Effects of purified quercetin glucosides on plasma GLP-1 concentrations
Figure 4.5 shows the differences in plasma GLP-1 concentrations thirty minutes 
following intragastric administration o f the control or treatment solutions. One-way 
ANOVA showed that there was a significant treatment effect on plasma GLP-1 
concentrations (p<0.0001). Post hoc analysis revealed that the differences lie between 
phloridzin-containing glucose solution compared with the other four solutions (P<0.001) 
with higher concentrations in the former, and between Q4’G and Q3,4’DiG (p<0.05) 
with higher concentrations in the latter. There were however no differences between the 
control and any o f the quercetin glucoside treatments.
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Figure 4.5: Plasma GLP-1 concentrations thirty minutes following intragastric 
administration o f glucose solution (3.2 g/kg by weight) as control or with the addition o f  
either phloridzin, Q3G, Q4’G or Q3,4’diG (1/50 the molar concentration o f  glucose). 
Results are expressed as mean ± SEM (N=6). (*P<0.05)
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4.5 Discussion
Studies regarding the biological effects o f polyphenols require identification o f  
the interactions that occur within the gut mucosa since an understanding o f  the 
absorption o f dietary flavonoids is fundamental in determining both their systemic 
biological activity as well as that occurring at the lumenal surface o f  the small intestine. 
The purpose o f  this set o f experiments was to indirectly examine the effects o f  purified 
quercetin glucosides on intestinal glucose uptake by using differences in blood glucose, 
plasma insulin and GI hormone concentrations as biomarkers o f  the interactions o f  these 
compounds with the gut epithelia. The differences observed in blood glucose 
concentrations after the oral glucose tolerance test (OGTT) using these quercetin 
glucosides strongly suggest that these molecules interact to some degree with brush 
border membrane (BBM) transporter proteins. Furthermore, since the secretion o f  
insulin is regulated in part by circulating glucose levels (Ashcroft 1980), one might 
expect that any differences in blood glucose concentrations would also be reflected in 
circulating insulin levels as well as in plasma concentrations o f the incretin hormones 
glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP- 
1), both o f which are secreted in a nutrient-dependent manner (Nauck et ah, 1993; Holst 
1999).
The quantity o f  glucose administered to the rats in this study was done on the 
basis o f  body weight (3.2 g/kg body weight) and is the concentration favoured by 
investigators when performing OGTT in rodents. However, the concentrations o f  
glucosides used were in the ‘supra-physiologicaP range since the dosage was 1/50 the 
molar concentration o f  glucose which amounts to approximately 64 mg/kg body weight. 
Assuming an average weight o f 250 g, this would then result in a mean dose o f  16 mg o f  
glucoside administered in one bolus to each animal. The human daily intake o f  
quercetin, expressed as the aglycone has been shown to be approximately 23 mg as 
measured in a Dutch population (Hertog et al, 1993) which amounts to just 25 % higher 
consumption over a whole day than that administered to the rats in one dose. It should
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therefore be clarified at this point that the dosage o f glucosides used in this study was 
not intended to mimic that which is habitually consumed by humans on a daily basis, but 
to ensure that any interactions with BBM transporters could be readily assessed through 
the use o f  a time course measurement o f  blood glucose concentrations.
When depicted graphically, the data clearly show that for the entire thirty minute 
duration o f blood sampling, the blood glucose concentrations were significantly lower in 
rats administered the phloridzin-containing glucose solution compared with the glucose 
control solution. These observations serve to confirm the efficacy o f this intragastric 
administration model in assessing the inhibitory effects o f the test components since the 
magnitude o f  inhibition observed using phloridzin closely resembles that which has been 
previously observed (Alvarado & Crane 1962).
Statistical analysis revealed that there was a highly significant treatment effect on 
blood glucose concentrations. At ten minutes, the significant differences observed were 
due to lower blood glucose concentrations after treatment with Q3G (P<0.05) and as 
expected, after treatment with phloridzin. There was no significant effect after treatment 
with Q3,4’diG but, there was a trend towards lower blood glucose concentrations after 
treatment with the Q4’G (P<0.10). These results substantiate observations made by 
other groups using different investigative methods. Using rat everted jejunal sacs, this 
same pattern o f interaction was observed by Gee et al. (2000), who showed that the total 
net transport o f Q3G was greater than that o f  Q4’G which was greater still than that o f  
Q3,4’diG. Furthermore, net transport o f  Q3,4’diG was similar to that o f the aglycone, a 
compound for which there is limited intestinal absorption (Manach et ah, 1995). In 
addition to this. Day et al, (2003) have shown that the in vitro hydrolysis o f  Q4’G by 
the intestinal lactase-phloridzin hydrolase (LPH) is 10 times greater than that o f  Q3G, 
suggesting that Q4’G is a better substrate for LPH than is Q3G. It then follows that 
Q3G could remain as the intact glucoside in the lumen o f  the intestine for longer thus 
having greater potential to interact with SGLTl, which would ultimately exert a greater 
degree o f  inhibition on glucose uptake via this route.
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One possible caveat to this hypothesis lies with data previously published by 
Kellet’s group which suggests the presence of GLUT2 protein at the BBM is 
accountable for a large proportion of glucose uptake from the lumen of the small 
intestine (Kellett & Helliwell 2000; Helliwell et al, 2000a; Helliwell et ai, 2000b). 
Also noted in the above series of papers was the absence of detectable aglycone in the 
collected perfusate after rat intestinal segments were perfused under low pressure with a 
phloridzin-containing solution. The explanation offered was that an insufficient period 
of time was allowed for the hydrolysis of phloridzin to occur owing to the short duration 
of the single-pass perfusion experiment (Kellett & Helliwell 2000). However, an 
estimate of age based on the body weight of the animals indicates that hydrolysis of 
phloridzin by LPH would have occurred since that rats used in these experiments were 
young enough to have had substantial expression of LPH at this time (Lee et al, 1997). 
Thus, the failure to detect phloretin in the collected perfusate, was more than likely due 
to its rapid uptake by the enterocyte.
If GLUT2 was indeed present at the BBM, then glucose transport via this protein 
would be transiently, but selectively inhibited by phloretin; a reasonable assumption as 
far as the experimental conditions used in this chapter are concerned. However, it is not 
possible from these results to determine what percentage o f inhibition is due to the 
phloridzin-mediated blockade of SGLTl or the phloretin-mediated blockade of GLUT2. 
However, taking into account that Q4’G is a much better substrate for LPH than both 
Q3G and Q3,4’diG, it is reasonable then to assume that larger amounts of the quercetin 
aglycone produced after dosing with this glucoside would be present than after dosing 
with either the Q3G or the Q3,4’diG. Furthermore, results from chapter 3 show that 
quercetin significantly inhibits glucose uptake via facilitated transport proteins present at 
the BBM. This then implies that if GLUT2 were the major transport protein, Q4’G 
would have a much greater effect (possibly up to ten times) on the inhibition of glucose 
uptake than Q3G would. This is explained by the fact that SGLTl starts to saturate at 
30-50 mM  but that the lumenal concentrations in these experiments are well in excess of 
one molar, thus providing a major role for GLUT2 as the primary transporter under these 
conditions if it is indeed present. However, this was not the case in this experiment
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since Q3G had a greater effect than Q4’G at the first time point with no further 
differences observed thereafter. Thus, the results obtained here, when taken together 
with previously published data (Day et al, 2003) show that overall, Q3G has a 
somewhat increased ability above and beyond the other two glucosides to inhibit glucose 
uptake, probably via an interaction with SGLTl. For this reason, it is therefore doubtful 
that the inhibition of facilitated transport proteins has occurred during this study and thus 
it is suggested that effects are predominantly mediated via transient blockading of the 
SGLTl protein. It should be noted however that these glucosides are not as potent as 
phloridzin since no significant differences between the three quercetin glucoside 
treatments was observed.
At twenty minutes post-gavage the differences seen were wholly due to lower 
glucose concentrations after treatment with the phloridzin-containing solution compared 
with the control and all of the quercetin glucoside treatments. This lends weight to the 
suggestion that the effects of Q3G are small and very transient since the effects seen at 
ten minutes post-treatment were no longer present at the next time point. Despite the 
fact that graphically the glucose concentrations after consumption of Q3,4’diG appear 
to be significantly higher than the control, this did not reach statistical significance. As 
with the ten minute blood sample, no significant differences were found between the 
various quercetin glucoside treatments.
Interestingly enough, at thirty minutes the mean blood glucose concentration in 
the control treated rats was virtually identical to that of the previous time-point, likewise 
in both the phloridzin treated and the Q3,4’diG treated rats. Blood glucose levels after 
treatment with the quercetin monoglucosides however increased even further between 
the twenty and thirty minute time-points and these values were both significantly higher 
than the mean control value. As far as the monoglucosides are concerned, this could be 
explained in terms of a delayed uptake due to the mild inhibition that was observed for 
up to ten minutes after dosing. This initial attenuation in blood glucose, as diminutive as 
it was, appears to have been compensated for by the continuing increase in glucose 
concentrations that was seen in the later stages of this experiment.
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The results from the measurement of insulin and the GI hormones were not very 
revealing in as far as there were no differences between the groups in either insulin or 
GIP concentrations at the thirty minute time point. The only significant differences 
observed in hormone concentrations were for that of GLP-1 with higher circulating 
concentrations after treatment with the positive control compared with both the control 
and the three test groups, and also after treatment with Q3,4’diG compared with Q4G. 
The rationale behind the thirty minute time course of blood sampling is due to the large 
plasma sample size needed to measure all three hormones. The comparatively large 
volume of plasma required to perform the ELISA and RIAs meant that a single large 
blood sample would have to be taken to ensure enough plasma was available to measure 
these hormones at the same time point. As far as rats are concerned, this meant that the 
hormone concentrations could only be measured at the end of the experiment upon 
sacrifice of the animals when as much blood as possible could be drawn via cardiac 
puncture. Furthermore, an earlier study which assessed the effects of actively 
transported carbohydrates and their analogues on blood glucose concentrations and GIP 
secretion using an in situ rat intestine perfusion model had demonstrated that thirty 
minutes appeared to be of sufficient duration (Sykes et al, 1980). In addition to this, 
data obtained from clinical trials assessing the effects of dietary polyphenols on glucose 
tolerance and hormone secretion in human volunteers, revealed that thirty minutes 
appeared to be an optimal time point at which to determine differences in plasma 
glucose profiles and hormone secretion (results in chapters 5, 6 and 7). With this 
knowledge, it was decided to set thirty minutes as the end point for these experiments.
In hindsight, after analysing blood glucose profiles, it would have been better to 
have anaesthetised and performed cardiac puncture on the animals after ten minutes 
since this is when the largest, and most relevant differences in the rate o f glucose uptake 
(as measured in blood glucose concentrations) were seen. Plasma GIP was measured as 
a marker of the rate of intestinal glucose absorption however, as previously stated, the 
inhibitory effects of the quercetin glucosides had been largely overcome at this point and 
so no significant differences were seen. The same logic applies to the effects on insulin
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secretion, which is more tightly regulated by sharp changes in blood glucose levels. It is 
initially enhanced but then rapidly suppressed at concentrations above approximately 7 
mM (Rasmussen et al, 1990) which probably explains why no differences were seen at 
this time. GLP-1 secreting cells are mainly situated at the terminal end o f the ileum and 
thus the increased plasma concentrations of GLP-1 following phloridzin compared with 
the control and the quercetin glucoside treatments is simply a reflection of the ability of 
phloridzin to shift the site of glucose absorption to more distal parts of the small 
intestine.
In summary, there is accumulating evidence that BBM transport proteins play a 
pivotal role in the absorption of dietary polyphenols and it is now a well established fact 
that glycosides are substrates for NaVglucose cotransporters (Lostao et al, 1994). 
Several parameters must be considered when attempting to define and model the events 
involved in the gastrointestinal (GI) absorption of nutrients which include the 
physicochemical properties of the components of interest and the anatomical and 
physiological features of the GI tract. Variations in these parameters between different 
models may affect the site and rate of absorption (DeSesso & Jacobson 2001) and prove 
to be problematic when extrapolating results between different models and indeed 
different species.
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4.6 Conclusions
To conclude, we have shown using a rodent model o f  intestinal absorption, that 
some o f the quercetin glucosides alter the profile o f  blood glucose concentrations 
probably by causing a slight delay in intestinal glucose uptake. We have also shown, in 
support o f  previous data that the monoglucosides are more effective than the diglucoside 
and we suspect that this is probably via blockading the SGLTl mediated uptake route. 
Further experiments to determine the magnitude o f  effects on hormone secretion could 
be carried out with the final blood sampling done ten minutes after administration o f the 
treatments, where we suspect that the biggest differences ^vill be found.
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Chapter 5
INVESTIGATION INTO THE EFFECTS OF APPLE JUICE 
PHENOLIC COMPOUNDS ON GLUCOSE TOLERANCE 
AND INSULIN, AND GASTROINTESTINAL HORMONE 
SECRETION IN HEALTHY VOLUNTEERS
5.1 Introduction
Basic science, clinical observation and epidemiological studies have over the 
years, all contributed to an emerging body of evidence as to the importance of daily 
consumption of fruit and vegetables in the prevention of various disease states (Block et 
al, 1992). Fruits and vegetables are important contributors to the dietary intake of fibre, 
accounting for almost one third of that consumed (Southgate 1998). They also provide a 
large percentage of antioxidant nutrients including the majority of dietary ascorbic acid, 
approximately 90 % of the intake of carotenoids (Southgate 1998) and as already stated, 
are a rich source of dietary polyphenols. The benefits of a fibre-rich and/or vitamin-rich 
diet can easily be achieved through the use of dietary supplements in those individuals 
who follow a diet inadequate in fruit and vegetables ultimately showing that the 
beneficial effects of some dietary nutrients are exhibited independent of the food 
matrices within which they are naturally contained.
The results in the previous two chapters have both indicated that some purified 
polyphenols have the ability to exert antagonistic effects on intestinal glucose uptake 
both in vitro using a cell culture model and in vivo using a rodent model. However, very 
few data are available as to the efficacy of these compounds on the inhibition of glucose 
transport when administered as part of the food matrix within which they naturally exist. 
The magnitude of the effects of any dietary component is modified by the food matrix 
within which they are contained due to alterations on parameters such as gastric 
emptying and intestinal motility (Evans 2000) which often render them far less effective 
than the purified form.
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Due to its potent inhibitory properties, phloridzin is commonly used in 
physiological studies o f glucose transport as an inhibitor o f  intestinal glucose uptake. 
However, the effects o f  this compound on glycaemia, as it is consumed within the diet, 
is unknown. Furthermore, there is currently no information available as to whether or 
not, phloridzin when taken per os has the same inhibitory effect on glucose uptake from 
the gut lumen in humans.
The presence o f  phloridzin in apples has been knovm for a long time and as such, 
it is recognised as a characteristic polyphenol o f apples (Tomas-Barberan et al, 1993). 
Phloridzin and related dihydrochalcones are also found in apple products including juice 
and cider where they are accompanied by a range o f other flavonoids (such as the 
quercetin-3-glycosides, (+)-catechin, (-)-epicatechin and procyanidins) and chlorogenic 
acids (such as 5-cafreoylquinic acid (5-CQA) and 4-p-coumaroylquinic acid (4pCoQA)) 
(Clifford 1999; Hollman & Arts 2000; Awad et al, 2000; Clifford 2000; Santos-Buelga 
& Scalbert 2000; Clifford et al, 2003).
In addition to phloridzin, it has been shown that three o f these flavonoids from 
the above mentioned list exhibit inhibitory effects on glucose transport. Although the 
results presented in chapter three did not show any effects o f 5-CQA, other authors have 
previously shown that this compound reduced glucose uptake in brush border membrane 
vesicles (BBMV) and postulated that this was due to dissipation o f  the sodium gradient 
(Welsch et al, 1989). It is therefore reasonable to propose that because apple juice is a 
rich dietary source o f flavonoids and phenolic acids, some o f which have been shown to 
affect glucose transport in one model or another, a bolus o f glucose consumed within an 
apple juice drink will have absorption kinetics different to that o f  a bolus o f  glucose 
consumed in water.
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5.2 Objectives
The aim o f  this study was to investigate whether apple juice consumption 
modulates glucose tolerance and plasma GI hormone and insulin secretion profiles in 
healthy volunteers.
5.3 Subjects
The study was approved by the University o f Surrey Ethics Committee 
(ACE/2000/67/SBLS) and subjects were recruited from within the School o f  Biomedical 
and Life Sciences. Nine lean healthy volunteers (4 men and 5 women) with a mean age 
o f 24 + 3.2 (SD) years were admitted to participate. Subjects were excluded if  they had 
a BMI > 25 kg/m^, a significant current or previous medical history, were receiving 
regular medication (apart from oral contraceptives) that may have affected 
gastrointestinal or central nervous systems, consumed more than 20 units o f  alcohol per 
week, smoked, or had donated blood within the 4 -6  months prior to the commencement 
o f the study. A  letter was sent to inform each GP about the study and a venous blood 
sample was taken for haematological and biochemical screening (full blood count, liver 
and renal function) to confirm their suitability to participate in the study. Subjects were 
provided 'with an information sheet and gave their written consent to participate in this 
study and to give blood.
5.4 General Procedure
The study design was a three-way, randomised cross-over with each subject 
serving as his or her own control. On the day o f  the study the subjects were required to 
come to the clinical investigation unit at 8:00 a.m. There was an overnight fast from 
8:00 p.m. prior to each study day and the subjects were asked to refrain from strenuous 
exercise and the consumption o f alcohol or caffeine the night before. They were also 
asked to consume an adequate carbohydrate diet (> 200 g) the day before and a sample
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menu for this was given. Upon arrival at the clinical investigation unit, an intravenous 
cannula was inserted into a forearm (antecubital) vein under local anaesthetic by a 
qualified doctor. A  baseline blood sample was then taken. Following this the subject 
consumed a 400 ml beverage consisting o f  either clear apple juice, cloudy apple juice, or 
the control. Blood samples were taken at frequent intervals for the following three hours.
5.5 Test beverages
5.5.1 Analysis of commercial apple juice for phloridzin and chlorogenic acids
Samples o f  sixteen brands o f  apple juice were purchased fi'om local retail outlets 
and were screened by HPLC for their phloridzin and chlorogenic acids content so as to 
select the juices with the greatest potential to exert such effects. Analytical HPLC for 
quantification o f food-home phenolic compounds is described in section 2.2.3.
5.5.2 Analysis of commercial apple juice for sucrose, glucose and fructose
Apple juices were analysed spectrophotometrically for glucose and fimctose 
before and after hydrolysis o f sucrose using a food bioanalysis kit (Digen Ltd., Oxford) 
which is described in detail in section 2.2.6.
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5.5.3 Standardisation of sugars in test beverages
The total contents o f D-glucose and D-fructose (both as the monosaccharide and 
as sucrose) were calculated for the selected juices (see table 5.1 below). Sucrose, D- 
glucose and D-fructose were added where necessary to the selected apple juices to ensure 
that each one was equimolar in each juice. The equimolar control beverage was 
prepared by adding all three sugars to water. A portion (400 ml) o f  each juice or control 
thus contained a total o f  25.00 g o f glucose and 30.68 g o f fructose.
Table 5.1: Carbohydrate and phenolic composition o f control, clear apple juice 
and cloudy apple juice
Control Clear Cloudy
Naturally occurring sucrose (g) N/A 10.62 11.10
Sucrose added (g) 11.10 0.48 0
Total sucrose (g) 11.10 11.10 11.10
Naturally occurring D-glucose (g) N/A 9.06 7.18
D-glucose added (g) 19.45 10.39 12.27
Total D-glucose (g)^ 25.0 25.0 25.00
Naturally occurring D-fructose (g) N/A 25.12 23.71
D-fructose added (g) 25.12 0 1.40
Total D-fructose^ 30.68 30.68 30.68
Phloridzin (pM) 0 67 148
Chlorogenic acids (pM) 0 378 1304
Phloretin xyloglucoside (pM) 0 16 105
(+)-Catechin (pM) 0 2 10
(-)-Epicatechin (pM) 0 <0.1 <0.1
Phloretin (pM) 0 <0.1 <0.1
 ^Final glucose concentration includes glucose component of sucrose 
 ^Final fructose concentration includes fructose component of sucrose
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5.6 Measurement of circulating metabolites and hormones
Collection o f blood samples and analysis o f plasma glucose and hormones is 
described in described in section 2.2.7.
5.7 Statistical analysis
Normal distribution o f  the data was confirmed using Kolmogorov-Smimov’s 
one sample goodness o f fit test. Two factor repeated-measures ANOVA was used to 
analyse differences in the means o f glucose, insulin, GIP and GLP-1 between the control 
and treatment groups. Significant differences were identified using Tukey’s post hoc 
analysis. Total and incremental area under the curve responses were calculated using 
the linear trapezoidal rule. Incremental area under the curve was calculated using the 
zero time point measurement as the basal value. Significant differences were measured 
using single factor repeated-measures analysis o f variance (ANOVA) with Tukey’s post 
hoc analysis and values o f p<0.05 were considered significant.
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5.8 Results
5.8.1 Phloridzin and chlorogenic acids contents of analysed juices
Phloridzin contents o f the juices ranged from 5.7 pg ml”  ^ to 11.9 pg ml~  ^ in clear 
juices and 4.1 pg ml"  ^ to 27.3 pg ml"^  in cloudy juices. The corresponding data for 
chlorogenic acids (5-caffeoylquinic acid and 4-^-coumaroylquinic acid) were 35.1 pg 
ml"^  to 68.6 pg ml“  ^ and 79.1 pg ml“  ^ to 255.6 pg ml"  ^ in the clear and cloudy juices 
respectively (appendix I).
5.8.2 Plasma glucose results
Plasma glucose concentrations following consumption o f  the three beverages are 
shown in figure 5.1. Two-factor repeated measures ANOVA over the entire time course 
o f the experiment showed no significant differences in plasma glucose concentrations 
between treatments. There was however, a significant treatment by time interaction over 
the full time course (3 hours) indicating a delayed absorption when glucose was 
consumed in the apple juice compared with the control (P<0.05). Post hoc analysis 
revealed plasma glucose concentrations to be significantly lower after consumption o f  
the clear apple juice compared with the control at both 15 minutes (P<0.0001) and 30 
minutes (P<0.05) Similarly, for cloudy apple juice compared with control there were 
significantly lower plasma glucose concentrations at 15 minutes (P<0.001), but 
significantly higher concentrations at 45 and 60 minutes (P<0.05 and P<0.005 
respectively).
Furthermore, significant differences in both the total integrated area under the 
curve (TAUC) and for the incremental integrated area under the curve (lAUC) were seen 
in plasma glucose concentrations. Post hoc analysis showed that between 0 and 30 
minutes (table 5.2, p. 129) glucose concentrations were lower after consumption o f  both 
the clear apple juice (P<0.01) and cloudy apple juice (P<0.005) compared with the
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control. For the cloudy juice apple only, this difference was maintained between 30 and 
90 minutes (P<0.01) (table 5.3, p. 130).
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Figure 5.1: Plasma glucose concentrations following consumption o f either control, 
clear apple juice or cloudy apple juice. Results are expressed as mean ± SEM (N=9). 
Two-factor repeated measures ANOVA showed there to be a significant treatment by 
time interaction (P<0.05) over the full time course o f the experiment.
5.8.3 Plasma insulin results
Plasma insulin concentrations are shown in figure 5.2. Two-factor repeated 
measures ANOVA showed that again, there were no significant differences in plasma 
insulin concentrations between the three treatments but that there was significant 
treatment by time interaction over the first ninety minutes (P<0.05). Post hoc analysis 
showed that insulin concentrations were significantly higher after consumption o f the 
control compared with the clear and cloudy apple juice at 15 minutes (P<0.005 and 
P<0.0005) also for the control compared with the clear apple juice at 30 minutes
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(P<0.0005). As with plasma glucose concentrations, there were significant differences in 
the TAUC between 0 and 30 minutes (P<0.05) (table 5.2, p. 129). Post hoc analysis 
showed that this was due to significantly lower concentrations after consumption o f the 
clear apple juice compared with the control (P<0.05).
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Figure 5.2: Plasma insulin concentrations following consumption o f either control, clear 
apple juice or cloudy apple juice. Results are expressed as mean ± SEM (N=9). Two- 
factor repeated measures ANOVA showed there to be a significant treatment by time 
interaction (P<0.05) over the first ninety minutes o f the experiment.
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5.8.4 Plasma GIP results
Plasma GIF concentrations after consumption o f the three beverages are 
illustrated in figure 5.3. This time however, two-factor repeated measures ANOVA  
showed that there was a significant treatment effect (?<0.05) and post hoc analysis 
showed that this was due to higher plasma GIF concentrations after consumption o f the 
control compared with both the clear apple juice (F<0.005) and the cloudy apple juice 
(F<0.05). Furthermore, there were also significant differences in the TAUC from 0 to 
30 minutes (F<0.005) (table 5.2, p. 129) and from 30 to 90 minutes (F<0.05) (table 5.3, 
p. 130) and also in the lAUC (F<0.00001) from 0 to 30 minutes.
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Figure 5.3: Plasma GIF concentrations following consumption o f either control, clear 
applejuiee or cloudy apple juice. Results are expressed as mean ± SEM (N=9). Two- 
factor repeated measures ANOVA showed there to be a significant treatment effect 
(F<0.05).
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5.8.5 Plasma GLP-1 results
Figure 5.4 shows plasma GLP-1 concentrations after consumption o f  the three 
beverages. Two-factor repeated measiires ANOVA showed that there was a significant 
treatment effect over the first 90 minutes (P<0.005). Post hoc analysis showed that this 
was due to higher plasma GLP-1 concentrations following cloudy apple juice compared 
with both the control (P<0.005) and clear apple juice (P<0.05). There were also 
significant differences in the TAUC from 30 to 90 minutes (P<0.05) (table 5.3, p. 130) 
with post hoc analysis showing that concentrations were higher after consumption o f the 
cloudy apple juice compared with both the control (P<0.02) and the clear apple juice 
(P<0.05).
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Figure 5.4: Plasma GLP-1 concentrations following consumption o f either control, clear 
applejuiee or cloudy apple juice. Results are expressed as mean ± SEM (N=9). Two- 
factor repeated measures ANOVA showed there to be a significant treatment effect 
(P<0.05).
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Table 5.2: Total (TAUC) and Incremental (lAUC) integrated responses for glucose, 
insulin, GIP and GLP-1 from 0 to 30 minutes following consumption of either control, 
clear apple juice or cloudy apple juice
Control Clear apple juice Cloudy apple juice
Total integrated responses 
(TAUC)
Plasma glucose (mmol/L.min) 201.7(11.5)“ 178.8 (S.S)"' 183.3 (7.4)“'"
Plasma insulin (pmol/L.min) 9216 (2096)“ 5406 (684)*^ 6386 (812)“'"
Plasma GIP (pmol/L.min) 4554 (532)“ 3298 (397)'' 3395 (479)"
Plasma GLP-1 (pmol/L.min) 506.5 (65.2) 515.1 (69.1) 617.6 (92.0)
Incremental integrated responses 
(lAUC)
Plasma glucose (mmol/L.min) 59.0 (8.2)“ 40.1 (5.4)'' 37.5 (4.2)"
Plasma insulin (pmol/L.min) 7384(1736) 4252 (561) 4941 (613)
Plasma GIP (pmol/L.min) 1404 (218)“ 796(151)" 559 (106)"
Plasma GLP-1 (pmol/L.min) 88.7 (25.8) 171.3 (45.2) 198.7 (71.2)
‘Statistical analysis was performed using a one-w ay A N O V A  with a T ukey’s post hoc test when P <0.05. 
Results are expressed as mean ±  SEM  (N =8)
 ^M eans not sharing a com m on superscript are significantly different at P<0,05
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Table 5.3: Total (TAUC) and Incremental (lAUC) integrated responses for glucose, 
insulin, GIF and GLP-1 from 30 to 90 minutes following consumption of either control, 
clear apple juice or cloudy apple Juice^’"^
Control Clear apple juice Cloudy apple juice
Total integrated responses 
(TAUC)
Plasma glucose (mmol/L.min) 339.6 (24.1) 347.6 (20.8) 380.1 (30.4)
Plasma insulin (pmol/L.min) 13151 (1862) 12108 (2136) 14870(1315)
Plasma GIF (pmol/L.min) 7832(799/ 6428 (701)'' 7351 (825/b
Plasma GLP-1 (pmol/L.min) 651.1 (97.5) 673.8 (93.3) 838.0 (133.9)
Incremental integrated responses 
(lAUC)
Plasma glucose (mmol/L.min) -147.0 (29.5)“ -110.8(17.7)“’'’ -85.8 (24.4)"
Plasma insulin (pmol/L.min) -16077 (6129) -7642 (1634) -10220 (3529)
Plasma GIF (pmol/L.min) 1532 (461) 1425(350) 1679(268)
Plasma GLP-1 (pmol/L.min) -184.6(171.8)“ -13.7 (63.0)“ 0.126 (93.1)"
 ^ Statistical analysis was performed using a one-w ay A N O V A  with a T ukey’s post hoc test when P <0.05. 
Results are expressed as mean ±  SEM  (N =8)
M eans not sharing a comm on superscript are significantly different at P<0.05
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5.9 Discussion
The polyphenolic compounds o f  apples have been studied extensively because 
they contribute to the colour and flavour o f apple juices. The chemical composition o f  
apple juice depends on parameters such as the cultivar, growing region, climate and 
maturity which can all lead to significant variations in carboxylic acid, sugar and 
phenolic composition (Mattick & Moyer 1983). Since phloridzin is a characteristic 
polyphenol o f apples (Tomas-Barberan et al, 1993) its presence in apple juice has been 
exploited and used as a marker o f authenticity o f commercially produced apple juices in 
light o f  the concern regarding the adulteration o f  commercial foodstuffs during the 
manufacturing process (Kermasha et al, 1995). The results o f  HPLC analysis o f  the 
randomly chosen brands o f  apple juice revealed the between-brand variation in contents 
o f phloridzin and other phenolic compounds (appendix I). The magnitude o f  this 
variation is in broad agreement with previous analyses (Tomas-Barberan et al, 1993; 
Kermasha et al, 1995; Versari et al, 1996). Although apple juice contains many 
phenolic compounds, several o f  which have been shown to exhibit relevant biological 
activity in vivo, the physiological effects o f phloridzin are the most well characterised 
and thus for the purposes o f this study it was those juices containing the highest 
concentrations o f  phloridzin that were chosen.
The overall objective o f  this study was to assess whether the consumption o f  
physiological amounts o f polyphenol-containing apple juice had any effects on glucose 
absorption (as measured by plasma glucose tolerance) with subsequent effects on plasma 
concentrations o f  insulin, GIP or GLP-1 in humans. Relative to the control, which was 
equimolar for glucose and fructose, there were statistically significant delays in glucose 
absorption after consumption o f  both the clear and the cloudy apple juice. Plasma 
glucose concentrations were significantly lower over the first 30 minutes with both 
juices, and significantly higher from 30 to 90 minutes with the cloudy juice relative to 
control. The LAUC data, a measure o f  the response relative to basal values, are 
consistent with these findings.
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Furthermore, this delayed pattern o f absorption was also reflected in the GI 
hormone profiles. The post-prandial secretion o f GIP, which occurs in the proximally 
located K cells o f the small intestine (Buchan et al, 1978) and is stimulated by the 
active absorption o f  glucose from the gut (Sykes et al, 1980), was suppressed between 
zero and 30 minutes after consumption o f both apple juices, with a slightly greater 
although not statistically significant suppression observed after consumption o f  the 
cloudy apple juice (as measured by lAUC). In contrast, GLP-1 secretion, which occurs 
in the distally located L cells o f  the small intestine (Elliott et al, 1993) was significantly 
enhanced by the treatments, especially by the cloudy juice. All o f  these data are 
consistent with delayed glucose uptake in the small intestine, i.e. uptake occurring lower 
down the small intestine as a consequence o f apple juice consumption.
Phloridzin given intravenously, and used in studies with isolated tissues, has 
been shown to inhibit active sugar transport by SGLTl (Crane 1960; Alvarado 1967). 
Accordingly, it seems reasonable to suggest that phloridzin, when taken orally in 400 ml 
o f  commercial apple juice, could be capable o f blockading SGLTl. It is possible, 
however, that these effects were also due, at least in part, to the ability o f  5-CQA to 
dissipate the sodium gradient essential to the proper functioning o f  SGLTl (Welsch et 
al, 1989). Another consideration is the possible effects that one or more o f  these 
phenolic components may exert on apically located enzymes within the small intestine. 
For example, previous reports have shown that tea polyphenols inhibit intestinal a -  
amylase or sucrase activity thereby reducing the lumenal concentration o f free glucose 
(Kara & Honda 1990; Honda & Hara 1992; Matsumoto et al, 1993). Furthermore, the 
tea polyphenols (-)-epigallocatechin gallate (EGCG) and (-)-epicatechin gallate (EGG), 
which in chapter three were shown to inhibit glucose transport using Caco-2 cells, have 
also previously been shown to inhibit glucose transport via SGLTl (Kobayashi et al, 
2000). Moreover, results from chapter three also showed that that both (-)-epicatechin 
and (+)-catechin were able to inhibit glucose uptake under sodium-dependent and 
sodium-free conditions. However, the concentrations o f  (+)-catechin and (-)-
132
epicatechin in the apple juices were determined to be very low and on this basis we can 
therefore conclude that these components o f apple juice did not contribute to this overall 
effect.
It was not possible to detect a significant treatment effect on plasma insulin 
concentrations, although there was a significant treatment by time interaction for the first 
30 minutes, with the mean plasma insulin value following the control higher than that 
following the juices. Interestingly, at 30 minutes when there was virtually no difference 
between plasma glucose levels after consumption o f either the clear or cloudy apple 
juice, plasma insulin concentrations were significantly lower in volunteers that had 
consumed the clear apple juice. It is well established that blood glucose levels are the 
most potent stimulator o f insulin release (Marks et al, 1991) contributing to 
approximately 50 % o f the insulin response. One possible explanation for this 
discrepancy is that during the post-absorptive period the concentration o f glucose is 
often much higher in arterial blood than in venous, making venous blood glucose 
concentration a less accurate indicator o f the extent o f  insulinotropic stimulation o f B- 
cell activity by post-prandial hyperglycaemia (Hampton et al, 1986). The possibility 
therefore remains that had arterial blood been collected in order to measure plasma 
glucose concentrations or, in addition to the venous blood samples had capillary blood 
measurements o f glucose (an indicator o f the arterio-venous difference) also been used, 
it may have been possible to detect larger differences between the blood glucose 
concentrations than those actually observed.
Taking into consideration the plasma glucose and GIP data, it is possible that due 
to the greater phloridzin concentration in the cloudy apple juice, glucose absorption may 
have been more rapidly displaced to a more distal region o f the small intestine where 
more GLP-1-secreting L-cells are present, ultimately leading to a greater mean GLP-1 
concentration than was seen following consumption o f the clear juice. GLP-1, in 
addition to its stimulation o f insulin secretion, also stimulates insulin biosynthesis and 
inhibits glucagon secretion, and it could be these combined effects that caused the
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greater insulin secretion after consumption o f the cloudy juice compared with the clear 
apple juice.
Cloudy apple juice compared with clear apple juice has greater concentrations o f  
several polyphenols other than phloridzin and chlorogenic acids; phloretin xyloglucoside 
being one example o f this. It is therefore possible that these other components may also 
have had an effect on the phenomena studied. The effect o f  these compounds on SGLTl 
has not been reported, but phloretin, the aglycone o f  phloridzin, is a known inhibitor o f  
GLUT2 (Lefevre & Marshall 1959), the facilitated transport protein present on the 
basolateral membrane that mediates the release o f  glucose and other monosaccharides 
from the enterocyte into the bloodstream (Cheeseman 1993). Furthermore, as previously 
mentioned there is also the suggestion that GLUT2 is found under fed conditions on the 
apical membrane (Kellett & Helliwell 2000; Helliwell et al, 2000a; Helliwell et al, 
2000b). It is therefore possible that phloretin, when present in the intestinal lumen could 
inhibit glucose uptake via the GLUT2 path into the enterocyte and could potentially 
contribute to the reduction in plasma glucose levels seen. Although phloretin in the 
juices used in this study was below the limit o f detection by HPLC, it is possible that it 
may have been produced in vivo fi*om its glycosides by lactase phloridzin hydrolase 
(LPH), a p-glucosidase present on the small intestine BBM (Day et al, 2000). If this 
hydrolysis did occur it could potentially increase local concentrations o f  phloretin and 
provide further means by which glucose uptake into the enterocyte transport is blocked. 
These possibilities can be further tested by quantifying and isolating the other phenolic 
compounds present in the juices and then by measuring their effects on intestinal glucose 
absorption using a combination o f in vitro and in vivo experiments or alternatively by 
administering phloretin with a bolus o f glucose to volunteers.
It has already been suggested that phloridzin and other selective inhibitors o f  
SGLTl may be pharmacologically useful as antidiabetic agents in the treatment o f  non­
insulin dependent diabetes mellitus (NIDDM) due to their ability to prevent glucose 
uptake into the small intestinal cells, thus improving glucose tolerance (Tsujihara et al.
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1996; Tsujihara et al, 1999). Volunteer studies like this one, allow us to better judge 
whether dietary polyphenols, when consumed in beverages, may have an active role in 
determining the glycaemic index of plant foods, and whether this could have clinical 
implications for diet therapy in the treatment of diseases such as NIDDM.
5.10 Conclusions
The data reported here indicate clearly that 400 ml of commercial apple juice 
consumed by volunteers has the ability to influence the glucose tolerance in human 
volunteers as measured in plasma glucose concentrations. It is suggested that this effect 
is mediated via a phloridzin-SGLTl interaction possibly in combination with other 
phenolic compounds (CGA) present in apple juice.
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Chapter 6
INVESTIGATION INTO THE EFFECTS OF COFFEE ON 
GLUCOSE TOLERANCE AND INSULIN, AND 
GASTROINTESTINAL HORMONE SECRETION IN 
HEALTHY VOLUNTEERS
6.1 Introduction
Although the main physiological effects resulting from the consumption o f  
coffee are usually ascribed to the presence o f  caffeine (Amaud 1993) coffee also 
contains a multitude o f other substances, several o f which are potentially biologically 
active (Viani 1988). For example, coffee brew is an extremely rich source o f  
chlorogenic acids (CGA), a family o f  esters formed between quinic acid and certain 
/ra«5-cinnamic acids (e.g. caffeic, /?-coumaric and ferulic) which are known respectively 
as the caffeoylquinic acids (CQA), the /7-coumaroylquinic acids (pCoQA) and the 
feruloylquinic acids (FQA). Furthermore, in addition to these mono-esters, other 
subgroups include the di-esters (i.e. diCQA) and mixed di-esters o f  caffeic and ferulic 
acid known as the caffeoylferuloylquinic acids (CFQA) (Clifford 2000; Clifford et al, 
2003).
CGA are widespread in the diet and always occur as a mixture o f  related 
substances. Coffee is the major source o f  CGA in the human diet with coffee drinkers 
consuming 0.5-1.0 g per day and coffee abstainers typically consuming less then 100 
mg/day (Clifford 1999). In coffee, 5-CQA is the predominant form o f  CGA, however it 
is also accompanied by the isomers 3-CQA and 4-CQA.
To reiterate previous work by others, Welsch et a l  (1989) showed a phenolic 
acid-mediated decrease in intestinal brush border membrane (BBM) D-glucose uptake, 
the active phenolic components being ferulic, caffeic and chlorogenic acids. 
Furthermore, Hsu et al, (2000) showed an antihyperglycaemic effect o f  a caffeic acid-
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rich fruit extract in both a streptozotocin-induced and insulin-resistant model o f  diabetic 
rats. More recently, Andrade-Cetto and coworkers have shown that extracts prepared 
from the leaves o f Cecropia obtusifolia, a plant traditionally used for the treatment o f  
diabetes, lowered plasma glucose levels in streptozotocin-induced diabetic rats to a level 
comparable with that o f  the reference compound glibenclamide (Andrade-Cetto & 
Wiedenfeld 2001). The main constituent in the latter extract has been identified, using 
the preferred lUPAC nomenclature (lUPAC 1976) as 5-caffeoylquinic acid (5-CQA), 
the major CGA o f  coffee beverage.
Although no significant effects o f 5-CQA on glucose uptake under either sodium 
dependent or sodium-independent conditions were observed using the Caco-2 cell 
culture model in chapter three, it should be noted that this treatment consisted solely o f  
the purified 5-CQA component o f CGA whereas the work by Hsu et a l and Andrade- 
Cetto et a l used crude extracts which would certainly contain other CGA and possibly 
other naturally occurring phenolic components. Taking this into consideration, it is 
possible that pure 5-CQA was not a good model for the mixture o f  CGA typically 
present in coffee beverage, especially as Welsch et a l had shown that ferulic acid was as 
effective as both caffeic acid and 5-CQA. It was thus suggested that the consumption o f  
CGA, as they exist within coffee brew, may have similar effects to those observed after 
treatment with apple juice in human volunteers as far as glucose absorption kinetics are 
concerned.
Very few data exist on the absorption and bioavailability o f  CGA in humans. 
However, Olthof et al, (2001) have shown that 33% o f a 2.8 mmol load o f  5-CQA was 
absorbed by ileostomy patients. This suggests that some fraction o f  dietary CGA will 
enter into the blood circulation via absorption from the small intestine, where an 
opportunity might exist for an interaction with one or more o f the BBM transporters. 
Such an interaction could explain the anti-hyperglycaemic effects previously reported.
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6.2 Objectives
The aim o f this study was to investigate whether coffee consumption modulates 
glucose tolerance and plasma GI hormone and insulin secretion profiles in healthy 
volunteers.
6.3 Subjects
The study was approved by the University o f Surrey Ethics Committee 
(ACE/2000/66/SBLS) and subjects were recruited from within the School o f  Biomedical 
and Life Sciences. Nine lean healthy volunteers (4 men and 5 women) with a mean age 
o f 26 ± 3.2 (SD) years were admitted to participate. Subjects were excluded i f  they had 
a BMI > 25 kg/m^, a significant current or previous medical history, were receiving 
regular medication (apart from oral contraceptives) that may have affected 
gastrointestinal or central nervous systems, consumed more than 20 units o f  alcohol per 
week, smoked, or had donated blood within the 4 -6  months prior to the commencement 
o f the study. A letter was sent to their GP to inform them about the study and a venous 
blood sample was taken for haematological and biochemical screening (full blood count, 
liver and renal function) to confirm their suitability to participate in the study. Subjects 
were provided with an information sheet and gave their written consent to participate in 
this study and to give blood.
6.4 General Procedure
The study design was a three-way, randomised cross-over with each subject 
serving as his or her own control. On the day o f the study the subjects were required to 
come to the clinical investigation unit at 8:00 a.m. There was an overnight fast from 
8:00 p.m. prior to each study day and the subjects were asked to refrain from strenuous 
exercise and the consumption o f alcohol or caffeine the night before. They were also
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asked to consume an adequate carbohydrate diet (> 200 g) the day before and a sample 
menu for this was given.
Upon arrival at the clinical investigation unit, an intravenous cannula was 
inserted into a forearm (antecubital) vein under local anaesthetic by a qualified doctor. 
A baseline blood sample was then taken. Following this the subject consumed a 400 ml 
beverage consisting o f  either regular coffee, decaffeinated coffee, or the control. Blood 
samples were taken at frequent intervals for the following three hours.
6.5 Test beverages
6.5.1 Analysis of commercial instant coffee granules for total caffeovlauinic acids
Samples o f  a number o f brands o f instant coffee granules were purchased from 
local retail outlets and were screened by HPLC for their total caffeoylquinic acid content 
(3-CQA, 4-CQA and 5-CQA) so as to select the brands with the greatest potential to 
exert CGA-mediated effects. Analytical HPLC for quantification o f  food-home phenolic 
compounds is described in section 2.2.3. Due to the lack o f  commercially valuable 
standards for 3-CQA and 4-CQA, these were quantified as 5-CQA equivalents. The 
caffeinated and decaffeinated brands chosen for use in the study each contained the 
following amounts o f  3-, 4-, 5-, and total-CQA respectively (mg/g): (10.60, 10.65, 19.96 
and 41.22) in the caffeinated and (8.26, 9.27,11.91 and 29.44) in the decaffeinated.
6.5.2 Standardisation of test beverages
The final concentration o f total CQA in the test beverages was 2.50 mM. This 
was achieved by weighing 8.7 g ± 0.01 mg o f caffeinated granules and 12.0 g ±  0.01 mg 
o f decaffeinated granules which were then dissolved together with 25 g o f glucose into 
200 ml o f boiling water. This was then made up to a final volume o f 400 ml using water 
and left to equilibrate to room temperature.. The control consisted o f  25 g o f  glucose 
dissolved in 400 ml o f  water.
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6.6 Measurement of circulating metabolites and hormones
Collection o f  blood samples and analysis o f  plasma glucose and hormones is 
described in described in section 2.2.7.
6.7 Statistical analysis
Normal distribution o f  the data was confirmed using Kolmogorov-Smimov’s 
one sample goodness o f  fit test. Two factor repeated-measures ANOVA was used to 
analyse differences in the means o f glucose, insulin, GIP and GLP-1 between the control 
and treatment groups. Significant differences were identified using Tukey’s post hoc 
analysis. Total and incremental area under the curve responses were calculated using 
the linear trapezoidal rule. Incremental area under the curve was calculated using the 
zero time point measurement as the basal value. Significant differences were measured 
using single factor repeated-measures analysis o f  variance (ANOVA) with Tukey’s post 
hoc analysis and values o f  p<0.05 were considered significant.
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6.8 Results
6.8.1 Total caffeovlauinic acid contents of analysed coffee granules
The mean quantities o f  3-, 4-, 5-, and total-CQA were as follows for all o f  the 
caffeinated and decaffeinated coffees analysed respectively (mg/g ± SEM): (6.68 ± 0.85, 
6.97 ± 0.86 and 10.79 ± 1.76) and (6.73 ± 0.44, 7.666 ± 0.51 and 10.03 ± 0.62) 
(appendix II).
6.8.2 Plasma glucose results
Plasma glucose concentrations following consumption o f the three beverages are 
shown in figure 6.1. Two-factor repeated measures ANOVA over the entire time course 
o f the experiment showed that there were no significant differences in plasma glucose 
concentrations between treatments. However, significant differences were seen over the 
first 30 minutes following beverage consumption in the absolute glucose response when 
a comparison o f  the total areas under the curve (TAUC) was made (p<0.05). Post hoc 
analysis revealed plasma glucose concentrations to be higher after consumption o f  the 
caffeinated coffee compared with both the control and the decaffeinated coffee (Table 
6 .1 ,p .l47).
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Figure 6.1: Plasma glucose concentrations following consumption o f either control, 
caffeinated or decaffeinated coffee. Results are expressed as mean ± SEM (N=9). 
There were no significant differences between control and treatments
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6.8.3 Plasma insulin results
Plasma insulin concentrations are shown in figures 6.2. Two-factor repeated 
measures ANOVA showed there to be neither a significant treatment effect between the 
means o f  plasma insulin concentrations after consumption o f  either beverage compared 
with the control, nor a treatment by time interaction. However, there was a significant 
difference in the relative insulin response seen in the incremental area under the curve 
(lAUC) from 0 to 30 minutes (p<0.05). Post hoc analysis revealed plasma insulin 
concentrations to be higher after consumption o f  the caffeinated coffee compared with 
the decaffeinated coffee (Table 6.1, p. 147).
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Figure 6.2: Plasma insulin concentrations following consumption o f either control, 
caffeinated or decaffeinated coffee. Results are expressed as mean ± SEM (N=9). 
There were no significant differences between control and treatments.
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6.8.4 Plasma GIP results
Plasma GIF concentrations after consumption o f the three beverages are 
illustrated in figure 6.3. A two-factor repeated measures ANOVA showed that there was 
a significant treatment effect (?<0.0005) and a significant treatment by time interaction 
(?<0.0001). Post hoc analysis revealed GIP concentrations to be significantly higher 
following control compared with both caffeinated coffee and decaffeinated coffee 
(P<0.0005) and a trend towards lower plasma GIP concentrations (/?<0.10) after 
consumption o f the decaffeinated coffee compared with the caffeinated coffee. 
Furthermore, there were also significant differences in the TAUC from 0 to 30 minutes 
(P<0.0005) (table 6.1, p. 147) and from 30 to 90 minutes (P<0.005) (table 6.2, p. 148) 
and the lAUC from 0 to 30 minutes (P<0.01) (table 6.1). Post hoc analysis revealed 
plasma GIP levels to be lower after both caffeinated and decaffeinated coffee 
consumption compared with the control.
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Figure 6.3: Plasma GIP concentrations following consumption o f either control, 
caffeinated or decaffeinated coffee. Results are expressed as mean ± SEM (N=9). Two- 
factor repeated measures ANOVA showed there to be a significant treatment effect 
(P<0.0005) and a significant treatment by time interaction (P<0.0001)
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6.8.5 Plasma GLP-1 results
Plasma GLP-1 concentrations after consumption o f the three beverages are 
illustrated in figure 6.4. Two-factor repeated measures ANOVA showed that there was 
neither a significant treatment effect nor a treatment by time interaction on GLP-1 
concentrations. There were also no significant differences in the TAUC or lAUC from 
0-30 minutes (table 6.1, p. 147). However, there were significant differences in the 
lAUC between 30 and 90 minutes (P<0.005). Post hoc analysis revealed the differences 
to be the result o f  higher concentrations o f GLP-1 after both caffeinated coffee and the 
decaffeinated coffee compared with the control (table 6.2, p. 148).
I
o
§
35
30
25
—  control 
« —  caffeinated  
- k — decaffeinated
20
15
10
5
0
180 21090 120 15030 600
Time (minutes)
Figure 6.4: Plasma GLP-1 concentrations following consumption o f either control, 
caffeinated or decaffeinated coffee. Results are expressed as mean ± SEM (N=9). 
There were no significant differences between control and treatments
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Table 6.1: Total (TAUC) and Incremental (lAUC) integrated responses for glucose, 
insulin, GIP and GLP-1 from 0 to 30 minutes following consumption of either control, 
caffeinated or decaffeinated coffee^’^
Control Caffeinated Decaffeinated
Total integrated responses
(TAUC)
Plasma glucose (mmol/L.min) 212.0 (7.3)' 227.1 (6.9)*’ 210.2 (6.6)'
Plasma insulin (pmol/L.min) 5322 (342) 5702 (611) 4520 (270)
Plasma GIP (pmol/L.min) 3760(350)' 3073 (426)*’ 2327 (391)'
Plasma GLP-1 (pmol/L.min) 509.4 (85.2) 565.7 (72.6) 619.5 (120)
Incremental integrated responses
(lAUC)
Plasma glucose (mmol/L.min) 55.6 (6.8) 56.4 (5.1) 46.2 (5.2)
Plasma insulin (pmol/L.min) 4462 (341)'’*’ 4782 (578)*’ 3730 (256)'
Plasma GIP (pmol/L.min) ' 2130 (308)*’ 1596 (224)' *’ 1101 (281)'
Plasma GLP-1 (pmol/L.min) 165.2 (80.1) 226.6 (48.1) 330.5 (124)
^Statistical analysis was performed using a one-w ay A N O V A  with a T ukey’s post hoc test when P <0.05. 
Results are expressed as mean ±  SEM
 ^M eans not sharing a com m on superscript are significantly different at P<0.05
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Table 6.2: Total (TAUC) and Incremental (lAUC) integrated responses for glucose, 
insulin, GIP and GLP-1 from 30 to 90 minutes following consumption of either control, 
caffeinated or decaffeinated coffee^’^
Control Caffeinated Decaffeinated
Total integrated responses
(TAUC)
Plasma glucose (mmol/L.min) 387.4 (32.1) 388.3 (27.2) 372.3 (22.3)
Plasma insulin (pmol/L.min) 8241 (1079) 8874 (1293) 7515 (847)
Plasma GIP (pmol/L.min) 5778 (571)' 4360 (522)*’ 4142 (382)”
Plasma GLP-1 (pmol/L.min) 572.7(114) 786.4(130) 759.2 (58.2)
Incremental integrated responses 
(lAUC)
Plasma glucose (mmol/L.min) 74.6 (28.4) 46.9 (24.0) 45.3 (25.5)
Plasma insulin (pmol/L.min) 6521 (1066) 7034 (1308) 5935 (812)
Plasma GIP (pmol/L.min) 2519 (645) 1407 (272) 1690 (409)
Plasma GLP-1 (pmol/L.min) -115.7 (59.5)' 108.3 (55.3)*’ 181.3 (53.2)*’
^Statistical analysis was performed using a one-w ay A N O V A  with a T ukey’s post hoc test when P <0.05 . 
Results are expressed as mean ±  SEM
 ^M eans not sharing a com m on superscript are significantly different at P<0.05
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6,9 Discussion
The objective o f this study was to assess whether the consumption o f  dietary 
amounts o f  chlorogenic acids in coffee had any effects on plasma concentrations o f  
glucose, insulin, GIP, and GLP-1 in humans. Welsch et al. postulated that a 5-CQA- 
mediated dissipation o f the Na^ electrochemical gradient was responsible for the 
observed decrease in glucose uptake in rat BBM vesicles, and both Hsu et al (1999) and 
Andrade-Cetto et al (2001) showed that plant extracts containing phenolic components 
also found in coffee had anti-hyperglycaemic effects in rodents. It was therefore 
suggested that coffee consumption in humans may have similar effects on intestinal 
glucose transport.
This study showed that both caffeinated and decaffeinated coffee drinks 
significantly attenuated postprandial GIP secretion compared with the control. The 
postprandial secretion o f GIP is stimulated by the absorption o f nutrients from the gut, 
rather than their presence in the intestinal lumen (Sykes et al, 1980) and the rate o f  
absorption o f glucose determines the magnitude o f  the GIP response (Ellis et ah, 1995). 
These data therefore strongly suggest that coffee decreases the rate o f  intestinal 
absorption o f  glucose.
Glucose homeostasis is known to be achieved by a coordinated physiological 
response to the ingestion o f  food and up until thirty minutes, the increase in plasma 
glucose concentrations can be attributed solely to the increased delivery into the 
circulation as a result o f  increased intestinal absorption in response to the load. Once 
this has peaked, peripheral metabolism o f glucose (i.e. delivery into muscle and fat 
tissue in addition to hepatic glucose metabolism) will have a significant effect on overall 
plasma concentrations and thus any differences seen from this point on cannot be solely 
attributed to effects on absorption (Frayn 1996). Integrated responses for glucose, 
insulin and GIP profiles were therefore analysed over this time period. Differences in 
GLP-1 were additionally assessed during the latter parts o f  the study, as this hormone is
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secreted from the distal region o f the small intestine and is secreted at a later stage 
(Layer 6/ a/., 1995)
Plasma glucose concentrations were significantly higher after consumption of 
caffeinated coffee compared with both the control and the decaffeinated coffee when a 
comparison o f the means and o f the TAUC was made. The nature o f the interaction 
between coffee consumption and glucose tolerance has been controversial for many 
decades. However, most of the well-known physiological effects o f coffee can be 
attributed to the presence o f caffeine, which share the properties of other 
methylxanthines (Rail 1980). These compounds stimulate cardiac muscle and the 
central nervous system, act on the kidney to promote diuresis and produce a slight 
elevation of basal metabolic rate (Milon et al., 1988). These physiological effects of 
caffeine began to receive attention only when it was first shown to inhibit the action of 
an intracellular enzyme, phosphodiesterase, which is involved in the catabolism of cyclic 
adenosine monophosphate (cAMP) (Butcher & Sutherland 1962). Increased levels of 
cAMP have been shown to increase liver phosphorylase activity and glycogenolysis 
which we suggest is partially responsible for the significantly impaired glucose tolerance 
seen after consumption o f the caffeinated coffee compared with both the control and the 
decaffeinated coffee. Moreover, caffeine is also an adenosine receptor antagonist 
(Leblanc & Soucy 1993) and therefore able to inhibit muscle glucose uptake even in the 
presence of insulin (Vergauwen et al, 1994). However, Sharp & Debnam (1994) 
previously showed that acute lumenal exposure of enterocytes to cAMP in vivo resulted 
in a significant hyperpolarisation of the potential differences across the BBM with 
subsequent stimulatory effects on sugar transport across the BBM and the basolateral 
membrane (BLM). In addition to this, lumenal treatment with isobutylmethylxanthine 
(IBMX), a phosphodiesterase inhibitor, also significantly increased Vm suggesting 
cAMP must therefore exert its effect by crossing the cell rriembrane. Furthermore, 
Debnam et al, (1998) have also provided evidence for a similar effect o f cAMP in the 
regulation of sodium-dependent glucose transport across isolated rat renal BBM.
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Taking into consideration the known actions of caffeine, it is possible that the 
observed differences in plasma glucose profiles further confirm the potent 
pharmacological actions o f caffeine, but also imply that CGA have an antagonistic effect 
on glucose transport since integrated glucose levels were lowest following the 
decaffeinated coffee beverage.
Pizziol et al. (Pizziol et al., 1998) have previously suggested that caffeine causes 
impaired glucose tolerance by inducing a rise in blood glucose levels that is insulin- 
independent. However, these authors use the terms caffeine and coffee interchangeably 
and do not consider the action o f other biologically active components present in coffee, 
for example the CGA among others. In the present study, plasma insulin concentrations 
showed small differences in the early part of the postprandial period, consistent with the 
mildly impaired glucose tolerance seen after consumption o f the caffeinated beverage 
compared with the decaffeinated beverage. These differences are consistent with the 
impaired glucose tolerance seen after consumption o f the caffeinated coffee compared 
with the decaffeinated coffee but not with the control.
Although glucose is the major regulator of insulin secretion, ‘incretin gut factors’ 
have been estimated to be responsible for as much as 50% o f the insulin secretion 
observed after an oral glucose load and the term “enteroinsular axis” was introduced to 
encompass the gut factors responsible for this (Unger & Eisentraut 1969; Morgan 1990; 
Ranganath et al, 1999). The secretion o f the incretin hormones GIP and GLP-1, were 
significantly altered in response to the test beverages compared with the control. GIP 
secretion was attenuated after consumption o f both the caffeinated and decaffeinated 
coffee compared with the control. GLP-1, in contrast to GIP, is secreted from the distal 
portion of the small intestine and responds to the presence o f nutrients in the gut lumen 
(Morgan et al, 1988). Its secretion can be increased when the absorption o f  
carbohydrate is delayed (Ranganath et al, 1998). Circulating GLP-1 levels were 
significantly enhanced by the treatments, especially by the decaffeinated coffee, later 
during the time course of sampling. These opposite incretin hormone effects would 
have minimised any effects o f coffee on insulin secretion. However, the GI hormone
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data are consistent with delayed glucose uptake in the small intestine, i.e. uptake 
occurring lower down the small intestine.
The results here suggest that at the level o f the BBM, coffee exerts it 
physiological effects via CGA-mediated Na"” electrochemical gradient dissipation; the 
driving force for active glucose assimilation. This is reflected in and supported by the 
GI hormone profiles but not those for plasma insulin and glucose. However, the potent 
biological effects of caffeine on both hepatic glucose output and muscular uptake 
suggest that plasma glucose and insulin concentrations are a poor biomarker when 
interpreting the gastrointestinal effects of coffee on glucose transport in the small 
intestine.
The previous chapter has shown that consumption of the same volume o f  
commercial apple juice containing significant amounts o f CGA (» 500 |iM) as well as 
other bioactive dietary phenols such as phloridzin (« 60 |iM ), significantly delays 
glucose uptake and shifts absorption to a more distal region in the gastrointestinal tract 
as indicated by a similar change over time in plasma GIP and GLP-1 concentrations. 
Compared with the present study, in which the test beverages were 2.5 mM total CQA 
which amounts to the dietary equivalent of two small strong cups o f coffee, the effects 
following apple juice consumption were less pronounced, but the differences were 
smaller than would be expected if CGA were the only agent responsible given the large 
difference in CQA concentration between the two. It is therefore likely that the majority 
of the effects seen after apple juice consumption were mediated by phloridzin, a potent 
competitive inhibitor of SGLTl and one which is commonly used in physiological 
studies to abolish glucose transport (Crane 1960) and that at micromolar concentrations, 
the effects of CGA are very small.
Recent evidence to support the clinical effects of dietary polyphenols is provided 
by van Dam et al. (van Dam & Feskens 2002) who showed in a prospective cohort study 
that the risk o f developing clinical type 2 diabetes was 0.5 times as likely in individuals
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who drank at least seven cups o f coffee a day compared with those who drank two cups 
a day or fewer. Their study strongly suggests that coffee consumption can have clinical 
benefits; our present study suggests a possible mechanism whereby these benefits might 
be mediated.
6.10 Conclusions
A comparison o f  the control with the decaffeinated coffee suggest that in terms 
o f overall effects on the regulation o f plasma glucose levels, CGA in coffee appear to 
play a small but significant role. However, CGA as previously stated are widespread 
throughout the plant kingdom and many other caffeine-free food sources, including 
apples, pears, and stone, berry and citrus fruits which contain appreciable amounts o f  
CGA (Clifford 1999) may exhibit CGA mediated effects on glucose tolerance which 
could be more pronounced. In conclusion, the data reported here indicate that CGAs 
when consumed as coffee, have the capacity to alter the pattern o f intestinal glucose 
uptake with subsequent effects on GI hormone secretion.
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Chapter 7
Chapter 7
INVESTIGATION INTO THE EFFECTS OF HIGH AND LOW 
FLAVONOID ONIONS ON GLUCOSE TOLERANCE AND 
INSULIN, AND GASTROINTESTINAL HORMONE 
SECRETION IN HEALTHY VOLUNTEERS
7.1 Introduction
The intestinal absorption and metabolism o f  quercetin has been studied in great 
detail and both the mechanisms o f  mucosal interaction (Gee et al, 1998; Gee et al, 
2000; Ader et al, 2001; Day et al, 2003) as well as the production o f  post-absorptive 
metabolites have been fairly well characterised (Gee et al, 2000; Day et al, 2001). It is 
generally accepted that the bioavailability o f  quercetin, and indeed polyphenols as a 
class o f  chemicals, is greatly dependent on the chemical form in which they are 
administered. In plant foods, these components exist in a multiplicity o f complex 
conjugates mainly with sugars, but also with other compounds such as carboxylic acids, 
amines and lipids, and on occasion, other phenols (Bravo 1998). Adequate 
solubilisation within the contents o f the intestine is a necessary prerequisite for 
flavonoid absorption however, accompanying compounds that are present in food, for 
example dietary fibre, are liable to affect their solubility and hence their degree o f  
absorption (Manach e/fl/., 1996)
Whilst the effects o f  the food-matrix on the oral absorption o f  plant-derived 
polyphenols have been hypothesised (Hollman et al, 2001; De Vries et al, 2001), 
relatively little is known about the impact o f food on the absorption o f  these 
components. Macronutrient and matrix-induced changes in the rate and extent o f  
absorption o f many components have already been investigated and recently Schramm et 
al  (2003) have reported that lipid- and protein-rich meals, in contrast to carbohydrate- 
rich meals, have minimal effects on flavanol absorption which implicitly suggests that 
carbohydrate as a macronutrient subclass, significantly increases the absorption o f
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certain flavanols (Schramm et al, 2003). Furthermore, it has also been shown that the 
bioavailability o f ferulic acid from cereals is severely limited by the matrix within which 
it is contained; namely the fibres to which it is cross-linked when compared with its 
bioavailability from a ferulic acid-enriched semi-purified diet (Adam et al, 2002). 
Clearly, macronutrient components within a meal have substantial effects on the ability 
o f polyphenols to interact with the gut mucosa.
Onions are one o f the richest dietary sources o f  fiavonols (Hertog et al, 1992a; 
Hollman & Arts 2000) and contain especially high quantities o f quercetin-4'-glucoside 
(Q4’G) and quercetin-3,4'-diglucoside (Q3,4’diG) (Day et al, 2001) both o f  which are 
more bioavailable than the more widely distributed quercetin-3-rutinoside (Hollman et 
al, 1999; Graefe et al, 2001). This thesis has already addressed the effects o f  purified 
quercetin glycosides on glucose absorption in rats and results show that these 
compounds appear to have very small, but antagonistic effects on glucose uptake when 
solubilised and administered in solution with a bolus o f glucose. The hypothesis that 
conjugation with a glucose moiety enhances the mucosal interaction and subsequent 
absorption o f  these components has been unequivocally substantiated, however the 
overall relevance o f  this in the context o f  mixed diet, where many other components are 
present in substantial quantities, needs to be considered.
Plant foods are a rich source o f dietary fibre, a dietary component for which the 
favourable effects on glucose metabolism have been consistently reported and as shown 
in literature as well as in previous chapters, there is also accumulating evidence that 
dietary polyphenols inhibit glucose uptake in various models. However, despite the fact 
that plant foods are an extremely rich source o f dietary polyphenols, there is little 
suggestion that the antihyperglycaemic properties o f plant foods may be attributed in 
part to their phenolic content as well as their fibre content.
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7.2 Objectives
Much work has previously been done on the bioavailability o f  quercetin 
glycosides. Furthermore, onions as a plant food are very widely consumed and are also 
rich in dietary fibre (Redgwell 1986; Ng et al, 2000; Jaime et al, 2002) and thus the 
availability o f  two iso-genic onion lines that differ only marginally in composition 
except for their quercetin glucosides provided the ideal material to investigate the effects 
o f quercetin glucosides, as they exist within the food matrix, on glucose absorption in 
volunteers Therefore, the aim o f  this study was to investigate whether the consumption 
o f iso-genic onions containing different amounts o f  fiavonol glucosides modulates 
glucose tolerance and plasma GI hormone and insulin secretion profiles in healthy 
volunteers.
7.3 Subjects
The study was approved by the University o f  Surrey Ethics Committee 
(ACE/2001/63/SBLS) and subjects were recruited from within the School o f  Biomedical 
and Life Sciences. Eight lean healthy volunteers (5 men and 3 women) with a mean age 
o f 27 ± 4.0 (SD) years were admitted to participate. Subjects were excluded i f  they had 
a BMI > 25 kg/m^, a significant current or previous medical history, were receiving 
regular medication (apart from oral contraceptives) that may have affected 
gastrointestinal or central nervous systems, consumed more than 20 units o f  alcohol per 
week, smoked, or had donated blood within the 4 -6  months prior to the commencement 
o f the study. A  letter was sent to their GP to inform them about the study and a venous 
blood sample was taken for haematological and biochemical screening (full blood count, 
liver and renal fimction) to confirm their suitability to participate in the study. Subjects 
were provided with an information sheet and gave their written consent to participate in 
this study and to give blood.
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7.4 General Procedure
The study design was a three-way, randomised cross-over with each subject 
serving as his or her own control. On the day o f the study the subjects were required to 
come to the clinical investigation unit at 8:00 a.m. There was an overnight fast from 
8:00 p.m. prior to each study day and the subjects were asked to refrain from strenuous 
exercise and the consumption o f  alcohol or caffeine the night before. They were also 
asked to consume an adequate carbohydrate diet (> 200 g) the day before and a sample 
menu for this was given. Upon arrival at the clinical investigation unit, an intravenous 
cannula was inserted into a forearm (antecubital) vein under local anaesthetic by a 
qualified doctor. A  baseline blood sample was then taken. Following this the subject 
consumed either the control (25 g o f  glucose in 400 ml o f  water) or the cooked white or 
yellow onion meal.
7.5 Test meals
7.5.1 Flavonoid analysis of iso-genic onions
The study used iso-genic onion lines that were kindly provided by Dr. Arnaud 
Bovy, Plant Research International, The Netherlands. These onions were obtained after 
extensive conventional breeding and had either high or low flavonoid contents. The 
quantification o f  fiavonol glycosides in these onions is described in section 2.2.4.1.
7.5.2 Nutrient analysis of iso-genic onions
Complete nutrient analysis o f  the onions is described in section 2.2.4.2.
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7.5.3 Preparation of the onion test meals
Results from the fiavonol glycoside analysis showed that yellow onions 
contained 28-times higher amounts than white onions (83.4 mg versus 3.0 mg per 100 g 
fresh weight respectively) (table 7.1). Complete nutrient analysis revealed only minor 
differences in total reducing sugars and crude fibre content between the two types.
Table 7.1 Complete nutrient and quercetin glucosides composition o f  white and 
yellow iso-genic onions
White onions (per 100 g 
fresh weight)
Yellow onions (per 100 
g fresh weight)
Moisture 89.0 g 89.5 g
Crude fat 0.9 g 0.8 g
Global protein 2.3 g 2.5 g
Crude fibre 1.5 g 0.7 g
Total mineral content 0.5 g 0.5 g
Direct reducing sugars 3.0 g 3.8 g
Total reducing sugars 5.3 g 6.8 g
Maltodextrin added 1 .5g Og
Final reducing sugars 6.8 g 6.8 g
Q 0.25 mg 0.65 mg
Q4’G 1.15 mg 38.22 mg
Q3,4’diG 1.67 mg 44.54 mg
Total Q equivalents 3.07 mg 83.41 mg
Each test meal consisted o f 368 g o f  onions, corresponding to 25 g o f  glucose 
equivalents. The onions were chopped finely and dry-fried until soft. Maltodextrin (1.5 
g per 100 g fresh weight) was added to each white onion meal to compensate for the
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difference in total glucose equivalents between the onion types. Meals were stored at -  
20 °C until ready for consumption.
7.6 Simulated digestion and starch hydrolysis of freeze-dried onion samples
In order to measure the release o f  carbohydrates from each o f  the two types o f  
onion, samples o f  the cooked onions that were fed to volunteers were subjected to 
simulated digestion in vitro which was subsequently followed by free glucose analysis. 
These methods are described in sections 2.2.5 and 2.2.6 respectively and samples were 
analysed in duplicate.
7.7 Measurement of circulating metabolites and hormones
Collection o f blood samples and analysis o f  plasma glucose and hormones is 
described in described in section 2.2.7.
7.8 Statistical analysis
Normal distribution o f the data was confirmed using Kolmogorov-Smimov’s 
one sample goodness o f  fit test. Two factor repeated-measures ANOVA was used to 
analyse differences in the means o f  glucose, insulin, GIF and GLP-1 between the control 
and treatment groups. Significant differences were identified using Tukey’s post hoc 
analysis. Total and incremental area under the curve responses were calculated using 
the linear trapezoidal rule. Incremental area under the curve was calculated using the 
zero time point measurement as the basal value. Significant differences were measured 
using single factor repeated-measures analysis o f  variance (ANOVA) with Tukey’s post 
hoc analysis and values o f  p<0.05 were considered significant.
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7.9 Results
7.9.1 Simulated starch hydrolysis results
Figure 7.1 illustrates the results from the simulated starch hydrolysis 
experiments. Samples were analysed in duplicate. From it can be seen that the rate o f  
hydrolysis o f the two onion types is approximately the same. These observations then 
imply that differences seen in glucose profiles in human volunteers is due to differences 
in the rate o f glucose absorption rather than due to any differences in actual digestion.
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Figure 7.1: The time course for hydrolysis o f starch in white and yellow onions 
subjected to a simulated digestion technique. Each point is the mean o f two separate 
experiments (bars represent duplicate values)
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7.9.2 Plasma glucose results
Plasma glucose concentrations following consumption o f the three treatments are 
shown in figure 7.2. Two-factor repeated measures ANOVA showed that there were 
significant differences in plasma glucose concentrations between treatments (P<0.005). 
Post hoc analysis revealed that the differences were due to higher plasma glucose 
concentrations after consumption o f  the control compared with both the white onions 
(P<0.025) and the yellow onions (P<0.0005), and after consumption o f  the white onions 
compared with the yellow onions (P<0.05). Furthermore, there were also significant 
differences in both the total area under the curve (TAUC) (P<0.00001) and the 
incremental area under the curve (lAUC) (P<0.00005) from 0 to 30 minutes (table 7.2, 
p. 172). Post hoc analysis revealed plasma glucose levels to be lower after consumption 
o f both white and yellow onions compared with the control (P<0.001 and P<0.0005 
respectively) and also after consumption o f  yellow onions compared with white onions 
(P<0.05).
To determine if  there were any significant differences in plasma glucose 
concentrations between the two onion meals alone a two-factor repeated measures 
ANOVA was performed. Results showed that there were significant differences in 
plasma glucose concentrations with lower concentrations observed after consumption o f  
the yellow onions (P<0.05) (figure 7.3).
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Figure 7.2: Plasma glucose concentrations following consumption o f either control, 
white onions or yellow onions. Results are expressed as mean ± SEM (N=8). Two- 
factor repeated measures ANOVA showed there to be a significant treatment effect 
(P<0.005).
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Figure 7.3: Plasma glucose concentrations following consumption o f either white 
onions or yellow onions. Results are expressed as mean ± SEM (N=8). Two-factor 
repeated measures ANOVA showed there to be a significant treatment effect (P<0.05).
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7.9.3 Plasma insulin results
Plasma insulin concentrations are shown in figures 7.4. Two-factor repeated 
measures ANOVA showed that there were significant differences in plasma insulin 
concentrations between treatments (P<0.05). Post hoc analysis showed that plasma 
insulin concentrations were significantly higher following consumption o f  the control 
compared with the yellow onions (P<0.05). There were no differences following 
consumption o f the white onions compared with the control, however, there was a trend 
towards higher plasma insulin concentrations after consumption o f  the white onions 
compared with the yellow onions (P<0.10). Furthermore, there were significant 
differences in TAUC fi*om 0 to 30 minutes (P<0.005) (table 7.2, p. 172) and firom 30 to 
90 minutes (P<0.05) (table 7.3, p. 173). Post hoc analysis revealed that this was due to 
lower plasma insulin concentrations after consumption o f  the yellow onions compared 
with the control (P<0.05). Similar differences in the LAUC from 0 to 30 minutes were 
also seen.
To determine if  there were any significant differences in plasma insulin 
concentrations between the two onion meals alone a two-factor repeated measures 
ANOVA was performed. Results showed that there were significant treatment by time 
interaction differences with reduced insulinconcentrations observed after consumption 
o f the yellow onions (P<0.005) (figure 7.5).
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Figure 7.4: Plasma insulin concentrations following consumption o f either control, 
white onions or yellow onions. Results are expressed as mean ± SEM (N=8). Two- 
factor repeated measures ANOVA showed there to be a significant treatment effect 
(P<0.05).
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Figure 7.5: Plasma insulin concentrations following consumption o f either white onions 
or yellow onions. Results are expressed as mean ± SEM (N=8). Two-factor repeated 
measures ANOVA showed there to be a significant treatment by time interaction 
(P<0.05).
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7.9.4 Plasma GIF results
Plasma GIP concentrations after consumption o f either the control or the two 
onion meals are illustrated in figure 7.6. Two-factor repeated measures ANOVA  
showed that there was a significant treatment effect (P<0.0005). Post hoc analysis 
revealed that GIP concentrations were significantly higher following consumption o f the 
control compared with both the white onions (P<0.0005) and the yellow onions 
(P<0.0001), however no differences were observed between the onion meals themselves. 
These same differences with the same degree o f  significance were also observed for the 
TAUC and the lAUC from 0 to 30 minutes and from 30 to 90 minutes (tables 7.2 and 
7.3 respectively).
Yet again, to determine if  there were any significant differences in plasma GIP 
concentrations between the two onion meals alone a two-factor repeated measures 
ANOVA was performed. Results showed that there was a significant treatment effect 
with reduced concentrations observed after consumption o f the yellow onions (P<0.01) 
(figure 7.7).
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Figure 7.6: Plasma GIF concentrations following consumption o f either control, white 
onions or yellow onions. Results are expressed as mean ± SEM (N=8). Two-factor 
repeated measures ANOVA showed there to be a significant treatment effect 
(P<0.0005).
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Figure 7.7: Plasma GIF concentrations following consumption o f either white onions or 
yellow onions. Results are expressed as mean ± SEM (N=8). Two-factor repeated 
measures ANOVA showed there to be a significant treatment effect (P<0.01).
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7.9.5 Plasma GLP-1 results
Plasma GLP-1 concentrations after consumption o f the control or the two onion 
meals are illustrated in figure 7.8. Two-factor repeated measures ANOVA showed that 
there was neither a significant treatment effect nor a treatment by time interaction on 
GLP-1 concentrations. There were also no significant differences in the TAUC or lAUC  
from 0 to 30 minutes or from 30 to 90 minutes.
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Figure 7.8: Plasma GLP-1 concentrations following consumption o f either control, 
white onions or yellow onions. Results are expressed as mean ± SEM (N=8). There 
were no significant differences between control and treatments
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Table 7.2: Total (TAUC) and Incremental (lAUC) integrated responses for glucose, 
insulin, GIP and GLP-1 from 0 to 30 minutes following consumption o f either control, 
white onions or yellow onions
Control White onions Yellow onions
Total integrated responses
(TAUC)
Plasma glucose (mmol/L.min) 177.8 (6.0)' 154.7 (4.3)^ 142.0 (3.1)'
Plasma insulin (pmol/L.min) 7906 (1489)' 5765 (1433)'’'^ 3696 (717)'’
Plasma GIP (pmol/L.min) 3969 (449)' 1800 (277)'’ 1480 (209)'’
Plasma GLP-1 (pmol/L.min) 717.5 (120.9) 737.7 (169.8) 552.0 (103.3)
Incremental integrated responses
(lAUC)
Plasma glucose (mmol/L.min) 37.6 (5.5f 16.3 (5.6)'’ 7.4 (2.7)'’
Plasma insulin (pmol/L.min) 5876 (1289)' 3507 (1214)'’ 2099 (583)'’
Plasma GIP (pmol/L.min) 2141 (250)' 94 (28)'’ 251 (94)'’
Plasma GLP-1 (pmol/L.min) 94.5 (143.1) 15.9 (33.8) -26.4 (13.0)
'^Statistical analysis was performed using a one-w ay A N O V A  with a T ukey’s post hoc test w hen P <0.05. 
Results are expressed as mean ±  SEM  (N =8)
" M eans not sharing a com m on superscript are significantly different at P<0.05
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Table 7.3: Total (TAUC) and Incremental (lAUC) integrated responses for glucose, 
insulin, GIP and GLP-1 from 30 to 90 minutes following consumption o f either control, 
white onions or yellow onions'^ '^
Control White onions Yellow onions
Total integrated responses
(TAUC)
Plasma glucose (mmol/L.min) 321.8 (16.0) 299.5 (12.4) 291.3 (8.7)
Plasma insulin (pmol/L.min) 11320 (2277)' 9177 (1453)'*'’ 7529 (966)*’
Plasma GIP (pmol/L.min) 7209 (852)' 3347 (488)'’ 3091 (348)'’
Plasma GLP-1 (pmol/L.min) 1144 (293) 1469 (311) 1092 (210)
Incremental integrated responses
(lAUC)
Plasma glucose (mmol/L.min) 41.3 (14.6) 72.0 (16.3) 22.0 (10.4)
Plasma insulin (pmol/L.min) 7261 (2086) 4662(1145) 4333 (614)
Plasma GIP (pmol/L.min) 3552 (565)' -64.9 (336)'’ 633 (226)'’
Plasma GLP-1 (pmol/L.min) -102.0 (402) 25.6 (67.8) -64.5 (49.4)
'^Statistical analysis was performed using a one-w ay A N O V A  w ith a T ukey’s post hoc test w hen P <0.05. 
Results are expressed as mean ±  SEM  (N =)
M eans not sharing a com m on superscript are significantly different at P<0.05
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7.10 Discussion
Previous work in this thesis using an in vivo rat model has demonstrated an 
effect, albeit a small and transient one, o f  quercetin glucosides on delaying the transport 
o f an intragastrically administered glucose load. It was therefore also o f  interest to 
quantify their possible effects as they exist within the food matrix, on glucose tolerance 
and subsequent hormone secretion in humans. This type o f  study would establish the 
magnitude o f  their effects as part o f the human diet and assess whether or not these 
effects are physiologically relevant. The production o f iso-genic onion lines that differ 
only marginally in composition except for their quercetin glucoside contents offered 
excellent material to perform such a study.
The feeding o f  the onion meals relative to the control showed that there were 
significant differences in glucose absorption as observed in the changes in plasma 
glucose profiles over time. Plasma glucose concentrations reached significantly higher 
values after consumption o f the control compared with both the white and yellow  
onions. These results were not unexpected since the control in this instance consisted 
purely o f a 25 g bolus o f glucose in 400 ml o f water which as a carbohydrate source, is 
very easily absorbed. It could be argued that this was not a representative control for 
this type o f  study due to the complete lack o f fibrous tissues that naturally occur in plant 
foods. However, given the complexity o f  the total carbohydrate composition and non- 
digestible cell wall polymers that exist within onions (Ng et al, 1998; Jaime et al, 2002) 
a perfectly matched control would have been too difficult to prepare on a nutrient for 
nutrient basis. Hence, the term control is used for consistency with other studies 
reported here and elsewhere and was included purely to illustrate the magnitude o f  effect 
that plant fibre has on glucose absorption. However, it should be noted that despite the 
big differences in glucose absorption between the glucose drink and the onion meals, 
there were also significant differences between the two onion meals, with an attenuation 
in plasma glucose concentrations observed after consumption o f  the high-quercetin, 
yellow onions compared with the low-quercetin white onions. Furthermore, this
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significance still held when a direct comparison was made for the TAUC response 
between just the yellow and white onions (P<0.01).
In addition to this, the consumption o f both white and yellow onions caused a 
significant reduction in the postprandial secretion o f GIP when compared with the 
glucose control. A  statistical comparison o f all three sets o f  data would suggest that this 
was merely due to the effects o f  the onion fibre since no differences were observed 
between the high and low quercetin onions. The ratio o f soluble to insoluble dietary 
fibre in onions has been shown to be higher than that o f many other vegetables (Jaime et 
al, 2002). The consumption o f  onions could therefore be considered beneficial since 
soluble dietary fibre has previously been shown to reduce postprandial glucose and 
insulin levels when consumed with a carbohydrate meal (Jenkins et al, 1978). 
However, a direct comparison o f the GIP data between the white and yellow onions 
showed that GIP secretion was significantly attenuated after consumption o f  the high- 
flavonoid yellow onions. The postprandial secretion o f GIP is stimulated by the active 
absorption o f  glucose from the gut (Sykes et al, 1980) and the magnitude o f  the GIP 
response is dependent on the rate o f  absorption o f glucose (Ellis et al, 1995). These 
findings, when extrapolated to this study, strongly suggest that this reduction in GIP 
secretion mediated via an inhibition o f glucose uptake.
It is probable, for two reasons, that the results obtained here are primarily due to 
differences in the intestinal absorption o f  glucose. The first is due to the data obtained 
from the simulated in vitro digestion experiments which indicated that there were no 
differences in the rate o f  release o f  glucose between the white onions and the yellow  
onions. The simulated in vitro digestion technique, adapted from Gee & Johnson 1985, 
provides information as to the rate o f release o f monosaccharides from the digestible 
starch source during the early stages o f  digestion which have been shown to be o f  great 
significance in determining the rate o f increase o f blood glucose in vivo. Given that 
maltodextrin was added to the white onion meals to compensate for the difference in 
glucose equivalents, it is possible that larger amounts o f  glucose would initially be 
detected after in vitro digestion since the maltodextrin should be more bioavailable in
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the first instance. Statistical analysis could not be carried out for this set o f  experiments 
due to an insufficient number o f  replicate measurements, however, the results suggest 
that there was no difference in the rate o f glucose release. This implies that the 
processing o f the yellow onions (i.e. peeling, chopping and cooking) was equivalent to 
that o f  the white onions and that the added maltodextrin was no more readily available 
than the endogenous glucose source.
The second reason for confidence that these results demonstrate the inhibitory 
effects o f  the quercetin glucosides is based on an understanding o f glucose homeostasis 
within the body. Glucose homeostasis is achieved by a coordinated physiological 
response to nutrient ingestion. The observed increase in plasma glucose concentrations 
up to thirty minutes can be attributed solely to the heightened delivery into the 
circulation as a result o f increased intestinal absorption in response to the administered 
load (Frayn 1996). After this time however, the metabolism o f  glucose in the periphery 
will have a significant effect on overall plasma concentrations and thus any differences 
seen from this point on cannot be solely attributed to effects on absorption.
The insulin profiles after ingestion o f  the three test meals almost directly mimics 
the glucose response. However, as with GIP secretion, the significant differences for the 
means o f the insulin concentrations, when a three-way comparison was made, found 
differences only between the control and the yellow onions, with lower concentrations 
observed after consumption o f the latter. The trend observed towards lower plasma 
insulin concentrations after consumption o f the yellow onions compared with the white 
onions (P<0.10) however turned into a significant difference when a comparison o f  just 
the white and yellow onions was made. Like both the glucose and GIP data, these 
results indicate a small degree o f  efficacy o f  the quercetin glucosides as far as inhibition 
o f glucose uptake is concerned.
The secretion o f  insulin occurs not only in response to changes in plasma glucose 
concentrations but also to that o f the incretin hormones; the latter o f  which has shown 
account for up to fifty percent o f  the insulin response observed postprandially (Fuessl et
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al, 1988; Morgan 1990; Tseng et al, 1996). As far as the matrix effects o f  food are 
concerned, Juntimen and colleagues have shown that postprandial insulin responses are 
determined by the form o f food and the botanical structure rather than by the amount or 
type o f  fibre in the food and they postulate that these effects may be mediated through 
GIP and GLP-1 (Juntunen et al, 2002). In this study, given that there were no 
differences in the GLP-1 response and only a small difference was observed in the GIP 
response, this is a likely explanation for the smaller differences seen in the plasma 
insulin response compared with the plasma glucose response.
The fact that dietary fibre is not a well defined component o f  food means that it 
is not unequivocally quantified or characterised and in general plant cell walls w ill vary 
enormously in the structure and composition depending on the species and the type o f  
cells it contains (Ferguson & Harris 2003). In addition to this, pressure cooking, boiling 
and microwaving have all been shown to cause a reduction in the amount o f  dietary fibre 
present in a wide range o f vegetables including onions, with the greatest losses occurring 
after pressure cooking (Rehman et al, 2003). Although, a significant loss o f flavonoid 
content in the pre-processing o f onions (peeling, trimming, and chopping) has been 
shown to occur, no further loss has been observed during cooking, irrespective o f  the 
method used (Ewald et al, 1999).
Taking into consideration the effects that dietary fibre has on the bioavailability 
o f nutrients within the gut, the cooking method o f  plant foods will indirectly affect the 
amount o f  fiavonoids and other nutrients available for absorption in the intestine. Thus, 
it could be that a method previously shown significantly to reduce the amount o f  fibre 
present in a particular food could in fact be an ideal method as far as maximising the 
bioavailability o f  fiavonoids is concerned. However, the effects o f cooking on other 
important nutrients present in a particular food (i.e. water-soluble vitamins) must be 
considered when choosing a cooking method that will maximise the possibility o f  
flavonoid absorption. One must consider whether the possibility o f  increased absorption 
o f  fiavonoids, and indeed hydroxycinnamic acids such as ferulic acid present in wheat 
bran is preferential to the inevitable destruction o f  other beneficial and more prevalent
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nutrient components. Given the low concentrations achieved in the plasma post- 
absorptively, more often than not this is unlikely to be the case.
Whilst their overall effects as part o f the food matrix are relatively small, the 
cumulative effect o f  polyphenol-rich foods, eaten over a lifetime may enable an 
individual to increase their insulin sensitivity. As insulin resistance is widely recognised 
as a major contributory factor in coronary heart disease (Reaven 1988) and other in vivo 
beneficial effects o f  polyphenols are continually being discovered, increased 
consumption o f polyphenol-rich foods may therefore be o f considerable health benefit in 
the prevention o f  cardiovascular and other kinds o f  disease.
7.11 Conclusions
These data obtained from this clinical study suggest that quercetin glucosides at 
concentrations present in onions have the capability o f interacting with intestinal glucose 
transport proteins with consequential effects on glucose uptake, as reflected in the 
postprandial plasma GIP, insulin and glucose profiles.
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Chapter 8 
GENERAL DISCUSSION
In order to investigate the effects o f dietary polyphenols on intestinal glucose 
transport and gastrointestinal hormone secretion, three experimental approaches were 
used. The presentation o f  results in this thesis is such that there is a logical progression 
beginning with a discussion o f  the results obtained from in vitro experiments using a cell 
culture model, followed by the presentation o f data obtained from in vivo studies in 
rodents, and finally concluding with observations obtained from three human feeding 
studies.
However this was actually not the order in which the experiments were carried 
out. The reason for this was based on practical problems with initial experiments 
designed to utilise a specified in vitro protocol, the everted rat gut sac model. Although 
this model provides legitimate results for the measurement o f polyphenol interactions 
with sugar transporters, it proved problematic for the purposes o f  obtaining accurate 
measurements o f  gut hormone secretion. Whether the manipulation o f  the tissue upon 
excision somehow disrupted the integrity o f  the GIF and/or GLP-1 containing cells, or 
whether there was some kind o f interference with the radioimmunoassay (RIA) 
procedure due to a matrix effect caused by the physiological buffers used in these type 
o f experiments is still unknown. Repeated experiments using different types o f  buffers, 
different regions o f the intestine, variations in the incubation times o f  the gut sac, and 
different batches o f antisera still failed to provide any meaningful data. Therefore, 
during this trouble-shooting period, human studies were commenced and from this time 
onwards much o f the experimental work, including further human studies, in vivo rodent 
experiments and some preliminary cell culture studies were performed concurrently.
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8.1 Caco-2 cell culture
The use o f  the Caco-2 cell culture model proved to be a fast and effective method 
for determining the inhibitory effects o f  purified polyphenols on intestinal glucose 
uptake in vitro. It enabled a large number o f  compounds to be tested under both sodium- 
dependent and sodium-Ifee conditions in order to assess the effects o f  polyphenols on 
glucose transport via SGLTl and facilitated glucose transporters.
These experiments for the first time have addressed the effects o f  polyphenols on 
both active and facilitated components o f glucose transport using a well established 
intestinal transport cell culture model. The results for most o f the components tested 
were largely consistent with their predicted activities based on their chemical structures 
(i.e. aglycone interactions with GLUT proteins) or with data previously published using 
other models. This was however, with the exception o f  the phenolic acids which, 
although previously shown to have effects in vitro (Welsch et ah, 1989) had negligible 
effects on intestinal glucose uptake under either sodium-dependent or sodium-ffee 
conditions using this model. Due to the inclusion o f a positive control at all times, it is 
likely that these observed lack o f effects are valid. Furthermore, observations from a 
single experiment using this model to measure any additive effects o f 5-caffeoylquinic 
acid (5-CQA) on phloridzin-attenuated glucose transport, showed no additional effects 
beyond those normally observed with the addition o f  phloridzin alone (results not 
shown). These results indicate that the phenolic acids as a purified subset o f  chemicals 
alone are not bioactive. However, it should be noted that much o f  the published data on 
the effect o f dietary phenolic acids is based on observations using crude extracts (Hsu et 
al, 2000; Andrade-Cetto & Wiedenfeld 2001) and that the presence o f  other 
components, could be responsible for the effects observed, as was observed for example 
in the volunteer study using instant coffee granules.
The inability o f Caco-2 cells to secrete both insulin and the gastrointestinal (GI) 
hormones o f interest, in addition to their lack o f LPH expression (Chantret et al, 1994)
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could be considered a disadvantage to this use o f this in vitro method. It was however 
anticipated on structural grounds that the vast majority o f the compounds tested would 
not interact with LPH, thus making this an acceptable model for generating the high- 
throughput screening data required. Furthermore, the lack o f LPH expression could 
have its advantages under certain circumstances. For example, the effects o f the dietary 
quercetin glucosides on glucose transport using this Caco-2 system were not examined 
in this thesis, but could be further investigated. The effects o f  the quercetin glucosides 
on glucose transport under these conditions are likely to be via their direct interaction 
with glucose transporters due to the absence o f LPH activity. Observations as to the 
extent o f  inhibition caused by these compounds under both sodium-dependent and 
sodium-ffee conditions over the same time period would prove insightful as to the nature 
o f the interaction o f these components with SGLTl and GLUT proteins.
8.2 Intragastric gavage rodent model
The precise nature o f the interaction o f flavonoid glucosides with SGLTl has 
been the subject o f  much research (Gee et al, 1998; Gee et al, 2000; Ader et al, 2001; 
Day et al, 2003). However, few studies have addressed the implications for intestinal 
glucose transport. The use o f  the in vivo rodent model in this project proved a very 
useful and informative tool when observing patterns o f  intestinal glucose absorption 
after the administration o f an oral dose o f glucose containing purified quercetin 
glucosides. Animals were used at a weight (approximately 250 g) which corresponds to 
an age o f  approximately 12 weeks, when the contribution o f LPH can be considered 
since its intestinal expression at this time is still very high (Lee et al, 1997; Goda et al, 
1999). Furthermore, the suggestion that hormone-mediated PKC pil activated rapid 
recruitment o f  GLUT2 to the BBM is responsible for a substantial amount o f  glucose 
uptake that occurs from the lumen o f  the small intestine in vivo but not in vitro (Kellett 
& Helliwell 2000; Helliwell et al, 2000a; Helliwell et al, 2000b) could also be
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indirectly observed since the gut tissue remained intact throughout the duration o f the 
experiment.
It was not possible to determine the transport kinetics o f glucose uptake in these 
experiments given the complex physiology o f  glucose homeostasis in vivo and thus the 
GLUT2-mediated contribution to glucose uptake could not be assessed. However, given 
the high level o f activity o f LPH and the ten times greater affinity o f  quercetin-4’- 
glucoside (Q4’G) for LPH than quercetin-3-glucoside (Q3G) (Day et al, 2003) one 
would expect that the increased liberation o f quercetin aglycone firom Q4’G by LPH 
would cause a greater transient inhibition o f  GLUT-mediated glucose uptake. This was 
however not the case casting doubt that GLUT2 plays a major role in intestinal glucose 
uptake in these circumstances. It is possible that the recruitment and insertion o f  
GLUT2 to the BBM may take longer than the thirty minutes allotted for this set o f  
experiments. Since Helliwell and coworkers in some instances did not measure glucose 
uptake until after the gut had been perfused for up to ninety minutes, this hypothesis 
remains speculative. An alternative explanation to the findings o f  Helliwell et a l is that 
the presence o f GLUT2 at the BBM is a stress-response and that its recruitment to the 
BBM is simply to avoid osmotic effects in the lower regions o f the intestine that would 
be observed under extreme conditions like intestinal perfusion where the intestine is 
exposed to excessively high amounts o f  glucose for an excessive period o f time.
The contribution o f  LPH in this type o f animal model could be addressed by 
comparing whole blood glucose profiles in different aged groups o f animals ranging 
fi*om newly weaned rats (exhibiting high LPH expression) up to 24 month-old rats (low  
LPH expression) (Lee et al, 1997) thus providing greater insight as to the role o f  this 
protein in the lumenal processing o f  flavonoid glycosides.
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8.3 Volunteer studies
Many epidemiological studies have suggested that increased fruit, vegetable, tea 
and wine consumption may help prevent the onset o f some diseases o f ‘Western 
Civilisation’ (e.g. NIDDM and CVD). Until recently, the most often quoted hypothesis 
to account for these effects was that in addition to the well established benefits o f  
various macro- and micro-nutrients, fruits and vegetables also contain other beneficial 
compounds, namely the phenols, polyphenols and tannins that ftinction as protective 
agents as a results o f their antioxidant activity.
However, the increasing literature on the ability o f  polyphenols to alter the pattern 
o f intestinal glucose uptake, in a potentially beneficial manner, through a variety o f  
different mechanisms, prompted the design o f three human intervention studies. These 
aimed to assess the effects o f dietary polyphenols on glucose tolerance and insulin and 
GI hormone secretion when consumed as part o f  a normal diet. Very few data are 
available addressing the effects o f  polyphenol consumption on acute human postprandial 
metabolism. Moreover, the observation o f polyphenol-modulated glucose transport in 
vitro, as seen in both the cell culture and rodent studies, would not necessarily guarantee 
a physiologically significant effect in vivo when a polyphenol is consumed in quantities 
that form part o f a normal diet.
Each polyphenol-rich food or beverage was chosen for a different reason and the 
fact that phloridzin, a widely used potent competitive inhibitor o f  active glucose 
transport, is present naturally in apples and apple products, made apple juice a ideal 
starting point in as far as addressing the possible antagonistic effects o f  dietary 
polyphenols on intestinal glucose transport in volunteers. Secondly, results from in vitro 
work by Welsch et a l,  (1989) showed that 5-CQA caused a major reduction in glucose 
uptake. Coffee is the major source o f 5-CQA in the human diet with coffee drinkers 
consuming 0.5-1.0 g per day (Clifford 1999) thus making coffee another good choice. 
Both apples and coffee contain other polyphenols (e.g. quercetin-3-glucoside, (+)- 
catechin and (-)-epicatechin, 5-CQA in apples and 3-CQA, 4-CQA,/?CoQA and FQA in
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coffee), which have also been shown to attenuate glucose uptake in a variety o f models. 
This made it difficult to attribute any effects on glucose transport to any one specific 
phenolic component. However, the final volunteer study provided an opportunity to use 
selectively bred strains o f  iso-genic onions differing only in flavonoid content. This 
meant that the efficacy o f  the widely studied quercetin glucosides on delaying glucose 
uptake could be assessed in the presence o f dietary fibre, a naturally occurring 
component for which the favourable effects in terms o f  delaying glucose uptake have 
been repeatedly reported. Thus, an important difference between the first two studies 
compared with the final study was that the use o f  the onions as a treatment allowed for 
an assessment o f  the effects o f specific polyphenols, whereas this was not possible in the 
first two studies. Furthermore, it also takes into consideration the effects o f  the solid- 
fbod matrix, an important determinant in the bioavailability o f nutrients.
Results from these studies showed that the postprandial secretion o f  GIF was 
significantly attenuated in the all three studies, indicating an inhibitory effect o f  
polyphenols in commercial apple juice, instant coffee granules and quercetin glucosides 
in iso-genic onions when compared with the control. The extent o f  the GIF response is 
dependent on the rate o f absorption o f  glucose (Ellis et al, 1995) and thus these findings 
strongly suggest that this reduction in GIF secretion is mediated via an inhibition o f  
glucose uptake. There was a significant decrease in GIF secretion after consumption o f  
both the high and low quercetin onions compared with the control, these effects being 
almost wholly mediated by the fibre content o f  the onions. However, when a comparison 
between just the two onion types were made, there was still a significant reduction in 
GIF secretion after consumption o f the yellow onions indicating a role for the quercetin 
glucosides in this process.
The absorption o f a 25 g bolus o f glucose, as measured by a delay in the appearance 
o f  glucose in plasma, was also significantly attenuated by the concurrent consumption o f  
apple juice and iso-genic onions. This suggests that polyphenols at normal dietary 
levels, have the ability to inhbit glucose transport, almost certainly via an SG LTl- 
mediated mechanism (as measured by differences in plamsa GIF profiles) but perhaps
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also via a GLUT2 mediated mechanism, if  indeed this is a transport process that occurrs 
at the BBM.
Furthermore, very similar changes were observed when plasma insulin profiles 
when measured to those for glucose tolerance, both in profile and magnitude. These 
results were not unexpected since changes in the secretion o f  insulin are stimulated by 
both increased circulating concentrations o f  glucose and incretin gut factors.
There were small differences in glucose profiles after consumption o f the 
caffeinated coffee compared with the control, which were mimicked in the insulin 
responses. As previously explained in chapter six, these systemic changes are likely to 
be due to the powerful effects o f caffeine and thus overall effects o f  CGA on glucose 
tolerance and the insulin response appear to be very small. However, the significant 
decrease in the secretion o f  GIF and significant increase in the secretion o f  GLF-1 after 
consumption o f the decaffeinated coffee compared with the control strongly suggest that 
CGA in coffee are capable o f  exerting physiological effects at the BBM.
GLF-1 secretion after consumption o f apple juice was modified in a similar manner 
to that after consumption o f  coffee indicating a suppression o f  upper intestinal glucose 
uptake. There were no differences in the secretion o f GLF-1 between any o f  the three 
treatments in the onion study which again we attribute to the high amounts o f  dietary 
fibre, but also to the poor sensitivity o f the GLF-1 RIA at the lower end o f  the standard 
curve, the region in which all o f  the experimental values fell.
The term metabolic syndrome refers to a sometimes lethal group o f  
atherosclerotic risk factors including obesity, hypertension and insulin resistance which 
are associated with increased risk for CVD and related mortality. The attenuation o f  the 
post-prandial increase in plasma glucose is desirable both with regard to Type II diabetes 
and insulin sensitivity (Ludwig 2002). As insulin resistance is widely recognised as a 
major contributory factor in coronary heart disease (Reaven 1988) and the beneficial 
effects o f polyphenols are now better established, increased consumption o f  polyphenol-
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rich foods like fruit and vegetables may therefore be o f considerable health benefit in the 
prevention of cardiovascular disease. Furthermore, these beneficial effects are 
independent of any antioxidant properties. The acute effects o f individual polyphenol- 
rich foods are relatively small; however, their cumulative effects, eaten over a lifetime 
may well confer a long-term benefit, particularly in terms o f increased insulin 
sensitivity. Postprandial hyperglycaemia has recently been recognised as an important 
risk factor in CVD and the beneficial effects of a low glycaemic index diet have been 
shown (Jenkins et al, 1981).
8.4 Concluding remarks
This thesis has addressed the hypothesis that dietary polyphenols inhibit intestinal 
glucose uptake and has presented results in support of this obtained through the use of in 
vitro studies, in vivo rodent studies, and volunteer studies. Although the effects o f these 
compounds in humans are small, the relevance of such interactions when a mixture of 
real foods are consumed at normal dietary levels may cause additive effects which could 
confer a real benefit when consumed over a lifetime. This information may aid health 
professionals in the formulating more suitable diets for those individuals who would 
benefit long term from a lower glycaemic diet. Commercial food processing o f plants 
often generates large amounts of waste, some of which is rich in dietary phenols and the 
use of these compounds has possible potential as food supplements. Information as to 
the efficacy o f different combinations of these compounds may assist industry in the 
formulation of food products that will provide long-term benefit to the nation’s health.
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8.5 Future Work
Although the work carried out in this thesis has yielded some interesting results, it 
still leaves many questions unanswered. Recommendations for future work to better 
understand the mechanisms whereby dietary polyphenols modulate intestinal glucose 
absorption are as follows:
1. To use high-throughput screening to test the potential o f  polyphenols, isolated from 
fruit juices and coffee extracts by preparative HPLC, to modify both SGLTl and 
GLUT-mediated glucose uptake in vitro, using Caco-2 cells.
2. To investigate the role o f  LPH in polyphenol modulated glucose uptake (especially 
that o f the glucosides) by comparing glucose uptake in the presence o f  polyphenols 
in a lactase deficient Caco-2 subclone (TC7 cells) with TC7 cells stably transfected 
with human LPH.
3. To investigate the role o f LPH in vivo in rodents by using different-aged groups o f  
animals showing decreased LPH expression with increasing age thus allowing an 
assessment o f  the contribution o f  this enzyme to the intestinal processing o f  these 
compounds.
4. To investigate in healthy volunteers the effects o f  consuming a mixed meal o f  high 
polyphenolic content, on glucose tolerance, insulin secretion and secretion o f  
gastrointestinal hormones thereby establishing whether the combination o f  certain 
foods will have an additive effects in the modulation intestinal glucose transport and 
insulin secretion.
5. To evaluate the role o f LPH and intestinal glucose transporters in polyphenol 
modulated glucose absorption, by comparing groups o f volunteers who have i) 
intestinal LPH activity present (both Caucasian and non-Caucasian) ii) intestinal
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lactase deficiency (non-Caucasian) and iii) raised SGLT-1 and GLUT-2 activity (i.e. 
individuals with NIDDM)
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Appendix I
Flavonoid and chlorogenic acids contents of analysed iuices(ug/ml)1415
Clear apple juice
Juice Catechin Epicatechin Phloretin Xyloglucoside Phloridzin Phloretin 5CQA 4pCoQA
1 0.93 n.d. 4.27 5.75 n.d. 28.61 6.46
2 0.41 0.03 5.51 6.90 n.d. 39.06 9.61
3 1.17 0.24 8.44 7.34 n.d. 53.45 15.18
4 1.54 0.45 6.39 6.05 n.d. 47.28 15.03
5 0.23 n.d. 3.13 9.84 n.d. 36.97 8.10
6 0.70 n.d. 4.99 5.73 n.d. 38.16 11.27
7 0.21 n.d. 3.94 11.94 n.d. 43.50 10.08
Mean 0.74 0.24 5.24 7.65 41.00 10.82
STDEV 0.50 0.21 7.77 2 3 7 7.P& 3.30
Cloudy apple juice
Juice Catechin Epicatechin Phloretin Xyloglucoside Phloridzin Phloretin 5CQA 4pCoQA
1 2.81 n.d. 17.72 14.35 n.d. 214.89 40.74
2 2.19 n.d. 12.70 5.88 n.d. 63.51 15.61
3 4.52 0.49 17.23 11.57 n.d. 72.09 13.25
4 5.92 n.d. 17.46 7.60 n.d. 191.30 33.79
5 0.59 1.59 4.09 4.06 n.d. 160.61 16.50
6 11.09 0.46 11.60 11.44 n.d. 142.74 21.06
7 0.69 n.d. 17.46 25.52 n.d. 123.41 24.11
8 1.85 n.d. 6.68 5.58 n.d. 121.11 20.01
9 1.21 n.d. 26.20 27.32 n.d. 146.49 38.29
Mean 3.43 0.85 14.57 12.59 137.35 24.82
STDEV 3.37 0.65 6.65 &J3 10.25
n.d. means below the limit of detection
Numbers in bold were those juices used in the volunteer study
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Appendix II
Total caffeovlquinic acid contents of analysed coffee granules (mg/g) 
Caffeinated coffee granules
16
3 C Q A 4 C Q A 5 C Q A Total CQA
1 7.58 8.59 11.65 27 .82
2 2.45 2 .77 3.30 8.53
3 8.29 8.69 14.02 31.00
4 9.44 9.61 16.64 35.68
5 6.65 6.53 9.78 22 .96
6 4 .89 4.91 7.39 17.18
7 5.24 5.54 7.42 18.20
8 4 .99 5.41 6.98 17.38
9 10.60 10.65 19.96 41.22
M e a n 6 . 6 8 6 . 9 7 1 0 . 7 9 2 4 . 4 4
S t d e v 2 . 5 6 2 . 5 7 5 . 2 9 1 0 . 3 6
Decaffeinated coffee granules
3 CQA 4 CQA 5 CQA Total CQA
1 5.41 6.44 8.06 19.91
2 7.72 8.93 11.54 28 .19
3 6.62 7.99 9.58 24 .19
4 5.88 6.48 8.82 21 .18
5 6.47 6.85 10.24 23 .56
6 8.26 9.27 11.91 29 .44
M e a n 6.73 7.66 1 0 . 0 3 2 4 . 4 1
S t d e v 1 . 0 9 1 . 2 5 1 . 5 1 3 .7 7
Numbers in bold  w ere those coffees used in the volunteer study
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